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Abstract 
The focus of the novel research reported in this thesis is the labelling of nucleic acids 
by catalyst-free 1,3-dipolar cycloaddition reactions.  Both nitrile oxide-alkyne 
cycloadditions (NOAC) and strain-promoted azide-alkyne cycloadditions (SPAAC) were 
explored.   
The possiblitity for ‘pre-synthetic’ functionalisation was demonstrated using non-
nucleosidic phorphoramidite building blocks generated by NOAC.  Three isoxazole 
phosphoramidites were prepared.  Following in situ generation of the nitrile oxides 
from 1,2-, 1,3- or 1,4-disubstituted hydroxyethoxybenzaldehyde oximes and highly 
regioselective cycloadditions to a simple alkyne, the isomeric isoxazoles were obtained 
in excellent yields.  Functional group interchange of the pendant hydroxy group to a 
phosphoramidite functionality facilitated coupling to DNA both by manual and 
instrument controlled solid phase DNA synthesis. 
Photoresponsive DNA, incorporating isomeric isoxazole-linked azobenzene moieties, 
was prepared by ‘post-synthetic’ modification of alkyne-functionalised 
oligonucleotides by NOAC.  The compatibility of the azobenzene functionality with 
NOAC protocols was first confirmed with small molecule examples; the resulting 
cycloadducts were characterised by NMR spectroscopy and mass spectrometry (MS).  
Oligonucleotides incorporating azobenzene moieties at either the 5’- or the 3’- termini, 
or at an internal position, were subsequently synthesised and the photochemical and 
kinetic properties of selected examples were determined.  A relationship was found 
between the thermodynamic and photochemical properties of the modified 
oligonucleotides and the substitution pattern on the aryl rings of the azobenzene 
moiety. 
DNA and 2’-OMe RNA sequences conjugated to a variety of chemically and biologically 
significant ligands were prepared by solid-phase SPAAC.  A strained-cyclooctyne 
phosphoramidite was first conjugated to the 5’-terminus of oligonucleotides.  Several 
azide labels were prepared, including benzyl, cinnamyl, biotinyl, cholesteryl and 
fluoresceinyl.  Conjugation was clean and efficient in all cases.  Oligonucleotides were 
characterised by HPLC and MALDI-TOF MS. 
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1.1 Introduction 
Ever since the elucidation of the structure of DNA by Watson and Crick,1  the iconic 
double helix is an image that resonates with people from all walks of life.  In the 
decades since, the role of nucleic acids in the storage and transmission of genetic 
information has become a hugely popular research topic.  In light of recent 
breakthroughs in the fields of genetics and molecular biology including the mapping of 
the human genome and the discovery of the potential therapeutic value of RNA 
interference (RNAi) pathways, there is a demand for research at the interface of 
chemistry and biology to help in bringing molecular advances to their full clinical 
potential. 
 
1.1.1 Structure of DNA and RNA 
DNA is made up of four structurally related monomers called nucleosides: adenosine, 
cytidine, guanosine and thymidine (figure 1.1).  Each consists of a sugar portion 
(deoxyribose) and a heterocyclic base portion.  Adenosine and guanosine possess a 
purine-type base (adenine and guanine), whereas in cytidine and thymidine the base 
(cytosine and thymine) is of the pyrimidine type.    
 
Figure 1.1.  The four canonical DNA nucleosides 
These monomer building blocks are linked together, in various combinations, via a 
phosphodiester linkage involving the oxygen atoms at the 3’ and 5’ carbons of adjacent 
sugar units to form individual strands of DNA.  Consequently, each strand of DNA 
possesses a free hydroxy group at either end, one borne on a 5’-carbon and the other 
on a 3’-carbon.  As such, sequences of DNA are read in a 5’ to 3’ (more common) or a 
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3’ to 5’ direction, e.g. the shorthand for the sequence shown in figure 1.2 is 5’-TCAGA-
3’. 
 
Figure 1.2.  A 5-mer sequence of DNA, highlighting the phosphodiester linkages and the 
terminal 5’- and 3’- hydroxy groups 
In the cellular environment it is rare to encounter DNA in its single-stranded form.  
DNA strands form stable duplexes via regular, predictable hydrogen bonding between 
the nucleoside bases on adjacent strands.  Guanine pairs with cytosine via three 
hydrogen bonds, whereas adenine pairs with thymine via two hydrogen bonds; the 
two strands wind around each other to form a double helix (figure 1.3).   
 
 
Figure 1.3.  (a) Base-paring between purine and pyrimidine bases; (b) The double helical 
structure of DNA2 
(b) (a) 
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RNA closely resembles DNA in structure, yet there are a few key differences between 
the two.  The sugar unit of RNA nucleosides (ribose) bears an extra hydroxyl group at 
the 2’-position (figure 1.4).  The 3’-OH is not involved in the phosphodiester backbone; 
it remains ‘free’ and has the potential to act as a nucleophile.  This additional reactivity 
renders RNA significantly less stable than DNA.  In addition, in RNA the base thymine is 
replaced with uracil, which differs only in the absence of a methyl group.  Finally, 
unlike DNA, RNA most commonly exists in cells in its single stranded form, although 
different sections of longer strands may base-pair with each other to form looped 
regions.  Noteworthy examples of double-stranded RNA (dsRNA) include certain 
viruses, which possess dsRNA genomes, and short interfering RNAs (siRNA), which are 
key components of the RNA interference pathway. 
 
 
Figure 1.4.  The four canonical RNA nucleosides 
 
1.2 RNA interference 
The discovery that gene expression in living cells can be controlled by base-pairing 
between small sequences of RNA and messenger RNA (mRNA) has ushered in a 
revolution in RNA biology.  The role of RNAi in eukaryotic cells involves defence against 
parasitic genes (e.g. from viruses) in addition to regulation of the expression of 
endogenous genes.  The diagnostic and therapeutic potential of RNAi first became 
apparent in the late 1990s when Craig C. Mello and Andrew Fire published their 
seminal report describing the selective control of gene expression following the 
introduction of exogenous RNA into C. Elegans.3   
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The mechanism of RNAi can be broken down into several steps, as shown in scheme 
1.1.4,5  Firstly, a long sequence of dsRNA, which may be exogenous or endogenous in 
origin, is cleaved into small RNA duplexes known as small siRNA by the RNase III 
enzyme Dicer.  Secondly, these siRNA segments are unwound, and one of the strands 
is preferentially taken up into the RNA-induced silencing complex (RISC).  The complex 
then searches the transcriptome for complementary sequences of messenger RNA 
(mRNA).  Finally, the siRNA-derived, single-stranded RNA (ssRNA) of the RISC complex, 
known as the guide strand, directs the enzymatic component of the RISC complex, an 
Argonaute protein, to cleave the complementary sequence of mRNA.   
 
Scheme 1.1.  The RNA interference pathway 
RNAi has emerged as a powerful tool for research in molecular biology, which exploits 
its selective and robust ability to effect gene knockdown.  The ability to selectively 
‘cancel out’ genes thought to have a role in a particular cellular process can be 
invaluable in determining the physiological role of particular gene products.  Studies 
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involving the model organisms C. Elegans and Drosophila have benefited greatly from 
this approach, and consequently the genes involved in many crucial biological 
pathways such as aging,6 cell cycle regulation7 and specific signalling pathways8 have 
unambiguously been identified. 
It is now commonplace for applications which exploit RNAi to employ chemically 
modified siRNAs.9  Due to the relatively small size of siRNAs (~21-25 nucleotides in 
length), chemical synthesis of exogenous sequences is straightforward, and allows 
various chemical modifications to be introduced.  Modifications are generally intended 
to increase stability, promote efficacy, or block binding to unintended targets.  Since 
the 2’-OH group of the sugar is not required for active RNAi,10 many modifications 
have been incorporated at this position. 2’-O-Methyl derivatives have been widely 
used; this modification significantly increases the stability of the sequence towards 
RNA digesting enzymes.11  Increasing the half-life of small RNAs is of obvious 
importance for RNAi therapeutics, which must survive long enough in vivo to reach 
their site of action.  Cellular uptake is another hurdle which must be overcome.  Owing 
to their size and high density of negative charge, siRNAs cannot easily cross cell 
membranes.  In this regard, modifications involving conjugation to lipophilic moieties 
such as cholesterol have proven useful.12 
 
1.3 Nucleic acid modification 
Applications which rely on the manipulation of oligonucleotides are not only limited to 
molecular research, genetic and therapeutic spheres; the reliable and predictable 
nature of base pairing between complementary strands of DNA has been exploited in 
the formation of two- and three- dimensional nanostructures.13  In these cases the 
DNA scaffold is functionalised with groups which can impart new electrical14,15 
magnetic,3,16 or light transporting17 properties, which are useful for the construction of 
nanowires.  DNA based asymmetric catalysis exploits the chiral nature of the double 
helix to facilitate enantioselective reactions between small molecules.18  Diagnostic 
applications require the conjugation of small molecules such as fluorescent dyes, e.g. 
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fluorescein,19 affinity tags, e.g. biotin,20 or other biomolecules, e.g. carbohydrates21 or 
peptides.22 
 
1.3.1 Solid phase oligonucleotide synthesis 
1.3.1.i Introduction 
Chemically prepared oligonucleotides can be obtained from solid phase synthesis.  The 
methodology most commonly employed involves phosphoramidite coupling chemistry 
to build sequences of up to ~250 nucleotides in length,23 and can be fully automated.  
In a typical procedure, the starting material is a commercially available nucleoside 
which has its 5’-OH group protected with a dimethoxytrityl (DMT) moiety, and is 
covalently linked to a resin, e.g. controlled-pore glass (CPG), by way of a linker 
attached at its 3’-hydroxy group.  One common linker consists of a succinyl moiety 
conjugated by means of an amide bond to a long-chain amino alkyl (LCAA) group, 
which is itself bound to the CPG support.  The key building blocks are nucleoside 
phosphoramidites, which are DMT protected at the 5’-position and bear a reactive 
phosphoramidite group at the 3’-position [figure 1.5 (a)].  
With the exception of thymine, the heterocyclic base portion of each nucleoside is 
nucleophilic, and protection is necessary prior to oligonucleotide synthesis.  The 
commercially available nucleoside phosphoramidites are available with protecting 
groups pre-installed.  Adenine and cytosine are typically protected with an acetyl (Ac) 
or benzoyl (Bz) group, while dimethylformamidyl (dmf) or isobutyryl (iBu) protected 
guanine is commonly used [figure 1.5 (b)].  The phosphorus (III) atom of the 
phorphoramidite group is also protected with a 2-cyanoethyl (CNE) group.  
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Figure 1.5.  (a) General structure of a CPG-bound nucleoside and the structures of the four 
canonical deoxynucleoside phosphoramidites; (b) Common base protecting groups 
Different resin pore sizes are available depending on the nature of the synthesis; 500 Å 
CPG is most suitable for the preparation of short (< 20 bases) sequences.  Larger pore 
sizes of 1000 Å (20-80 bases) and 3000 Å (> 80 bases) can be used for larger scale 
syntheses.  Many suppliers also offer different loadings of the nucleoside on the resin, 
these typically range from 15-100 µmol/g.  
 
1.3.1.ii Synthetic cycle 
Each cycle of oligonucleotide synthesis can be divided into four steps. 
Step 1: Deblocking.  The DMT protecting group is removed with a solution of acid 
(typically 2% trichloroacetic acid (TCA) in DCM).  Immediately following exposure to 
the acid, an intense orange colour is observed as a result of the generation of the DMT 
cation.  Many automated syntheses quantitatively detect the release of this 
chromophore at the beginning of each cycle to monitor the efficiency of coupling. 
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Scheme 1.2.  First step of oligonucleotide synthesis – deblocking 
Step 2: Coupling.  The support-bound, 5’-deprotected nucleoside is exposed to a 
mixture of an acidic azole catalyst, e.g. 5-benzylmercapto-1H-tetrazole (BMT), and a 
solution of the second nucleoside bearing a phosphoramidite functionality at the 3’-
position, which is in excess.  The reaction solvent is anhydrous CH3CN.  Initial 
protonation of the isopropylamine group is followed by nucleophilic substitution with 
the BMT anion, thus activating the phosphoramidite moiety.  Coupling then occurs 
between this activated phosphoramidite and the 5’-OH group of the CPG-nucleoside, 
forming a phosphite triester linker.  Coupling is usually very rapid (~30 s), and once 
complete, all excess reagents are removed by washing. 
 
Scheme 1.3.  Second step of oligonucleotide synthesis – coupling 
Chapter 1  Introduction 
10 
 
Step 3: Capping.  After each coupling step, a small amount (< 1%) of the resin-bound 
nucleoside/oligonucleotide may remain unreacted.  The unreacted 5’-OH groups can 
potentially undergo further chain elongation in subsequent steps of the synthesis, 
leading to oligonucleotides with internal base deletions.  Accumulation of these 
‘mutations’ at each step can lead to a complex mixture of oligonucleotides.  In order to 
avoid this, the free 5’-OH groups are capped after each coupling step.  Capping 
involves exposure to a mixture of acetic anhydride and 1-methylimidazole.  Acetylation 
of the OH group prevents further chain growth. 
Scheme 1.4.  Third step of oligonucleotide synthesis - capping 
Step 4: Oxidation.  The P(III) phosphite triester group formed during coupling is 
unstable under the acidic conditions necessary for the deblocking step which initiates 
the next synthetic cycle.  To overcome this problem, iodine oxidation in the presence 
of H2O and pyridine is conducted, leading to a P(V) species.  The resulting 
phosphotriester retains the CNE protecting group to ensure no reactions occur at 
phosphorus during subsequent synthetic cycles.   
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Scheme 1.5.  Fourth step of oligonucleotide synthesis – oxidation 
Upon completion of steps 1-4, the next cycle can begin by deblocking the 5’-O-DMT 
group of the previously coupled nucleoside.   
 
1.3.1.iii Pre- and post-synthetic modifications 
In addition to the canonical nucleosides functionalised with a phosphoramidite group, 
modified nucleosides bearing a label on either the sugar or the base portion can be 
incorporated into oligonucleotides in a similar manner.24,25  Non-nucleosidic 
phosphoramidites can also be introduced in this way,26 thus providing a means of 
incorporating quite different functionalities into the backbone of the sequence.  The 
introduction of modified monomers into an oligonucleotide to yield a labelled 
sequence as the final product is known as pre-synthetic modification.  A general 
representation of the pre-synthetic modification of an oligonucleotide sequence, 
involving preparation of a labelled nucleoside phosphoramidite by click chemistry (see 
section 1.4), is given in scheme 1.6.  While the potential to fully automate site specific 
modification of oligonucleotides is appealing, there are many cases in which this 
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approach is compromised by poor coupling yield and/or extended coupling times for 
the introduction of the modified phosphoramidite(s).  This can lead to problems 
downstream where oligonucleotide purification is required. 
 
Scheme 1.6.  Pre-synthetic modification of an oligonucleotide. 
Post-synthetic modification of oligonucleotides adopts a similar approach to the pre-
synthetic strategy; however, conjugation of the label of interest takes place after 
oligonucleotide synthesis is complete.  Smaller, less disruptive modifications, e.g. 
alkynes,27 are introduced into the sequence during automated synthesis; the small size 
of these groups means that coupling efficiency is not significantly reduced.  The label 
of interest, bearing a complementary reactive group, e.g. an azide,27 is conjugated to 
the functionalised oligonucleotide after the sequence has been assembled.  A general 
representation of post-synthetic oligonucleotide modification is shown in scheme 1.7. 
 
Scheme 1.7.  Post-synthetic modification of an alkyne modified oligonucleotide 
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1.3.1.iv Cleavage and deprotection 
Once the required oligonucleotide sequence has been prepared and the desired 
modifications have been introduced, cleavage from the solid support is necessary to 
obtain a solution of DNA/RNA for analysis or further application.  Treatment with an 
aqueous solution of a base such as ammonium hydroxide or methylamine affords the 
cleaved oligonucleotide by hydrolysis of the ester linkage of the succinyl group 
(scheme 1.8). 
 
Scheme 1.8.  Final step - oligonucleotide cleavage from the solid support 
Base deprotection and removal of the CNE moiety used to protect the phosphate 
groups usually occurs in tandem with cleavage from the resin; the mechanism of 
removal of the CNE moiety is shown in scheme 1.9(a).  A typical deprotection/cleavage 
procedure involves incubation in 40% aqueous MeNH2 for 30 min at 65 
oC.  However, 
certain chemically modified oligonucleotides may be sensitive to these conditions.  In 
such cases, use of more labile or ‘ultramild’ base protecting groups can facilitate milder 
deprotection following incubation in methanolic potassium carbonate at room 
temperature for 3 hr.28  Popular examples of these ultramild protecting groups include 
phenoxyacetyl (Pac), isopropyl phenoxyacetyl (iPr-Pac) and Ac groups for adenosine, 
guanosine and cytosine bases respectively [scheme 1.9 (b)]. 
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Scheme 1.9.  (a) Deprotection of the phosphate group; (b) The ‘ultramild’ protecting groups 
Pac, iPr-Pac and Ac 
 
1.3.2 Enzymatic synthesis of modified nucleic acids 
It is very difficult, or indeed impossible, to prepare densely functionalised sequences of 
DNA or RNA of > 50-60 nucleotides in length by the incorporation of modified 
phosphoramidites during chemical synthesis (see section 1.3.1.iii).29  On the other 
hand, DNA and RNA polymerase enzymes have been shown to incorporate 
modifications into sequences up to 500 nucleotides in length.30-33  A general approach 
to the preparation of long sequences of functionalised DNA is shown in scheme 1.10.  
In addition to a template sequence from which the strand to be synthesised is read, 
this technique requires a primer sequence from which to begin polymerisation.  The 
length of the new, modified sequence is determined by the length of the template 
strand, which may be a gene segment,30 or a synthetic sequence prepared by solid 
phase synthesis.31  Nucleoside triphosphates (NTPs) are required as the monomeric 
building blocks; for modified NTPs, those which incorporate the modification at the 5-
position of pyrimidines bases or at the 7-position of purine bases are found to be well 
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tolerated by DNA polymerases.29  Although incorporation of modified NTPs bearing 
larger labels is frequently unpredictable, incorporation of smaller functional groups, 
e.g. azides, alkynes, is well tolerated.34,35  Subsequent post-synthetic modification of 
these functionalised sequences can yield long sequences of densely labelled DNA.27 
 
Scheme 1.10.  Synthesis of modified DNA using a primer-template system and one modified 
NTP 
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1.3.3 Modified oligonucleotides by click chemistry 
A range of chemical reactions have been exploited for the conjugation of different 
labels to nucleic acids.  These include the Diels-Alder cycloaddition,36 the Staudinger 
ligation37 and and the Huisgen 1,3-dipolar cycloaddition.38 These may be employed at 
the post-synthetic stage, or indeed for the preparation of modified nucleosides for use 
in pre-synthetic modification.  Those reactions classified under the umbrella of ‘click 
chemistry’, a concept first outlined by Sharpless in 2001, have enormous potential for 
the modification of oligonucleotides, and will be discussed in more detail in the 
following sections. 
 
1.4 Click chemistry 
1.4.1 Introduction 
The drive towards efficient, green syntheses has gathered significant momentum over 
the past decade.  In addition to stricter environmental controls from regulatory bodies, 
pharmaceutical manufacturers also strive to lower the costs associated with the 
discovery, development and large scale production of drugs.  Thus, any chemical 
philosophy which places an emphasis on efficient, environmentally friendly 
transformations has widespread appeal. 
Since its inception by Sharpless in 2001,39 the click chemistry ideology has attracted 
huge interest.  Acknowledging that the ultimate goal of synthesis is not necessarily the 
production of compounds, but the production of properties, click chemistry focuses on 
the application of simple existing chemical strategies to the construction of complex 
structures by linking together small, modular building blocks.  For a reaction to be 
considered a ‘click’ reaction, it must fulfil a set of criteria, many of which place an 
emphasis on green principles.  These reactions must be wide in scope, modular, 
generate only inoffensive, easily removable by-products, and give reaction products in 
very high yields and with excellent control of stereoselectivity.  Click reactions are 
further characterised by simple reaction conditions, benign solvent, or indeed no 
solvent at all, readily available starting materials and simple product isolation.  Click 
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reactions should be thermodynamically favourable, and selective for the formation of 
a single product.  
The most common click reactions result in the formation of carbon-heteroatom bonds.  
Reactions include substitution reactions, e.g. ring opening of strained heterocycles 
such as epoxides40 and aziridines,41 carbonyl chemistry of the non-aldol type such as 
formation of oximes ethers and hydrazones,42 amides,43 ureas44 and thioureas,45 and 
cycloadditions, in particular 1,3-dipolar cycloadditions.46 
 
1.4.2 1,3-Dipolar cycloadditions 
Also known as the Huisgen cycloaddition, the 1,3-dipolar cycloaddition is a classic 
reaction in organic chemisty, involving combination of a 1,3-dipole and a dipolarophile 
to form a variety of heterocycles (figure 1.6).  The history of 1,3-dipoles dates back to 
the late 19th century, when Curtius discovered diazoacetic ester.47  Shortly thereafter, 
the reaction of diazoacetic ester with α,β-unsaturated esters was described, 
demonstrating the first example of a 1,3-dipolar cycloaddition reaction.48  The 
discovery of nitrones49 and nitrile oxides50 followed in the 1890s, and by the time the 
Diels-Alder reaction was discovered in 1928,51 the synthetic value of cycloaddition 
chemistry was quite apparent.  However, it was not perhaps until the 1960s, and 
Huisgen’s systematic studies of the 1,3-dipolar cycloaddition,52 that the true synthetic 
value of 1,3-dipoles became fully appreciated. 
 
Figure 1.6.  General representation of the 1,3-dipolar cycloaddition 
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1.4.2.i Types of dipoles and dipolarophiles 
A large variety of dipoles and dipolarophiles exist, and consequently the scope for 
production of a range of heterocycles is huge.  The most common dipolarophiles are 
alkenes and alkynes, but other molecules possessing multiple bonds beween carbon 
and heteroatom, or between two heteroatoms, such as nitriles and carbonyls, also fall 
into this category.  A large number of 1,3-dipoles have been reported, but in practice 
only a small fraction of these have found widespread use.  These can be divided into 
two different types: the allyl anion type and the propargyl/allenyl anion type.  The non-
linear allyl anion type have four π electrons spread between three parallel pz orbitals, 
which are perpendicular to the plane at which the dipole is bent [figure 1.7 (a)].  
Examples include nitrones, azomethine ylides, carbonyl ylides, carbonyl imines and 
nitro compounds.  The linear propargyl/allenyl type have an extra π orbital orthogonal 
to the the allyl molecular orbital, which does not participate in cycloaddition [figure 1.7 
(b)].  For the propargyl/allenyl family, the middle atom (b) is limited to nitrogen.  
Examples include nitrile oxides, azides and diazoalkanes.   
 
Figure 1.7.  Resonance contributors and arrangement of π orbitals for (a) allyl anion type and 
(b) propargyl/allenyl anion type 1,3-dipoles 
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1.4.2.ii Frontier molecular orbital analysis of 1,3-dipolar cycloaddition 
The regioselectivity and relative reactivity of 1,3-dipolar cycloadditions can be 
explained with reference to the relative energies of the frontier molecular orbitals 
(FMOs) of the reacting dipole and dipolarophile.  The Sustman classification of 1,3-
dipolar cycloadditions as type I, type II or type III depends on the dominant orbital 
interaction between dipole and dipolarophile FMOs.53,54  In type I reactions, the 
dominant FMO interaction is that between the HOMO of the dipole (HOMOdipole) and 
the LUMO of the dipolarophile (LUMOdipolarophile); reactions involving electron-poor 
dipolarophiles usually fall into this category.  In type II reactions, the similar energy gap 
between dipole and dipolarophile FMOs means that HOMOdipole-LUMOdipolarophile and 
HOMOdipolarophile-LUMOdipole interactions are both important.  Type III reactions are 
dominated by the interaction of the HOMOdipolarophile with the LUMOdipole; this is the 
most common interaction for reactions involving electron-rich dipolarophiles.  These 
three types of interactions are represented in figure 1.8 below.  For a given dipole, the 
rate of cycloaddition with a range of dipolarophiles is seen to increase as the energy 
gap between the reacting HOMO and LUMO decreases.55 
 
Figure 1.8.  Frontier orbital interactions for 1,3-dipolar cycloaddition between a 
propargyl/allenyl type dipole and three differently substituted alkenes 
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In his book on the frontier orbital analysis of organic chemical reactions, Fleming 
presents an excellent discussion of the FMO considerations of 1,3-dipolar 
cycloadditions in relation to regioselectivity.56  The experimentally observed 
regiochemical outcomes of a number of test case cycloadditions have been predicted 
by analysis of the interacting frontier orbitals.  An interesting example is the reaction 
between azides and alkynes.  Thermal cycloaddition affords nearly equal amounts of 
the 1,4- and 1,5-disubstituted triazole cycloadducts.52  This is explained in terms of the 
relative energies and the coefficients of the frontier orbitals involved in figure 1.9.  The 
coefficient of a particular atomic orbital is a measure of its contribution to the 
molecular orbital, or in other words the amount of electron density around the atom in 
question.  In figure 1.9, the circles drawn around the atoms represent the relative sizes 
of the coefficients of each atomic orbital; the clear and darkened circles serve to 
identify the changes of sign in the wave-function.  As can be seen from the relative 
energies of the dipole and dipolarophile FMOs, the transition states of azide-alkyne 
cycloadditions receive significant contributions from both HOMOdipolarophile-LUMOdipole 
and HOMOdipole-LUMOdipolarophile interactions.  Each interaction will result in the 
molecular orbitals of the dipole and dipolarophile aligning in a distinct orientation in 
the transition state, with the coefficients matching (large with large, small with small). 
As each of these transitions states gives rise to a different regiosisomer, little 
regioselectivity is observed. 
 
Figure 1.9.  Frontier orbital model accounting for the lack of regioselectivity in  the 
cycloaddition between phenyl azide and phenylacetylene 
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1.4.3 CuAAC 
Often described as a ‘near-perfect’ chemical reaction, the copper-catalysed azide-
alkyne cycloaddition (CuAAC) is synonymous with click chemistry.  While the thermal 
version was first described over a century ago by Michael,57 and later popularised by 
Huisgen,52,58 the copper catalysed variant was first reported simultaneously and 
independently by the groups of Meldal and Sharpless in 2002.59,60  Copper catalysts 
drastically change the mechanism and outcome of azide-alkyne cycloadditions, giving 
exclusively a 1,4-disubstituted triazole at room temperature in excellent yields.  This is 
in stark contrast to the uncatalysed version, which requires prolonged heating and 
results in a mixture of 1,4- and 1,5-disubsituted triazolyl products with little or no 
regioselectivity.  As discussed in section 1.4.2.ii, the poor regioselectivity is as a result 
of the similar energy gap between the HOMO-LUMO energy levels of the azide and the 
alkyne.  CuAAC proceeds via a completely different mechanism to the 1,3-dipolar 
cycloaddition.  The CuAAC reaction is also highly selective, which is important for 
conjugation between more complex molecules bearing diverse functionalities.  Scheme 
1.11 below shows a proposed catalytic cycle for the CuAAC reaction based on density 
functional theory (DFT) calculations.61 
 
Scheme 1.11.  Proposed mechanism of the CuAAC reaction based on DFT calculations. 
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The catalytic cycle is initiated by π coordination of the alkyne to Cu(I).  This causes the 
alkyne proton to become more acidic, facilitating its removal by base.  Subsequently, a 
σ-acetylide intermediate is formed.  In the next step, the azide is activated by 
coordination to copper, which causes the azide’s terminus to become more 
electrophilic.  This is followed by the C-N bond forming event, resulting in a strained 
copper metallacycle.  Subsequent formation of the copper triazolide intermediate is 
fast and energetically favourable.  Finally, protonation of this species is followed by 
dissociation, giving the 1,4-disubstituted triazole and regenerating the catalyst ligand 
complex for more cycles. 
Considering the numerous benefits described above, it is perhaps unsurprising that a 
diverse range of applications of this ligation strategy have been reported.  The 
potential of CuAAC in the realm of drug discovery and biochemical studies has been 
the subject of a review by Kolb and Sharpless.62  Other reviews have focused on 
polymer and materials science applications,63,64 while the utility of CuAAC as a ‘green’ 
reaction has also received attention.65  Exploitation of this reaction for bioconjugation 
represents a facile way to covalently link two large molecular entities, e.g. fusing two 
proteins together or attaching a peptide linker to a carbohydrate.  In this regard, 
reviews covering the application of CuAAC to carbohydrate,66 protein,67 and DNA68 
conjugation have been reported. 
 
1.5 Aims of thesis 
The objective of this research was the conjugation of small molecules to DNA/RNA, 
which may impart upon these biopolymers desirable properties such as increased half-
life, bioavailability, binding affinity, fluorescence etc.  As mentioned in the preceding 
chapter, CuAAC has received much attention as a tool for chemical modification, yet 
application of other examples of the 1,3-dipolar cycloaddition to DNA conjugation have 
been somewhat neglected.  In particular, the nitrile oxide-alkyne cycloaddition (NOAC) 
and strain-promoted azide-alkyne cycloaddtion (SPAAC) present viable, catalyst-free 
alternatives for the formation of functionalised nucleosides and oligonucleotides.  The 
aim of this novel work was to explore both pre- and post-synthetic oligonucleotide 
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modification by exploitation of NOAC as well as SPAAC chemistry.  Specific aims were 
as follows: 
 Pre-synthetic modification of DNA employing modified phosphoramidite 
building blocks generated by NOAC (chapter 2). 
 Post-synthetic functionalisation of DNA with an azobenzene photoswitch via 
NOAC and photochemical characterisation of the resulting conjugates (chapter 
3). 
 Post-synthetic labelling of a range of DNA and RNA sequences by solid-phase 
SPAAC, employing a simple monocyclic cyclooctyne as the dipolarophile. 
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Chapter 2 
Nitrile oxide-alkyne cycloadditions 1: 
 Pre-synthetic modification of DNA by NOAC  
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2.1 Introduction 
 
2.1.1 Nitrile oxides 
The chemistry of nitrile oxides is well documented in several important reviews and 
monographs.69,70  The parent compound, fulminic acid, has been known for over two 
centuries, and many derivatives of this dipole have been prepared.  The most common 
applications of nitrile oxides involve the formation of Δ2-isoxazolines and isoxazoles, 
which result from their cycloaddition with alkenes and alkynes, respectively [scheme 
2.1 (b)].  These reactions are thermodynamically favoured and do not generally require 
a catalyst.  Most nitrile oxides are unstable, some are even explosive.  Many small 
nitrile oxides dimerise to stable five-membered furoxans [scheme 2.1 (c)] upon storage 
either neat or in solution at such a high rate as to render them non-isolable.  As a 
result, they are usually prepared in situ in the presence of a dipolarophile, which traps 
the nitrile oxide to form the heterocycle before the competing dimerisation can occur. 
 
Scheme 2.1.  (a) Main resonance contributors of the nitrile oxide dipole; (b) Reaction of nitrile 
oxides with monosubstituted alkynes and alkenes to form isoxazoles and isoxazolines, 
respectively; (c) Dimerisation of nitrile oxides to form furoxans 
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2.1.2 Generation of nitrile oxides 
Generally speaking, nitrile oxides (1) are unstable, and as such are usually prepared in 
situ and used immediately.  Suitable starting materials include oximes (2) which are 
prepared from the parent aldehyde (3).71-73  From the oxime, a number of choices are 
available for generation of the dipole.  Hydroximoyl halides (4) can be obtained by 
halogenation of the respective oximes,74-76 and their subsequent base induced 
dehydrohalogenation is a common approach to in situ nitrile oxide formation.77-79  The 
dehydration of nitroalkanes (5) with an aryl isocyanate, usually in the presence of 
triethylamine as a base, is another possible route; this is known as the Mukaiyama 
procedure.80  The precursor nitroalkanes can be obtained via oxidation of the 
corresponding oxime81 or via nucleophilic substitution of the parent haloalkane (6).82  
A less common approach involves the thermolysis of furoxans (7), which relies on 
extremely high temperatures.83  Stable furoxans may however be convenient starting 
materials for the generation of short-lived nitrile oxides.  These various strategies for 
the preparation of nitrile oxides are represented in scheme 2.2. 
 
Scheme 2.2.  The various routes available for the preparation of nitrile oxides 
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If a hydroximoyl halide is used as a nitrile oxide precursor, a one-pot synthesis starting 
from the parent oxime is the most common approach.  A variety of halogenating 
agents such as tert-butyl hypochlorite, N-chlorosuccinimide (NCS) and N-
bromosuccinimide (NBS) are available for generation of hydroximoyl halides, and in 
situ dehydrohalogenation in the presence of a base such as pyridine yields the nitrile 
oxide. 
The halogenating agent selected by this author is chloramine-T (Ch-T) (8).  The exact 
mechanism of dipole generation has been debated.  Hassner and Rai proposed initial 
chlorination of the oxime followed by base-catalysed elimination of hydrogen chloride 
to give the nitrile oxide.84  A more likely scenario, perhaps, is the mechanism proposed 
by Padmavathi et al. (scheme 2.3).85  This involves initial deprotonation of the oxime 
OH proton, followed by nucleophilic substitution and finally elimination of a 
stoichiometric amount of tosyl amine to yield the nitrile oxide.  
 
Scheme 2.3.  Proposed mechanism of nitrile oxide formation by Ch-T85 
 
2.1.3 1,3-Dipolar cycloaddition of nitrile oxides 
Many aspects of the 1,3-dipolar cycloaddition have already been discussed in section 
1.4.2.  As highlighted therein, the application of FMO theory has had a formidable 
impact in helping to explain experimental results.  FMO considerations of transition 
states resulting from the cycloaddition of nitrile oxides to alkenes and alkynes lead to 
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their classification as type II/borderline type III 1,3-dipolar cycloadditions,46 i.e. the 
interaction of the HOMOdipolarophile with the LUMOdipole is slightly dominant, although 
the LUMOdipolarophile/HOMOdipole interaction is also important.  As such, both electron-
withdrawing and electron-donating groups have been shown to increase the reactivity 
of the dipolarophile towards nitrile oxides.  However, other factors such as the steric 
contributions of any substituents present also need to be considered to offer a more 
accurate explanation of observed reactivity.   
Cycloaddition reactions of nitrile oxides with substituted alkenes/alkynes can 
theoretically lead to 3,5- and 3,4-disubstituted isoxazolines/isoxazoles [scheme 2.4 
(a)].  In most cases the 3,5-disubstituted product is formed with high regioselectivity; 
this experimental observation is supported by ab initio and FMO calculations.86,87 The 
nature of the substituents on the dipole has little or no influence on the 
regioselectivity when terminal alkenes/alkynes are used, although in some cases 
substitution of the dipolarophile can have an effect.  In one example, β-cyclodextrin is 
tethered to the dipolarophile, and the host-guest interaction between aryl nitrile 
oxides and the cyclodextrin moiety is exploited to control the relative orientation of 
the dipole and dipolarophile, resulting in reversal of the usual regiochemistry [scheme 
2.4 (b)].88  It is more difficult to predict the regiochemical outcome using disubstituted 
dipolarophiles; in these cases the product ratio is seen to depend largely on the 
substitutents present on the alkene/alkyne. 
 
 
 
 
 
 
Scheme 2.4.  (a) Nitrile oxide-alkyne cycloaddition resulting in formation of regioisomeric 
products; (b) Example of selective generation of a 3,4-disubstituted isoxazole88 
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The bulk of the literature describing the 1,3-dipolar cycloaddition of nitrile oxides 
concerns their reaction with alkenes to form isoxazolines.  These reactions are highly 
regioselective, and huge scope exists for the synthesis of substituted heterocyclic 
products by synthetic manipulation of the dipole and dipolarophile.  In addition, the 
isoxazoline heterocycle formed can serve as a synthon for other functional groups such 
as 3-hydroxycarbonyls and 3-amino alcohols.89  The isoxazoline ring also has value in its 
own right.  It exhibits significant pharmacological activity, and examples of isoxazoline 
containing compounds displaying anti-microbial,90  anti-nociceptive90,91 and anti-
stress92 activity have been reported. 
In spite of the many benefits it shares with the alkene version, the nitrile oxide alkyne 
cycloaddition (NOAC) has received much less attention.  Many isoxazole containing 
compounds display interesting biological activity, and their pharmacological properties 
include anti-inflammatory,93 analgesic94 and HIV inhibitory activity.95  The relatively 
weak N-O bond of the heterocycle represents a potential site for cleavage, particularly 
under basic or reductive conditions.  Ring cleavage can be used as a route to 
bifunctional compounds such as 1,3-dicarbonyls,96 3-hydroxycarbonyls97 and 
enaminoketones.98  One attractive feature of the NOAC is its high regioselectivity; it 
tends to yield 3,5-disubstituted isoxazoles almost exclusively.38,99,100   In addition, 
NOAC forms planar heterocyclic products with no issues of diastereoselctivity to 
contend with.   
 
2.1.4 Nucleic acid labelling by nitrile oxide cycloadditions 
Huisgen 1,3-dipolar cycloaddition is known to be an effective approach for the 
modification of nucleic acids; in particular the CuAAC reaction has received much 
attention.68  However, exposure to Cu(I) can lead to oxidative cleavage of DNA/RNA, 
and the cytotoxic effects of copper-contaminated oligonucleotide products remain an 
issue for biological applications.  Copper-free methodologies can avoid these 
problems, and examples such as nitrone101 and nitrile oxide38 cycloadditions have been 
effectively employed in the preparation of modified nucleic acids.  Our group has 
Chapter 2  Pre-synthetic modification by NOAC 
30 
 
demonstrated metal-free, regiospecific labelling of both DNA and RNA by NOAC, while 
others have reported similar findings employing alkenes as the dipolarophile. 27, 38  
In one example, Carell and co-workers synthesised a styrene modified nucleoside 
phosphoramidite, which was readily incorporated into a series of oligonucleotide 
sequences.  These styrene-functionalised oligonucleotides then underwent efficient, 
regioselective reaction with a range of nitrile oxides, furnishing exclusively the 3,5-
disubstituted isoxazoline products.27  Our group employed an alternative strategy, in 
which the non-nucleosidic phosphoramidite 9 was prepared and used to introduce a 
terminal alkyne to the 5’- terminus of a resin-bound DNA sequence.  1,3-dipolar 
cycloaddition was then carried out between the alkyne-functionalised oligonucleotide 
and benzonitrile oxide on the solid phase, leading to regioselective formation of 3,5-
disubstituted isoxazole-DNA conjugates (scheme 2.5).38 
 
(i) BMT, CH3CN, rt, 30 min, then I2 (0.1 M) THF-pyridine-H2O 
(ii) Ch-T, aq. NaHCO3 (4%), EtOH, rt, 30 min 
Scheme 2.5.  DNA conjugation by NOAC on the solid phase38 
We were interested in developing an alternative to this post-synthetic approach to 
oligonucleotide modification.  In this chapter, a pre-synthetic strategy is outlined, 
wherein modified phosphoramidite monomers generated by NOAC are employed to 
deliver modifications to DNA.  This method, in which the NOAC reaction takes place 
off-resin, may represent a welcome alternative for large scale applications, or in cases 
where the oligonucleotide may carry additional functionalities sensitive to the 
conditions of the ‘click’ reaction.   
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2.2 Results and Discussion 
 
2.2.1 Pre-synthetic oligonucletide modification involving NOAC 
The desired strategy for oligonucleotide conjugation is contrasted with the standard 
post-synthetic cycloaddition approach in scheme 2.6.  The 1,3-dipolar cycloaddition is 
potentially a powerful synthetic method, and careful selection of the dipole and 
dipolarophile components can afford heterocyclic products displaying a range of 
chemical properties.  It is our hypothesis that if either the dipole or the dipolarophile 
bears a pendant hydroxy group that cycloaddition, followed by generation of the 
corresponding phosphoramidite, can yield a versatile building block which can 
facilitate convenient, catalyst-free oligonucleotide conjugation.  This off-resin 
approach would certainly increase the versatility of click chemistry as it applies to 
oligonucleotide conjugation, and provide an alternative to more commonly used 
approaches such as solid phase oximation and CuAAC.  There is large scope for the 
introduction of many different labels to DNA/RNA in this manner, potentially yielding 
nucleic acids tagged with a variety of reporting or targeting probes. 
 
Scheme 2.6.  Retrosynthetic (a) pre- and (b) post-synthetic approaches to chemically modified 
oligonucleotides 
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Applications which utilise products of the CuAAC reaction as key building blocks in the 
construction of modified nucleic acids have been reported.  In one example, trivalent 
glycoclusters, themselves generated by CuAAC, have been conjugated to aminooxy 
terminated DNA by way of solid-supported oximation.102  Other examples have 
employed phopshoramidite derivatives of click chemistry derived triazole monomers.  
The triazole moiety is most frequently borne at the C-5 position of pyrimidine bases 
including deoxyuridines,103-105 cytidines,24 and thymidines.106 Location of the triazole 
component at the 5’-position of the sugar25 and as a spacer between the base and 
sugar moieties107 has also been demonstrated.  Finally, non-canonical108 and non-
nucleosidic26 triazole phosphoramidites have been described.  It is perhaps surprising 
that, whilst isoxazoles are an interesting heterocyclic family with diverse applications, 
isoxazole bearing phosphoramidites are not well known.  To the best of our 
knowledge, the D-threoninol derivative 11 (figure 2.1) prepared for inclusion in a 
library of cyclic oligonucleotides targeted to Hepatitis C virus NS5B, represents the only 
known example.109 
 
Figure 2.1.  Isoxazole phosphoramidite 1117 
 
2.2.2 Synthesis of phosphoramidite monomers 
Scheme 2.6 highlights the requirement of the pre-synthetic approach (route a) for 
isoxazole cycloadducts bearing a pendant hydroxy moiety which serves as the site of 
introduction for phosphoramidite groups.  To this end, the isomeric 
hydroxyethoxybenzaldehyde oximes 13a-c were selected as nitrile oxide precursors for 
the NOAC reaction.  These were conveniently prepared from the commercially 
available aldehydes 12a-c, and were obtained in excellent yield (86-96%) following 
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reaction with hydroxylamine hydrochloride in the presence of sodium acetate.  In each 
case, complete conversion of the aldehyde to the desired oxime was confirmed by 1H 
NMR spectral data.  As a representative example, the 1H NMR spectra of the para- 
disubstituted compounds 12c and 13c are shown (figure 2.2), highlighting loss of the 
resonance at 9.90 ppm representing the aldehyde proton and appearance of a new 
signal at 8.08 ppm characteristic of the imino proton of the oxime functional group.  A 
small upfield shift of the doublet resonances representing the two pairs of equivalent 
aromatic protons is also observed. 
 
Figure 2.2.  1H NMR spectra of para-disubstiuted hydroxyaldehyde 12c (blue) and 
corresponding oxime 13c (red) 
The reaction of the oximes 13a-c with Ch-T in aqueous ethanol afforded the 
corresponding nitrile oxides (18a-c), which were trapped in situ with propargyl phenyl 
ether (14) yielding the cycloaddition products 15a-c (scheme 2.7).  These isoxazole 
cycloadducts were obtained in 81-85% isolated yield following stirring of the reaction 
mixture for 18 hr at room temperature.  Purification of the crude products was 
achieved by flash column chromatography.   
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(i) NH2OH.HCl, NaOAc, EtOH/H2O, reflux, 1 hr 
(ii) Ch-T, EtOH/H2O, rt, 18 hr 
(iii) BMT, CH3CN, rt, 30 min 
Scheme 2.7.  Synthesis of the phosphoramidite monomers 17 
Each cycloaddition reaction displayed highly regioselective formation of the 3,5-
disubstituted isoxazole cycloadduct.  In each case, assignment of the regiochemistry of 
the product followed from analysis of the 1H NMR spectral data.  A singlet resonance in 
the range of 6.59-6.76 ppm was observed, which was deemed characteristic of a H-4 
isoxazole ring proton; a H-5 proton resulting from 3,4-substitution would resonante in 
the region of 7.5-8.5 ppm.110-112  Indeed, close examination of the 1H NMR spectra of 
the crude cycloadducts revealed low intensity signals at ~8.5 ppm – evidence of the 
formation of small amounts of the 3,4-disubstituted isoxazole.  In addition, a minor 
signal at ~4.9 ppm is observed in these spectra, which is deemed to represent the 
methylene protons adjacent to the 3,4-disubstituted isoxazole ring.  In the case of the 
cycloadducts 15a and 19a, the two regioisomeric products could not be separated by 
chromatographic methods.  The 1H NMR spectrum of 15a is shown (figure 2.3); in this 
case the relative integration of the signals corresponding to the regioisomeric adducts 
is ~1:21 in favour of the 3,5-disubstituted isoxazole. 
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Figure 2.3.  1H NMR spectrum of 15a, highlighting minor amounts of 19a 
The phophoramidites 17a-c were obtained in reasonable yield following coupling of 
the isoxazole cycloadducts 15a-c with 2-cyanoethyl-N,N,N’N’-
tetraisopropylphosphorodiamidite (16) in the presence of BMT as activator (scheme 
2.8).   After 30 min stirring of the reaction mixture at rt in anhydrous acetonitrile, 
complete consumption of the starting alcohol was confirmed by TLC analysis.  An 
equimolar amount of BMT and the starting materials 15 and 16 were used to prevent 
formation of a bis-substituted P(III) byproduct.  Generation of 17a-c was supported by 
31P NMR spectroscopy; the spectra of the crude products each displayed a resonance 
in the region of ~148-149 ppm which is characteristic of phosphorus (III).  Typically the 
31P NMR spectra of the crude samples displayed additional resonances in the region of 
~10-20 ppm.  Presumably these signals represent P(V) oxidation by-products, which 
are difficult to avoid given the air sensitive nature of the phosphoramidites.   
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Scheme 2.8.  Mechanism of formation of the isoxazole-phosphoramidites 17a-c 
Although 17a-c were found to be suitable for solid phase coupling without purification, 
pure samples were required for characterisation purposes; therefore removal of the 
P(V) impurities was necessary.  Purification of phosphoramidites via flash column 
chromatography can be tricky, as the weakly acidic nature of the silica stationary phase 
can be detrimental to these labile compounds.  We found that neutralisation of the 
silica with 1% triethylamine (TEA) prior to column loading and elution under an 
atmosphere of nitrogen was sufficient for purification of the crude products without a 
significant sacrifice in yield.  31P NMR spectral data for 17c is shown before and after 
purification (figure 2.4).   
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Figure 2.4.  31P NMR spectra of crude (blue) and purified (red) 17c 
 
2.2.3 DNA labelling 
Coupling between resin-bound DNA and the phosphoramidite monomers 17a-c is 
represented in scheme 2.9.  Conjugation of the phosphoramidite 17a to CPG-
thymidine (20) was explored as the test case reaction.  Coupling was carried out 
manually on the solid phase on a 1 µmol scale.  Firstly, the CPG-thymidine was placed 
in a DNA synthesis column, and a 1 mL syringe containing a solution of 17a in 
anhydrous acetonitrile was attached to one end.  At the other end, a second 1 mL 
syringe was attached containing a solution of BMT in the same solvent.  The two 
solutions were then passed through the synthesis column for a period of 15 min.  To 
ensure complete coupling, a second portion of each solution was then attached and 
the process was repeated for a further 15 min.  Following oxidation of the resin-bound 
DNA conjugate with I2, cleavage from the solid support was effected following 
incubation in aqueous MeNH2 for 30 min at 65 
oC.  Reversed-phase (RP) HPLC analysis 
of the resulting aqueous solution confirmed >95% conversion to the desired product 
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(figure 2.6).  A significant difference in rentention time between the starting material 
(thymidine, 21) and the product 23a was noted.  This is unsurprising, since a relatively 
large non-polar molecule is introduced during the formation of the product.  Evidently, 
the highly polar thymidine starting material (21) is weakly retained by the non-polar 
C18 column, and is thus eluted at a much earlier time than the less polar product 23a.  
This empirical evidence for the formation of the isoxazole-conjugate 23a is supported 
by mass spectral analysis. 
 
(i) BMT, CH3CN, rt, 30 min 
(ii) I2 (0.1 M) THF-pyridine-H2O 
Scheme 2.9.  (a) Solid phase synthesis of chemically modified nucleic acids using isoxazole-
phosphoramidite monomers 
 
Figure 2.5.  Structures of cleaved and deprotected DNA starting materials and products 
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Figure 2.6.  Overlaid chromatograms of thymidine starting material 21 (blue) and the labelled 
nucleoside 23a (red) 
Compatibility of the procedure with an oligonucleotide was confirmed when coupling 
of 17a to CPG-decathymidine (24) was demonstrated under identical reaction 
conditions.  RP-HPLC analysis of the crude product (figure 2.7) following cleavage from 
the resin indicated that the reaction proceeded smoothly in near quantitative yield, 
and formation of the product 27a was supported by MALDI-TOF MS analysis.  A 
significant increase in retention time of the oligonucleotide starting material and 
product was observed in comparison to the previous monomeric example.  This is a 
trend generally observed for the analysis of oligonucleotides by RP-HPLC, i.e. retention 
time increases as chain length increases.  Much like the previous example, the product 
27a was seen to elute at a later time than the oligonucleotide starting material 25.   
 
Figure 2.7.  Overlaid chromatograms of decathymidine starting material 25 (blue) and the 
labelled oligonucleotide 27a (red) 
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The scope of this reaction was further demonstrated in conjugation to the resin-
supported 12-mer 28, which contained all four bases with their standard protecting 
groups.  Coupling of 28 with the phosphoramidite 17a afforded the resin-bound 
conjugate 30a.  Cleavage and deprotection followed incubation in aqueous ammonium 
hydroxide for 24 hr at room temperature, and characterisation of the product by RP-
HPLC and MALDI-TOF MS confirmed formation of 31a in near quantitative yield.  
Similar results were observed when the regioisomeric phosphoramidite building blocks 
17b and 17c were employed instead of 17a.  Thus, manual solid phase coupling of 17b 
and 17c to the resin-bound 12-mer 28 yielded the CPG-DNA-conjugates 30b and 30c.  
RP-HPLC analysis of the cleaved and deprotected products 31b,c showed a similar 
profile to that of 31a (figure 2.8).  There was negligible difference in the retention time 
of all three isomeric conjugates, and all eluted more slowly than the parent 12-mer 29.  
As expected, MALDI-TOF MS analysis supported formation of the desired products. 
 
Figure 2.8.  Overlaid chromatograms of mixed base 12-mer starting material 29 (blue), and the 
labelled oligonucleotides 31a (red), 31b (green), 31c (orange), which were prepared by manual 
phosphoramidite coupling 
These results were most encouraging, but we wished to take it further and explore the 
possibility to automate the introduction of ‘click-prepared’ phosphoramidite 
monomers to DNA in search of further convenience and flexibility.  Thus, pure samples 
of 17a-c were prepared with a view to automating coupling to the resin-supported 12-
mer 28 on an Expedite DNA synthesiser.  In the first example, a solution of the 
phosphoramidite 17c in anhydrous acetonitrile and 0.2 µmol of 28 in a DNA synthesis 
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column were installed on the instrument.  We employed the standard protocol used 
for the coupling of nucleosidic phosphoramidites, i.e. 37 equiv. of phosphoramidite 
and 1.5 min coupling time, in search of the support-bound conjugate 30c.  After 
standard work-up, coupling efficiency was adjudged by RP-HPLC analysis of the cleaved 
product 31c to be >90%.  However, conjugation of 17a and 17b to 28 under identical 
conditions displayed inferior coupling yields (figure 2.9); presumably the increased 
steric demand of these regioisomeric monomers offers an explanation for the poorer 
reactivity.  Exposure of 28 to a larger amount of 17a or 17b (50 equiv.) for a longer 
time (15 min) was sufficient to increase the level of conversion to the products 30a and 
30b to over 90%.  In each case, HPLC data demonstrates a favourable comparison 
between manual and automated approaches.   
 
Figure 2.9.  Overlaid chromatograms of the mixed base 12-mer starting material 29 (blue) and 
the labelled oligonucleotides 31a (red), 31b (green) and 31c (orange) prepared on the DNA 
synthesiser using the standard coupling protocol. 
 
2.2.4 Conclusions 
Novel isoxazole building blocks have been prepared by copper-free NOAC.  These 
heterocyclic products, bearing a pendant hydroxy functionality, were constructed from 
modular components of the NOAC reaction, and engineered to meet the chemical 
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specifications of automated DNA synthesis.  Thus, the presence of the pendant 
hydroxy functionality facilitates introduction of a phosphoramidite group, which was 
exploited to conjugate these ‘click-prepared’ heterocycles to DNA on the solid phase.  
Coupling has been demonstrated on the level of a single nucleoside and also with 
oligonucleotides containing all four natural bases.  While on-resin click chemistry with 
alkyne-functionalised oligonucleotides is well established, the off-resin or pre-synthetic 
approach described herein presents an alternative tool for nucleic acid modification.  
The ability to efficiently automate conjugation may be attractive for larger scale 
applications, and additionally oligonucleotides bearing functionalities incompatible 
with 1,3-dipolar cycloaddition conditions are spared this exposure.  We believe that 
through preparation of various isoxazole cycloadducts bearing a pendant OH group(s), 
huge scope exists for the construction of diverse DNA, and indeed RNA conjugates. 
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3.1 Introduction 
 
3.1.1 Photoresponsive molecules 
The ability to control the behaviour of biologically active molecules by external, easily 
controllable stimuli has many benefits.  Whether one is investigating a particular 
cellular mechanism, or developing a drug, an important criterion to consider is how 
selectively the biological processes involved can be manipulated.  For example, spatio-
temporal control of drug activity may reduce side effects and increase efficacy.  By 
designing molecules which respond to an external trigger, it becomes possible to effect 
their permanent or indeed reversible activation. 
Light is an ideal trigger since it is highly orthogonal.  In most biological examples, with 
the exception of a few highly specialised cell types such as those of the eye or those 
involved in photosynthesis in plants, cells do not react to light.  In addition, cells are 
not harmed by light unless the wavelength used is very short.  Light sensitive 
molecules may bear a photo-labile protecting group, in which case they are referred to 
as ‘caged’ and undergo an irreversible transition from an inactive to an active state 
upon irradiation with light of a certain wavelength.  Alternatively, they may be 
photochromic compounds, i.e. they exist in equilibrium between two isomeric forms 
which absorb light of different wavelengths.  These bistable photo-switches have an 
advantage over caged compounds in that they do not generate any by-products upon 
activation, which may lead to toxicity problems in biological settings.113,114    This is 
offset, however, by the problem of finding the right location for attachment of the 
switching moiety, in addition to difficulties in achieving proper binary on/off 
behaviour.   
The applications of light-activated caged compounds have been the subject of several 
review articles.115-117 Photo-labile protecting groups have been recognised as a useful 
tool by synthetic chemists for many years.  However, their greatest potential arguably 
lies at the interface of chemistry and biology.  Placement of a caging group at the 
correct location can render an otherwise active molecule completely inactive.  Factors 
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to consider when choosing a particular caging group include the quantum yield for the 
deprotection reaction and the toxicity of the inevitable by-product(s).  Some of the 
most common photo-labile protecting groups include the ortho-nitrobenzyl group (32), 
nitrodibenzofurane (33), coumarin (34) and their derivatives (figure 3.1).  
 
Figure 3.1.  Some common photo-labile protecting groups 
The three most widely reported types of reversible photo-switches are diarylethenes, 
spiropyrans and azobenzenes.  Diarylethenes typically consist of two thiophene rings 
bridged by a double bond.  They isomerise reversibly via a 6-π electrocyclic reaction 
from an open-ring, unconjugated form to a conjugated, closed ring form upon 
absorption of light of the appropriate wavelength (figure 3.2).  Significantly, this photo-
switch is unaffected by thermal conditions.  Diarylethenes also display excellent fatigue 
resistance, short response time and high quantum yield.  However, they experience 
very little change in shape upon isomerisation, which limits their use to applications 
which exploit the reversible change in their electronic properties, such as polymer 
chemistry118 and high density data storage.119 
 
Figure 3.2.  Isomerisation of a diarylethene 
Spiropyrans, and the closely related spirooxazines, exist in equilibrium between two 
forms: a ring-closed spiro form and a conjugated, ring-opened merocyanine form 
(figure 3.3).  In the spiro form, the conjugated system of the pyran/oxazine and 
another aromatic part of the molecule are seprated by an sp3 hybridised ‘spiro’ carbon.  
Upon irradiation with UV light, the spiro carbon to oxygen bond breaks and the former 
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achieves sp2 hybridisation, resulting in a planar, conjugated system.  Consequently, the 
merocyanine form can absorb visible light and is therefore highly coloured, whereas 
the spiro form is colourless.  Spiropyrans are widely reported in the literature, and 
their applications include metal complexation120 (due to coordination of the metal to 
the phenolate anion in the merocyanine form), DNA intercalation121and 
modification,122 and bio-imaging.123  
 
Figure 3.3.  Reversible equilibrium of a spiropyran 
A search of the literature reveals many examples of the functionalisation of nucleic 
acids with azobenzenes.  There are of course many reasons why azobenzenes make 
ideal candidates for the construction of photoresponsive nucleic acids, which will be 
discussed in detail in the following section. 
 
3.1.2 Azobenzenes 
3.1.2.i Introduction 
Azobenzene is the parent molecule of a class of compounds consisting of two phenyl 
rings separated by an azo bond.  The defining feature of these compounds is their 
popularity as dyes and colourants.  These compounds display a large electronic 
absorbance maximum, the position of which varies according to the location and 
nature of any substituents on the phenyl rings, allowing for chemical fine tuning of 
colour.  Arguably their most interesting property, however, is their readily induced, 
reversible, trans to cis isomerisation upon the absorbance of light of a particular 
frequency.  The geometric change which accompanies this photochemical 
transformation can have a significant effect on the chemical, mechanical, optical and 
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electronic properties of materials which incorporate azobenzenes into their overall 
structure.   
 
3.1.2.ii Photchemistry and photophysics of azobenzenes 
The trans isomer of azobenzene (35) is approximately 50 kJ·mol-1 more stable than the 
cis isomer,124 and the barrier to isomerisation is ~200 kJ·mol-1.125  As a result, under 
dark conditions the trans form dominates.  Absorbance of light anywhere within the 
broad trans absorbance band leads to isomerisation to the cis state in high quantum 
yield; this occurs on a timescale of picoseconds.126,127  While the trans form is almost 
planar and has a dipole moment near zero, the cis isomer adopts a bent conformation 
with the phenyl rings twisted ~55o out of the plane of the azo bond, and has a dipole 
moment of 3 Debye.128  The structures and electronic absorption spectra of the 
individual geometric isomers are represented in figure 3.4. 
 
 
 
 
 
Figure 3.4.  (a) Structures of cis and trans isomers of azobenzene (35); (b)  Space-filling models, 
coloured by electrostatic potential (red-negative to blue-positive); (c) Electronic absorption 
spectra of the trans and cis isomers of azobenzene (ethanol).129 
Once in its cis form, azobenzene may revert to the trans form, either through 
absorbance of light in the cis absorbance band, or via thermal relaxation.  Due to 
overlapping of the absorption bands of the cis and trans isomers, it is impossible to 
obtain 100% of either isomer following irradiation.  For example, in unsubstituted 
azobenzene, irradiation produces a photo-stationary state with a maximum of ≈80% cis 
and ≈95% trans.129  The cis isomer will, however, thermally convert back to >99.99% of 
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the trans state.  The quantum yield of each isomerisation process (φcis and φtrans) and 
the thermal rate constants (k) are intimately related to the substitution pattern on the 
phenyl rings.   These parameters will affect the amount of each isomer in the photo-
stationary state; other influencing factors include irradiation intensity and wavelength, 
temperature, and the host matrix viz solution,130 polymer matrix131 or monolayer.132 
 
3.1.2.iii Isomerisation mechanism 
A single mechanism cannot satisfactorily explain all aspects of the isomerisation 
process, even for unsubstituted azobenzene.   Four mechanisms have been proposed 
as pathways for azobenzene isomerisation – inversion, rotation, concerted inversion, 
and inversion-assisted rotation;133-134  these are represented in figure 3.5.  
 
Figure 3.5.  Proposed mechanisms for azobenzene isomerisation135 
The inversion mechanism involves an increase in one N=N-C angle to 180o.134  In the 
rotational mechanism, the N=N π bond breaks, allowing free rotation about the N-N 
bond.  As a result, the C-N-N-C dihedral angle changes, while the N-N-C angle remains 
unchanged at ~120o.136  The concerted inversion pathway involves both N=N-C angles 
increasing to 180o, resulting in a linear transition state.  In inversion-assisted rotation, 
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a large change in the C-N-N-C dihedral angle and a small yet significant change in the 
N=N-C angle occur simultaneously.  Significantly, the transition state that results from 
concerted inversion has no dipole moment, whereas the other three isomerisation 
pathways possess polar transition states.   Since relaxation from all four of these 
transition states can yield either the cis or the trans isomer, each pathway predicts 
photo-stationary states comprising both isomers; the relative proportions of each will 
depend on the electronic and steric properties of the ring substituents. 
 
3.1.2.iv Effects of substitution on the spectral and kinetic properties of azobenzenes 
Azobenzene derivatives can be divided into three classes on the basis of their 
substitution pattern and the effect this has on their absorbance spectra; the 
azobenzene type, the aminoazobenzene type and the pseudo-stilbene type (figure 
3.6).137 
 
Figure 3.6.   Examples of the three spectroscopic classes of azobenzenes : (a) azobenzenes, (b) 
aminoazobenzenes, and (c) pseudo-stilbenes 
Substituted azobenzenes, like the parent azobenzene, are characterised by a high 
intensity π-π* band in the UV region and a low intensity n-π* band in the visible 
region.  Compounds in the aminoazobenzene class generally possess electron donating 
groups (e.g NH2) at the ortho and/or para positions.  In these compounds, the π-π* 
and n-π* bands are very close and may be overlapping in the near visible UV region.  
Pseudo-stilbene type molecules are characterised by substitution at the 4- and 4’- 
position with an electron donor and an electron acceptor (a ‘push-pull’ substitution 
pattern), resulting in a strongly asymmetric electron distribution.  In such molecules 
Chapter 3  Photoresponsive DNA by NOAC 
50 
 
the π-π* band is shifted toward the red (past that of the n-π*) to assume a reverse 
order with respect to the spectra of the parent azobenzene molecule.  Due to the 
range of spectral properties resulting from substitution, different azobenzenes display 
characteristic rates and extents of isomerisation, and in general individual 
azobenzenes interact differently with light of a given wavelength.    
Manipulation of the position of the λmax of an azobenzene compound via substitution 
will alter the wavelength of light necessary to effect photo-isomerisation.  Such 
manipulation may prove advantageous in biological applications, where irradiation 
with UV light can lead to tissue damage.138   
It is also important to consider the correlation observed between the position of the 
trans π-π* absorption band (described here simply as λmax) and the thermal relaxation 
of the cis isomer.  In general, red-shifted azobenzenes, i.e. those with their λmax in the 
visible region, are found to exhibit faster thermal relaxation processes.139,140  The 
results of a study by Woolley et al. clearly show, for a series of para disubstituted 
azobenzenes, the relationship between the electron donating ability of the 
substituents, the value of  λmax and the thermal half-life of the cis isomer (figure 3.7).
141  
In general, as λmax shifted towards the visible region, a corresponding decrease was 
observed in the half-life (t1/2) of the cis isomer.   
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Figure 3.7.  The relationship between λmax  of the trans form and the t1/2 
of the cis form of a series of para-disubstituted azobenzenes. 
Compound λmax (trans) 
t1/2 
(cis-trans) 
Compound λmax (trans) 
t1/2 
(cis-trans) 
36 342 nm 43 hr 41 450 nm 2 ms 
37 366 nm 12 min 42 445 nm 6 sec 
38 372 nm 80 s 43 437 nm 5 min 
39 382 nm 11 sec 44 488 nm 0.8 sec 
40 480 nm 25 ms 45 530 nm 0.7 sec 
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The thermal stability of the cis form may be improved via introduction of substituents 
at the ortho142 or meta143 positions.  When probing a biological process, increasing the 
stability of the cis isomer is often desirable, particularly if the process in question 
occurs on the timescale of minutes/hours.  In such a case it would be preferable to 
maintain the on/off state of the photo-switch over this time period, rather than relying 
on constant irradiation.  Conversely, if a pulsed conformational switch is desired as 
part of a biochemical switch, rapid return to the trans state would be preferable. 
 
3.1.2.v General Applications 
Azobenzenes have frequently been used to alter bulk material properties, and such 
applications have been the subject of several review articles.144-146  Many if not all of 
these applications exploit the cis to trans photo-switch of the azobenzene 
chromophore, which is considered a remarkably clean photochemical reaction.137  The 
main criteria for a useful photo-trigger include reversibility, large geometrical or 
electrical change, low sensitivity to the environment, fatigue resistance and high 
quantum yield;144 azobenzenes meet all of these conditions, with the proviso that 
fatigue resistance and quantum yield are dependent on the substitution pattern of the 
phenyl rings. 
In the fields of nanotechnology and materials science, azobenzenes have been 
incorporated into a variety of materials.  In one example, an azobenzene substituted at 
its meta positions with two urethane moieties linked to two cholesteryl units (46) was 
used as an organogelator to gelatinise cyclohexane (figure 3.8).147  Upon irradiation 
with light at 365 nm, photo-isomerisation from the trans to the cis form occurred; the 
subsequent change in geometry about the azo bond resulted in a loss of the hydrogen 
bonding between the N-H and C=O groups of the urethane units responsible for 
forming the gel, leading to a gel-sol transition.  Sol-gel phase transition was effected 
upon irradiation at 436 nm, as a result of isomerisation from cis to trans geometry.  
Thus, photo-controlled gel-sol-gel phase transitioning through the breaking and 
reforming of hydrogen bonds was demonstrated.   
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Figure 3.8.  Substituted azobenzene 46 used in gel-sol-gel application 
In an example of an azobenzene functioning as a photo-switchable organic monolayer, 
a silicon surface was functionalised with a pseudo-stilbene type azobenzene.148  Trans-
cis isomerisation resulted under alternate UV and visible light irradiation.  The 
electrical conductivity of the material, measured under both conditions, showed a 
distinct difference between the trans and cis forms; such photo-regulation of electrical 
conductivity may have potential applications in microelectronics and molecular 
electronics.    
Rotello and co-workers demonstrated that incorporation of azobenzene into the side-
chains of polystyrene can be used to effect a reversible change in polymer structure.149  
Isomerisation of these side-chains into the more compact cis isomer can relax the 
polymer structure, allowing for enhancement of aromatic stacking and dipole-dipole 
interactions between the side chains. 
The unique photophysical properties of azobenzenes have also been exploited in a 
range of biomolecular applications.  In addition to nucleic acids (which will be covered 
in more detail in section 3.1.7), there are many examples of conformational control of 
azobenzene modified proteins and peptides.150 -151  In one example, this 
conformational switch was exploited in a restriction enzyme to effectively photo-
regulate DNA cleavage.152  The photo-switchable moiety was incorporated into a single 
chain version of the restriction enzyme PvuII by cross-linking two suitably located 
cysteine residues with a bifunctional azobenzene derivative (figure 3.9).  A range of 
modified variants of the enzyme were produced by altering the site of modification 
and by introducing multiple cross-links.  Some of the modified variants, which carried 
the cross-links close to the catalytic centre, were modulated in their DNA cleavage 
activity by a factor of up to 16 following illumination with UV light (trans-cis) and blue 
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light (cis-trans).  Significantly, this change in activity was achieved in seconds, and was 
fully reversible.    
 
Figure 3.9.  (a) The crystal structure of scPvuII with the residue pairs chosen for cross-linking in 
colour; (b) An expansion of the region comprising β strands β1, β2, and β3 and the catalytic 
centre, together with a model of the azobenzene photswitch cross-linking positions C49 and 
C62.152 
Several studies have explored the potential of photochromic ligands to control the 
function of proteins through a reversible change in shape and/or polarity of an integral 
bistable photo-switch; examples include nicotinic acetylcholine receptor agonists,153 
enzyme inhibitors154 and ionotropic glutamate receptor (iGluR) agonists.155  In the 
latter example, an azobenzene substituted glutamate derivative was prepared and its 
cis/trans agonist profile was investigated.  Reversible isomerisation of the 
photoresponsive agonist under irradiation at 380 nm and 500 nm was shown to 
effectively control iGluR activity, while maintaining good efficacy and affinity. 
 
3.1.2.vi Nucleic acid applications 
In the first reported example of an oligonucleotide modified with an azobenzene 
chromophore, Nakano and co-workers designed the azobenzene phosphoramidite 
building block 47.156  The key functionalities are borne, by way of amido linkages, at 
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the 4- and the 4’- positions; a DMT protected alcohol at one end, and a 
phosphoramidite group on the opposite side.  
 
Figure 3.10.  Azobenzene phosphoramidite 47 designed by Nakano156 
The presence of these terminal groups, compatible with automated oligonucleotide 
synthesis, facilitated straight-forward incorporation of the azobenzene moiety into a 
growing oligonucleotide strand.  Irradiation of the modified oligonucleotide with light 
at 313 nm resulted in a marked decrease in the characteristic absorbance of the trans 
isomer of azobenzene, showing isomerisation to the cis form.  Significantly, the initial 
spectrum was regenerated completely upon exposure of the photosensitive 
oligonucletide to dark conditions, so displaying reversibly of the isomerisation.  The 
authors also noted that the photo-isomerisation characteristics of the azobenzene unit 
were not affected by incorporation into the oligonucleotide. 
While the potential to alter nucleic acid conformation via direct incorporation of 
azobenzene into the sugar-phosphate backbone was indeed interesting, the scope of 
these photosensitive modifications was subsequently broadened by incorporation of 
azobenzene residues into the side chains of oligonucleotides.157  This was achieved by 
employing the non-natural phosphoramidite 48 (figure 3.11), which in contrast to 
linker 47, bears a pendant azobenzene group which sits out of the sugar-phosphate 
backbone. 
 
Figure 3.11.  Azobenzene phosphoramidite 48 used by Komiyama and co-workers157-159 
Chapter 3  Photoresponsive DNA by NOAC 
56 
 
Komiyama and co-workers have demonstrated that photo-isomerisation of 
oligonucleotides modified with 48 destabilises duplex formation.158,159  DNA melting 
studies indicated duplexes bearing a single modification on one strand were 
significantly destabilised when the azobenzene chromophore was isomerised from its 
trans to its cis form.  This discovery lent considerable weight to the hypothesis that 
azobenzenes could be used to photo-regulate the structure, and in turn function, of 
DNA. 
In an effort to elucidate the structural detail of photo-regulation, circular dichromism 
(CD) studies were undertaken; these help to determine the position of the azobenzene 
moiety in the secondary structure of the DNA duplex.159  They indicated that the trans 
isomer, which has a planar structure,160 intercalates between two base pairs of the 
double helix.  This π stacking interaction stabilises the duplexes of modified 
oligonucleotides with respect to the native duplex.  It is these interactions which are 
disrupted upon photo-isomerisation from the planar trans form to the non-planar cis 
form, evidenced by a significant decrease in the melting tempterature (Tm) of cis-
azobenzene modified duplexes with respect to both the trans-azobenzene appended 
conjugates and the native duplex.  
Exploitation of the optical control of duplex stability has helped to provide information 
on DNA recognition.   Komiyama and co-workers have demonstrated photo-regulation 
of  the DNA polymerase reaction,161 DNA transcription162,163 and RNA digestion.164  In 
one elegant example, outlined in figure 3.12, optical control of DNA polymerisation 
was effected.  A 54-mer DNA template was hybridised at two different positions to an 
18-mer primer and a modulator sequence, which was modified with the azobenzene 
linker 48 near its 5’ terminus.   DNA elongation, mediated by T7 DNA polymerase, was 
blocked when the pendant azobenzene chromophore of the modifier sequence was 
present in its trans form, leading to the production of truncated 34-mer DNA.  
However, following irradiation with UV light (300<λ<400 nm), which effected the 
isomerisation to cis geometry, the full length 54-mer DNA was produced.  It is the case 
that when the modifier sequence bears the azobenzene moiety in its trans form, a 
duplex forms with the template strand due to the relative ease of accommodation of 
the planar trans-azobenzene within the duplex.  The T7 DNA polymerase requires 
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single-stranded DNA as a template, and thus as it moves along the DNA strand, it is 
blocked by the double-stranded region.  Hence elongation ceases at the 5’ terminus of 
the modulator strand.  However, when the modulator strand carries the non-planar cis 
azobenzene moiety, dissociation of the duplex results due to steric repulsion.  This 
allows the DNA polymerase to continue further along the template strand, yielding the 
full-length DNA. 
 
Figure 3.12.  Mechanism of photo-regulation of DNA polymerisation161 
Photo-regulation of gene expression has also been demonstrated.  In this example, an 
azobenzene moiety was tethered to a T7 promoter sequence and transcription by T7 
RNA polymerase (RNAP) was effected.163  In terms of the position of the incorporation 
of the modified azobenzene subunit, two regions of the promoter were investigated – 
the loop binding region and the unwinding region.  Kinetic studies demonstrated that 
the mechanism of transcription regulation differed depending on the site of 
incorporation of the azobenzene unit.  When the azobenzene moiety was present in 
the loop-binding region of the promoter, the trans form strongly intercalated between 
base pairs, interfering with the binding of RNAP.  Photo-isomerisation to the cis form 
following UV irradiation forced the the cis-azobenzene to flip out of the duplex, 
facilitating binding of the RNAP.  
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Figure 3.13.  DNA sequence identifying promoter region, loop binding region and unwinding 
region40 
 
Figure 3.14.  Mechanism of photo-regulation of gene expression with azobenzene modification 
in the loop-binding region 
Incorporation of the modification into the unwinding region of the promoter sequence 
effected photo-regulation of transcription through a different mechanism.  In the 
native duplex, the base pairs in the unwinding region of the duplex are melted by 
RNAP and the template strand is directed into the catalytic site of transcription.  
Intercalation of trans-AB, however, stabilises the duplex and prevents it from 
unwinding.  On trans-cis isomerisation, melting of this region is facilitated due to the 
steric hindrance of nonplanar cis-AB. 
In addition to DNA,  construction of photoresponsive RNA strands has been 
successful.165  A pendant azobenzene moiety was incorporated into a single RNA 
strand via a D-threoninol derivative using standard phosphoramidite coupling 
chemistry, and RNA/RNA duplex formation was investigated between the 
photoresponsive modified strand and unmodified, complementary RNA sequence 
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Duplex 
Tm (
oC) 
  
trans cis ΔTm 
RxG/RC 48.8 36.5 12.3 
RxA/RU 41.8 29.4 12.4 
RxU/RA 41.6 31.2 10.4 
RxC/RG 46.1 37.0 9.1 
Figure 3.15.  (a) Structure of azobenzene unit and sequences of RNA; (b) Thermal melting 
analysis data165 
This study found significant changes in the Tm of the modified duplexes resulting from 
reversible trans-cis isomerisation of the azobenzene moiety and thus an efficient tool 
with which to photochemically regulate RNA duplex formation.  Further duplex 
destabilisation was observed upon incorporation of 2’,6’-dimethylazobenzene, most 
likely owing to the increased steric hindrance induced when trying to accommodate 
the non-planar cis form in the duplex.  Comparison between azobenzene modified RNA 
duplexes and the unmodified, native RNA duplex showed a slight (~2 oC) 
destabilisation, indicating that even the trans form destabilised the duplex to some 
extent.  This can be explained by the fact that the rigid A form structure of the 
RNA/RNA duplex does not easily accept intercalators between the base pairs.166   
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Figure 3.16.   Energy-minimized structure of (a) the native RNA/RNA duplex (RnG/RC), and the 
azobenzene modified RNA/RNA duplexes (b) trans RXG/RC, and (c) cis-RXG/RC
167
 
The ability to efficiently photo-regulate RNA duplex formation may have applications in 
RNAi research, which requires RNA to be in the duplex form to be active.  Single 
stranded RNA cannot be taken up by the RISC complex, and therefore cannot effect 
gene knockout/suspression.  Construction of photoresponsive RNA duplexes may 
therefore provide a useful tool for the spatio-temporal control of siRNA activity (see 
section 1.2 for more information on RNAi). 
 
3.1.2.vii Azobenzene-modified nucleic acids by click chemistry 
The preparation of oligonucleotides covalently linked to an azobenzene 
moiety/moieties has most commonly been achieved by employing azobenzene-
modified phosphoramidites as monomeric building blocks in solid phase synthesis.  To 
the best of our knowledge, there are no reported examples of the assembly of 
azobenzene-modified oligonucleotides in which click chemistry has been used as the 
key conjugation step.  Indeed, the application of click reactions such as 1,3-dipolar 
cycloadditions could be potentially valuable for the preparation of a range of photo-
switchable oligonucleotides.  Accordingly, this chapter will discuss the application of 
NOAC chemistry to the modification of oligonucleotides with azobenzenes. 
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3.2 Results and Discussion 
 
3.2.1 Azobenzene-oligonucleotide conjugates by NOAC 
The results presented in chapter 2 describe the synthesis of modified oligonucleotides 
prepared from NOAC-generated phosphoramidite building blocks.  For the post-
synthetic preparation of azobenzene-oligonucleotide conjugates by NOAC, one of the 
components of the cycloaddition (alkyne or nitrile oxide) must be incorporated into 
the oligonucleotide during solid phase synthesis.  The alkyne moiety is better suited to 
this, as a variety of 2’-O-propargyl nucleosides are commercially available.  Using the 
optimised conditions for NOAC outlined in chapter 2 as a starting point, we wished to 
examine the potential of this chemistry for the preparation of azobenzene-modified 
oligonucleotide sequences.  The proposed retrosynthetic approach to the desired 
oligonucleotide conjugates 49 is shown in scheme 3.1.   
 
Scheme 3.1.  Retrosynthetic analysis of azobenzene-modified oligonucleotides 
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3.2.2 Preliminary cycloadditions, synthesis of 55a-d 
The retrosynthetic approach outlined in scheme 3.1 requires the oximes 52a,b as key 
intermediates.  These oximes are not known compounds, and a trawl of the literature 
suggested their synthesis would require several steps.  Thus, we elected to begin this 
study looking at small molecule examples of the NOAC involving some easily prepared 
azobenzene compounds (scheme 3.2).   
 
(i) K2CO3, BrCH2C(CH), acetone, 18 hr 
(ii) Ch-T, RCHNOH (57a-d), EtOH/H2O, 40
oC, 1 hr 
(iii) NH2OH.HCl, C5H5N, EtOH, MW (120 
oC, Pmax = 300 W), 30 min 
Scheme 3.2.  Synthesis of cycloadducts 55a-d 
The first hypothesis tested was that the azo group would be compatible in the 
presence of Ch-T, which we used to prepare nitrile oxides in situ from oximes.  To 
address this concern, the propargyl ether 54 was prepared.  This compound, with its 
terminal triple bond, could potentially serve as the dipolarophile partner in a click 
cycloaddition reaction, and provide information on the inertness, or otherwise, of the 
azo group to the NOAC protocol.  Nucleophillic substitution of propargyl bromide with 
the phenol 53 in the presence of K2CO3 gave 54 in quantitative yield.  The 
1H NMR 
spectral data of 54 corresponded to that reported in the literature.168  Click 
cycloaddition between 54 and benzonitrile oxide (58a), generated in situ from 
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commercially available benzaldehyde oxime (57a), furnished the cycloadduct 55a as an 
orange solid in 91% yield; it can be inferred from this excellent yield that no adverse 
reaction occurred between the azo group and Ch-T.  1H NMR spectral data, shown in 
figure 3.17, supports selective formation of a 3,5-disubstituted isoxazole cycloadduct.  
Loss of the triplet at 2.58 ppm confirms consumption of the starting alkyne 54.  
Furthermore, the signal representing the methylene protons adjacent to the ether 
linkage, a doublet with a chemical shift of 4.78 ppm in 54, shifts downfield to resonate 
at 5.28 ppm, presenting as a singlet.   The singlet at 6.69 ppm is characteristic of the H-
4 proton of the isoxazole; significantly there is no evidence of the regioisomeric 3,4-
disubstituted product, which would have a characteristic signal in the range of 7.50-
8.50 ppm.110-112 
 
Figure 3.17.  1H NMR spectra of alkyne click partner 54 (blue) and cycloadduct 55a (red) 
To investigate the influence of daylight on 55a, a solution of the compound in CDCl3 
was left to stand on the laboratory bench.  Evidence for light-induced trans-cis 
isomerisation was examined by recording 1H NMR spectra over a time interval.  After a 
period of three hours, the 1H NMR spectrum (figure 3.18) indicated that a significant 
amount (~25%) of the thermally stable trans isomer was converted to the cis isomer.  
Several additional peaks appeared in the spectrum.  Analysis of the spectrum shows an 
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extra signal in the region characteristic of the isoxazole proton; a singlet at 6.62 ppm is 
deemed to represent the cis isomer (the same proton in the trans isomer presents at 
6.69 ppm).  An additional resonance representing the methylene protons of the cis 
isomer is observed at 5.01 ppm.  Significantly, upon standing overnight in the dark, 
isomerisation back to > 95% trans-55a was observed.* 
 
 
Figure 3.18.  1H NMR spectra of pure trans-55a (red) and a mixture of trans-55a and cis-55a 
(blue) after 3 hr standing in daylight 
To explore the generality of the cycloaddition with an azo-alkyne, further reactions 
were attempted between 54 and the aryl nitrile oxides 58b and 58c, themselves 
prepared in situ from their parent oximes, 57b and 57c.  Oxime preparation followed 
                                                     
 
*
 For the sake of clarity, in all other schemes and NMR spectra in this chapter, only the 
thermodynamically more stable trans-azobenzene isomer will be illustrated. 
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from condensation of the aldehydes 56b and 56c with NH2OH.HCl.  Oximation was 
carried out in ethanol under microwave irradiation; sealed, pressurised vials, 
facilitating heating of the reaction mixture to a temperature above the boiling point of 
the solvent were employed.  Consequently, formation of both 57b and 57c was 
complete in 30 mins, which is an improvement on the reaction time of 2 hr reported 
for the synthesis of similar oximes by conventional heating approaches.72  Both 57b 
and 57c are known in the literature, and their 1H NMR data corresponded to that 
previously reported. 71,73  The ensuing cycloadducts, 55b and 55c, were both obtained 
with isolated yields of 86%, and their structures were confirmed by 1H NMR spectral 
data.  The characteristic signals for the isoxazole ring proton in each case appeared at 
~6.8 ppm.  Significantly, in the case of the 2-fluorophenyl cycloadduct 55b, this signal 
appeared as a doublet, with a coupling constant of 3.6 Hz (figure 3.19).  Since 
fluorine19 has a spin of ½ and a relative abundance of 100%, this multiplicity is a 
consequence of a five bond (5J) coupling between the isoxazole proton and the 
fluorine atom present at the 2-position of the adjacent phenyl ring.  This coupling 
interaction was confirmed when a 1H NMR spectrum with 19F decoupling showed the 
signal for the isoxazole proton collapsed to a singlet.  Interpretation of the 13C NMR 
spectrum of 55b proved less trivial; it was complicated by the 2/3/4/5 bond coupling 
between the fluorine atom and the carbon atoms.  In some cases CF coupling is very 
large, e.g. J = 250.3 Hz for the ipso carbon atom.  
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Figure 3.19.  1H NMR spectrum of 55b with (red) and without (blue) 19F decoupling 
 
Cycloaddition of 54 with 2-nitrophenyl nitrile oxide (58d) prepared in situ from 
commercially available 2-nitrobenzaldehyde oxime (57d) was less efficient than that 
observed with the analogous dipoles 58a-c.  A final isolated yield of 35% of 55d was 
obtained.  Presumably, the low yield was a result of the steric interference of the bulky 
nitro group at the ortho position impacting negatively on the alignment of the nitrile 
oxide to the dipolarophile in the transition state, leading to cycloaddition formation.  A 
summary of the isolated yields obtained is provided in table 3.1. 
Nitrile oxide R Product (% Yield) 
58a Ph 55a (91) 
58b 2-Fluorophenyl 55b (86) 
58c 1-Naphthyl 55c (86) 
58d 2-Nitrophenyl 55d (35) 
 
Table 3.1.  Isolated yields of cycloadducts 55a-d following cycloaddition of 54 with nitrile 
oxides 58a-d 
 
3.2.3 Amide cycloadditions, synthesis of 62-64 
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Following the success of the cycloaddition between a range of nitrile oxides and an 
azobenzene substrate with an ether linked alkyne moiety, we next sought to increase 
the structural complexity, and probed the potential of nitrile oxide cycloadditions with 
an azobenzene substrate carrying a propargyl moiety linked through an amide 
functional group (scheme 3.3). 
 
 
 
(i) Ch-T, PhCHNOH (57a), EtOH/H2O, 40 
oC, 1 hr 
Scheme 3.3.  Cycloadditions of the propargyl amides 59-61 with in situ generated phenyl nitrile 
oxide (58a) 
The substrates 59-61 were gifted by our collaborators in Queens University, Belfast.  
These were obtained as orange solids following amide coupling between the parent 
carboxylic acids and propargyl amine.169  Employing an identical experimental 
procedure used in the synthesis of 55a-d, the cycloadducts 62-64 were obtained with 
isolated yields in the range of 70-81%.  As a representative example, the 1H NMR 
spectrum of the para-disubstituted cycloadduct 64 is shown (figure 3.20).  As 
previously discussed, the characteristic isoxazole resonance at 6.62 ppm confirms 
regioselective formation of the 3,5-disubstituted isoxazole 64.  Suprisingly, the 
spectrum displays a large singlet resonance at 7.98 ppm, which integrates for 4 
protons.  This likely represents two out of the three pairs of equivalent protons Ha, Hb 
and Hc.  One would expect these signals to appear distinct from each other, and 
appear as doublets (or in the case of Ha possibly a doublet of doublets).  The amide 
proton has a chemical shift of 6.78 ppm, and appears a triplet as a result of coupling to 
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the adjacent methylene protons, which themselves present as a doublet resonance at 
4.85 ppm.   
These results confirm the compatibility of the amide functionality, as well as the azo 
group, with Ch-T.  This may be of significance when employing NOAC in the 
conjugation of small molecules to proteins/polypeptides.  
 
 
Figure 3.20.  1H NMR spectrum of 64 
 
3.2.4 Synthesis of 3- and 4-(phenylazo)benzaldehyde oximes (52a,b) 
3.2.4.i Synthesis of azo-aldehyde precursor 67a by a Grignard method 
The initial attempts to synthesise the oxime 52a focused on condensation of the 
phenyliminodimagnesium reagent 65 with 4-nitrobenzaldehyde (66) to form the 
aldehyde precursor 67a (scheme 3.4) by modification of an experimental procedure 
described in the literature for the preparation of a series of mono- and bis-substituted 
azobenzenes.170  The desired intermediate 65 was prepared following reaction of 
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aniline with two equivalents of ethyl magnesium bromide in anhydrous THF under an 
atmosphere of argon.  4-(Phenylazo)benzaldehyde (67a) was subsequently obtained 
following condensation of the freshly prepared solution of 65 with 4-
nitrobenzaldehyde.  In addition to the targeted azo-aldehyde 67a, this reaction also 
produced a significant amount of the undesired azoxy derivative 68.  The ratio of the 
azo to the azoxy products varied from as low as 1:9 to a maximum of 1:1 as the 
concentration and number of equivalents of 65 were altered, and in our hands it was 
difficult to make the reaction reproducible.    
 
(i) THF, 0 oC → 55 oC, 40 min 
(ii) THF, 0 oC → 55 oC, 3 hr 
Scheme 3.4. Synthesis of the azo-aldehyde 67a by the Grignard approach 
It has been reported that azoxybenzene (70) is the intermediate species in the 
condensation of 65 with nitrobenzene (69), yielding azobenzene (35).  It is further 
suggested that deoxygenation of 70 by a further portion of 65 yields the final product 
35 (scheme 3.5).170  With this in mind, we attempted to increase the ratio of 67a to 68 
in the crude product by increasing the number of equivalents of 65 from 5 to 8, 
relative to 66.  Under these modified conditions, the highest ratio of the azo to azoxy 
product was obtained; no further improvement was observed following an increase in 
the relative amount of 65 to 12 equivalents or increasing the reaction time from 3 to 
18 hr.    
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Scheme 3.5.  Deoxygenation of azoxybenzene (70) with 65, yielding azobenzene (35) 
In spite of the poor chemoselectivity, a sample of the desired azo-aldehyde was 
obtained following separation of the azo and azoxy products by flash chromatography 
on silica gel.  In terms of characterisation of the two species, 1H and 13C NMR 
spectroscopy were not particularly useful.  Instead, a combination of mass analysis and 
UV-Vis spectroscopy were used.  The overlaid UV spectra of the two products (EtOH) 
are shown in figure 3.21.  The presence of a local maximum in the region of 413 nm is 
characteristic of a compound containing an azo bond; an azoxy group does not absorb 
light at this wavelength.171  Thus, on the basis of UV data, samples were 
unambiguously identified as either azo-aldehyde 67a or azoxy-aldehyde 68.  These 
findings were supported by mass analysis. 
 
Figure 3.21.  UV spectra of the azo-aldehyde 67a (red) and the azoxy-aldehyde 68 (black), 
analysed in EtOH 
Once 67a and 68 had been differentiated on the basis of their UV and mass data, the 
small differences in their 1H NMR spectra could be used as a tool to quantitatively 
determine the relative amounts of each compound in the crude product of future 
reactions.  Thus, the chemical shift of the aldehyde proton of 68 resonated slightly 
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more downfield than the corresponding proton of 67a.  The ratio of the two products 
in the crude could then be determined by the relative integration of these two peaks.   
 
Figure 3.22.  1H NMR spectra of crude product mixture containing both 67a and 68 (blue), and 
purified 67a (red) and 68 (green) 
A search of the literature suggested it may have been possible to increase the yield of 
67a through deoxygenation of the isolated azoxy-aldehyde 68 using commercially 
available triethyl phosphite.172  Thus, 68 was dissolved in a mixture of toluene and 
triethyl phosphite and heated under reflux for a period of 18 hr.  1H NMR spectral 
analysis of the resulting crude product showed little conversion of the azoxy to the 
azo-aldehyde (~15%).  The percentage conversion was improved incrementally up to a 
maximum of 50% upon heating of the reaction mixture under microwave irradiation 
for a period of up to 3 hr, at temperatures ranging from 75 oC to 170 oC.  However, in 
all cases, the amount of the azo-aldehyde produced was offset by the significant 
degradation of the starting material and/or product under the extreme conditions.   
The low isolated yield of 67a and the failure to significantly enhance it by 
deoxygenation of 68, coupled with the poor reproducibility of the reaction, led us to 
pursue a more efficient route to the desired azo-aldehyde 67a. 
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3.2.4.ii Synthesis of the azo-aldehyde precursor 67a, starting from 4-
(phenylazo)benzoic acid (71) 
Having abandoned the route outlined in scheme 3.4, we adopted a procedure which 
described an alternative synthesis of 67a,173 the precursor to the oxime 52a (scheme 
3.6).  Starting from commercially available 4-(phenylazo)benzoic acid (71) reduction 
with lithium aluminium hydride (LAH) yielded the primary alcohol 72a as an orange 
solid in 66% yield.  Following oxidation of 72a with Dess-Martin periodinane (DMP), 
the desired aldehyde 67a was obtained in 97% yield.  In the case of both 72a and 67a, 
the 1H NMR spectral data corresponded to that reported in the literature.173  Finally, 
the oxime 52a was obtained in 94% yield following condensation of 67a with 
hydroxylamine hydrochloride in the presence of pyridine.  The 1H NMR spectra of 67a 
and 52a are shown below (figure 3.23).  The azo-aldehyde 67a is unusual in the sense 
that its spectrum displays a broad singlet at a chemical shift of 8.01 ppm which 
integrates for 4 protons.  This is most likely due to poor resolution of the signals of two 
pairs of equivalent protons.  Formation of the oxime from the aldehyde was confirmed 
by loss of the signal for the aldehyde proton at 10.11 ppm, and the appearance of a 
new signal characteristic of an oxime imino proton at 8.20 ppm.  
 
(i) LAH, THF, 30 min 
(ii) DMP, DCM, 1 hr 
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(iii) NH2OH.HCl, pyridine, EtOH, MW (Pmax = 300 W, T =  120 
oC), 1 hr 
Scheme 3.6.  Optimised synthesis of the azobenzene-oxime 52a 
 
Figure 3.23.  1H NMR spectra of the azo-aldehyde 67a (blue) and the azo-oxime 52a (red) 
  
3.2.4.iii Synthesis of azo-aldehyde precursor 67b 
Synthesis of the regioisomeric oxime 52b required initial preparation of the meta-
disubstituted azo-aldehyde 67b.  This aldehyde was arrived at by a slightly different 
route to that used to access 67a.  3-(Phenylazo)benzoic acid is not commercially 
available, and the synthetic route adopted started with condensation between 
nitrosobenzene (73) and the substituted aniline 74b in the presence of acetic acid 
(scheme 3.7).  Chromatographic separation of the crude product mixture gave the 
desired product 72b as an orange oil in 82% yield.  The oxime 52b was obtained 
following oxidation to the aldehyde 67b, and subsequent condensation with 
NH2OH.HCl under microwave irradiation gave the final product 52b as an orange solid, 
with a total yield of 85% over the two steps. 
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(i) CH3COOH, 0 
oC for 1 hr, then rt for 3hr for 72b, 18 hr for 72c 
(ii) DMP, DCM, 1hr 
(iii) NH2OH.HCl, pyridine, EtOH, MW (Pmax = 300 W, T =  120 
oC), 1 hr 
Scheme 3.7.  (a) Synthesis of the oxime 52b; (b) attempted synthesis of oxime 52c 
Efforts to synthesise the regioisomeric azo-oxime 52c proved unsuccessful.  While the 
primary alcohol 72c could be obtained under the same conditions used for 72b (albeit 
with a longer reaction time of 18 hr), attempted oxidation to the desired aldehyde 67c 
with DMP resulted in degradation of the starting material.  This was evidenced in the 
1H NMR spectrum of the crude product, which showed no characteristic aldehyde 
peaks. Additionally, over the course of an hour, the colour of the reaction mixture 
changed from orange, which is characteristic of azobenzene compounds, to black, 
indicating loss of the azo group. 
  
3.2.6 Cyclisation reaction of 73c 
Since the primary alcohol 72c was unsuitable for oxidation to the corresponding 
aldehyde, we attempted instead to exploit it for the synthesis of the  azo-alkyne 75, 
which is analagous to 54 but has a longer linker between the phenyl ring and the 
alkyne (scheme 3.8).  Thus, nucleophilic substitution of propargyl bromide with 72c 
was attempted.  This reaction was carried out in the presence of NaH to deprotonate 
the alcohol proton, with a view to subsequent nucleophilic attack of propargyl bromide 
by the alkoxide anion.  However, the 1H NMR spectrum of the resulting crude product 
showed no evidence of the desired alkyne 75.  Also, significantly, the colour of the 
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solution changed from orange to brown during the reaction, suggesting reactivity 
involving the N=N group.  
 
(i) BrCH2C(CH), NaH, DMF, 1 hr 
Scheme 3.8.  Attempted reaction to form the azo-alkyne 75 
A search of the literature uncovered an interesting reaction in which an electron 
deficient azo group undergoes nucleophilic attack by a primary alcohol (scheme 3.9).174  
This led us to conclude that an intramolecular attack of the alcohol (alcoholate anion) 
of 72c on the adjacent azo group may be preferential to intermolecular reaction with 
propargyl bromide.  This hypothesis was supported by the results of two trial 
reactions; one in which 72c was heated under reflux in DMF in the absence of base for 
1 hr, and another in which it was stirred with NaH in DMF under argon for 1 hr.  In both 
cases, the 1H NMR spectra of the sample following work-up corresponded to that 
observed for the crude product resulting from the attempted synthesis of the 
propargyl ether 75.  In light of this, we propose that when a strong base is present, an 
intramolecular cyclisation of 72c occurs following deprotonation of the alcohol group.  
The resulting alkoxide ion attacks the adjacent azo group, ultimately yielding the 
heterocylic product 76 [scheme 3.10 (a)].  In the absence of base, thermal activation is 
sufficient to allow attack of the azo group by the alcohol, which loses its proton after 
the addition [scheme 3.10 (b)]. 
 
Scheme 3.9.  Nucleophilic attack of an azo group by an alkoxide ion174 
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Scheme 3.10.  Proposed mechanism of formation of the heterocyclic product 76 (a) with and 
(b) without base 
In addition to mass analysis, formation of 76 is supported by  1H, 13C DEPTQ and 1H1H 
COSY NMR spectral data.  The 1H NMR spectrum of the product (figure 3.24) displays a 
narrow doublet at a chemical shift of 8.39 ppm, which corresonds to the proton of the 
heterocycle adjacent to the oxygen atom.  The DEPTQ NMR spectrum supports 
formation of a product containing three quaternary carbon atoms (figure 3.25), while 
the 1H1H COSY spectrum in particular proved useful in the characterisation of the 
product; the coupling between relevant protons is highlighted in figure 3.26. 
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Figure 3.24.  1H NMR spectrum of 76 
 
 
Figure 3.25.  DEPTQ NMR spectrum of 76 
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Figure 3.26.  1H COSY NMR spectrum of 76, with an expansion of a region inset highlighting 
coupling between protons Hd and He 
 
3.2.7 Small molecule cycloadditions with oximes 52a & 52b 
Before considering conjugation to DNA of the nitrile oxides 78a and 78b, to be derived 
in situ from the oximes 52a & 52b respectively, we were interested in a simple NOAC 
study of the azo-oximes 52.  In each case, the nitrile oxide was first generated in situ by 
treatment of the parent oxime with Ch-T in aq. EtOH and trapped with propargyl 
phenyl ether (14) in a one-pot reaction, forming the cycloadducts 77a and 77b as 
orange solids with isolated yields of 89% and 46% respectively (scheme 3.11). 
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(i) Ch-T, EtOH/H2O, 40 
oC, 1 hr 
Scheme 3.11.  Synthesis of cycloadducts 77a and 77b 
The high yield of the para-disubstiuted cycloadduct 77a in relation to the meta-
disubstituted product 77b is most likely due to electronic effects.  The nitrile oxide 
functionality of the para-disubstituted azobenzene 78a is in conjugation with the 
entire azobenzene system; it may therefore lose electron density through the π system 
to the azo group, which has been shown previously to have some electrophilic 
character (section 3.2.6, page 75).  As the NOAC involves the transfer of electrons from 
the HOMO of the dipolarophile to the LUMO of the dipole,56 any loss of electron 
density from the latter will activate it towards cycladdition.  Since the nitrile oxide 
group of the meta-disubstituted azobenzene 78b is not in conjugation with the azo 
group, this activation does not occur; these electronic effects may be responsible for 
the yield of 77a being significantly larger than that of 77b.   
The 1H NMR spectra of the cycloadducts 77a and 77b are shown in figure 3.27.  In each 
case, the signals for the isoxazole proton at ~6.7 ppm and the methylene protons at 
approximately ~5.2 ppm are characteristic of 3,5-disubstituted isoxazoles.  The 
cycloadduct 77b displays more signals in the aromatic region due to its lack of 
symmetry.  
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Figure 3.27.  1H NMR spectra of cycloadducts 77a (blue trace) and 77b (red trace) 
 
3.2.8 Site specific introduction of the azobenzene photoswitch to DNA 
3.2.8.i Modification at the 3’-terminus 
To begin to explore the application of click cycloaddition chemistry to the synthesis of 
nucleic acid derivatives bearing photoresponsive groups, we chose commercially 
available CPG supported 2’-O-propargyl uridine (79) as starting material.  We believed 
the propargyl moiety borne on the ribose would function as a dipolarophile.  Whilst it 
may be more sterically hindered than the propargyl phenyl ether used in the small 
molecule study, we expected it to be sufficiently available to function to trap the 
transient nitrile oxide.  The resin loaded propargyl uridine also has the 5’-OH group 
available for oligonucleotide chain extension.   
Agitation of a suspension of 79 in the presence of 30 equiv. of the oxime 52a and 30 
equivalents of Ch-T, in aqueous ethanol overnight at room temperature, furnished the 
isoxazole cycloadduct 81a by way of NOAC to the transient dipole 78a.  Cleavage from 
the resin under standard conditions (MeNH2, 65 
oC, 30 min) yielded an aqueous 
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sample of the conjugate 82a (scheme 3.12); analysis by RP-HPLC showed that the 
reaction proceeded in near quantitative yield (figure 3.28).   
 
(i) Ch-T, EtOH/H2O, rt, 18 hr 
(ii) MeNH2, 65 
oC, 30 min 
Scheme 3.12.  Solid phase cycloaddition to form the conjugates 82a 
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Figure 3.28.  Overlaid chromatograms of  the azobenzene-labelled nucleoside 82a (blue trace) 
and the starting material reference, 2’-O-propargyl uridine (80) (red trace) 
Significantly, the chromatogram of 82a shows evidence of two products of differing 
retention time (82aI and 82aII); one with the pendant azobenzene in the cis 
conformation and one where the substituents around the azo functionality have a 
trans relationship.  Since the HPLC system was equipped with a diode-array detector 
(DAD), it was possible to use the software to analyse the UV profile of each individual 
peak within the chromatogram.  Thus, it was apparent that the later eluting, major 
product (82aI) had a local maximum at 325 nm, whereas the early eluting, minor 
product (82aII) did not absorb at this wavelength (figure 3.29).   
Under the classifications for azobenzenes described by Rau137 (see section 3.1.2.iv, 
page 49), our product can be characterised as the ‘azobenzene type’.  The trans 
isomers of this class are known to have a λmax in the region of ~325 nm, while the cis 
isomers do not absorb light in this region.  From this it was possible to conclude that in 
the major product (82aI) the azobenzene moiety had trans configuration, and in the 
minor product (82aII) the azo group had cis configuration.† 
 
                                                     
 
†
 Any future compound numbers which are suffixed by ‘I’, will denote the pendant azobenzene in the 
trans geometry, while those which are suffixed by ‘II’ will refer to cis geometry  
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Figure 3.29.  UV spectra of the trans- and cis-azobenzene appended nucleoside conjugates 
82aI (red) and 82aII (blue) of 82a 
Having proved the concept that nucleic acid derivatives bearing an azobenzene 
photoswitch could be prepared by NOAC chemistry on the solid phase, we attempted 
to access a photoswitch-bearing oligonucleotide by standard phosphoramidite 
coupling chemistry on a DNA synthesiser starting from the solid-supported cycloadduct 
81a (scheme 3.13).  Firstly, the short 3-mer 83a was grown; thymidine monomers were 
selected as these are the most ‘simple’ and require no protecting group.  Standard 
conditions for automated DNA synthesis were adopted, and following cleavage of the 
crude product from the resin, analysis of the resulting aqueous sample 84a by RP-HPLC 
showed that all the starting material had been consumed.  MALDI-TOF MS analysis 
confirmed formation of the desired product.  Thus, the presence of the isoxazole-
linked azobenzene did not interfere negatively with oligonucleotide chain extension.   
With this information to hand, we endeavoured to grow an oligonucleotide containing 
a mixture of natural bases, with their standard protecting groups.  Starting from the 
solid-supported 81a, the mixed 4-mer 85a was grown.  Deprotection and cleavage 
from the resin gave an aqueous solution of 86a;  HPLC and MALDI-TOF MS analysis 
confirmed quantitative formation of the desired product.  In the case of both the 3-
mer 84a and the mixed 4-mer 86a, the chromatograms showed evidence of both the 
cis and trans isomers of the azobenzene-bearing oligonucleotides (figure 3.30).  The 
successful syntheses of these oligonucleotides suggest that, within the innate 
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restrictions of solid phase synthesis, e.g. length of sequence, any desired sequence of 
DNA can be made bearing the isoxazole-azobenzene moiety at the 3’-terminus. 
 
(i) Ch-T, 52a, EtOH/H2O, 18 hr, rt 
(ii) MeNH2, 65 
oC, 30 min  
Scheme 3.13.  Synthesis of 3’-modified azobenzene-oligonucleotide conjugates 84a and 86a 
 
 
Figure 3.30.  HPLC traces of azobenzene-labelled nucleosides/oligonucleotides; starting 
material reference, 82a (orange trace), 3-mer, 84a (blue trace), and mixed 4-mer, 86a (red 
trace) 
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3.2.8.ii Modification at the 5’-terminus 
To broaden the scope of this chemistry, incorporation of the azobenzene moiety at the 
5’ end and in the middle of an oligonucleotide chain was explored.  The approach 
adopted to achieve these goals is summarised in scheme 3.14.  Commercially available 
2’-O-propargyl uridine phorphoramidite (88) was coupled to CPG-T4 (87).  Manual solid 
phase coupling‡ was considered necessary as the commercial pack size of the 
phosphoramidite (100 µmol) was deemed too small to install on the DNA synthesiser 
under standard dilution conditions.  The alkyne-functionalised oligonucleotide was 
then installed on the synthesiser and standard oxidation, capping and deblocking 
procedures were carried out.  At this point the propargyl bearing 5-mer 89 was 
removed from the system and a small portion was cleaved from the resin to act as a 
reference before any further steps were attempted.  HPLC and MALDI-TOF MS analysis 
of the cleaved oligonucleotide 90 confirmed quantitative formation of the desired 
product.  Cycloaddition was carried out on the solid phase with the nitrile oxide 78a 
(generated in situ from the oxime 52a by the Ch-T protocol) using the previously 
optimised conditions, yielding the resin-bound cycloadduct 91a.  As with earlier 
examples, HPLC analysis of an aqueous sample of the cleaved cycloadduct 92a 
demonstrated complete consumption of the starting material, and formation of both 
cis and trans isomers of the azobenzene-modified oligonucleotide.  As before, MALDI-
TOF MS analysis confirmed formation of the desired product.  Thus, a strategy for the 
modification of oligonucleotides at the 5’-terminus was demonstrated.   
 
                                                     
 
‡
 For a description of manual phosphoramidite coupling on the solid phase, see section 2.2.3, page 34 
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(i) Ch-T, 52a-b, EtOH/H2O, 18 hr, rt 
Scheme 3.14.  Synthesis of the azobenzene modified oligonucleotides 50a-b by routes A and B 
 
3.2.8.iii Modification at an internal position  
Two strategies were considered for the prepartion of oligonucleotide substrates 
bearing the azobenzene photoswitch at an internal position.  These we dubbed the 
‘grow-and-click’ or the ‘click-and-grow’ approach.  Employing the latter methodology, 
the azobenzene-conjugated 5-mer 91a was installed on the DNA sythesizer as a 
substrate from which the 9-mer 50a was grown.  Characterisation of the cleaved 
product 94a by HPLC and MALDI-TOF MS analysis confirmed succesful synthesis of an 
oligonucleotide bearing a pendant azobenzene moiety in the middle of the chain. 
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The alternative, ‘grow-and-click’ approach has also been demonstrated.  Following 
manual coupling of the phosphoramidite 88 to CPG-T4 (87), the resin-supported 
product 89 was installed on the DNA synthesiser and the propargyl bearing 
oligonucleotide 51 was grown.  Cycloaddition between 51 and the nitrile oxide 78a, 
which was prepared in situ following reaction of the oxime 52a and Ch-T, successfully 
yielded the cycloadduct 50a.  Significantly, even though in this case the dipolarophile 
was borne in the middle of the sequence, no decrease in yield was observed with 
regard to the corresponding end-modified oligonucleotides 81a, 83a and 85a.  As 
expected, the HPLC trace of the cleaved product 94a prepared by the ‘click-and-grow’ 
approach was identical to that prepared by the ‘grow-and-click’ approach. 
Cycloaddition of 51 with the in situ generated meta-disubstituted nitrile oxide 78b was 
carried out using the same experimental conditions used for the para-disubstituted 
isomer 78a.  Cleavage of the product 50b from the resin yielded an aqueous sample of 
94b, which was characterised by HPLC (figure 3.31) and MALDI-TOF MS analysis.  
Comparison of the chromatograms of the regioisomeric products (94a and 94b) shows 
evidence of both cis and trans isomers; the retention time of each was almost identical 
for both (94a and 94b).  Significantly, the yield of 50b (~80% conversion) was noticably 
less than that of the isomeric cycloadduct 50a (~95% conversion), in which the azo 
group is para- to the dipole functionality.  This observation is directly parallel to the 
attenuated yield observed for formation of the cycloadduct 77b in comparison to 77a 
(section 3.2.7, page 79).   
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Figure 3.31.  HPLC traces of crude oligonucleotide reaction products bearing an azobenzene 
photo-switch at an internal position; T9–alkyne starting material reference 93 (blue), meta-
disubstituted cycloadduct 94b (orange), and para-disubstituted cycloadduct 94a (red) 
 
3.2.9 Photochemical characterisation of modified oligonucleotides 94a and 94b 
A trawl of the literature reveals few examples in which the photochemistry and/or 
isomerisation kinetics of azobenzenes bearing a substituent in a position meta- to the 
azo group have been investigated.  Fewer reports still directly compare these 
properties in isomeric 1,3- and 1,4-disubstituted azobenzenes.  This is perhaps 
surprising, considering the distinctly different electronic characteristics one might 
expect of such regioisomers.  We were therefore interested in exploring the 
photoresponsive properties of the novel azobenzene-modified oligonucleotides 94a 
and 94b.  In particular, we were keen to explore the influence, or otherwise, of the 
conjugating isoxazole ring between the azobenzene units and the oligonucleotide 
chain, and thus wished to compare the characteristics of 94a and 94b to similar 
compounds reported in the literature.   
Prior to examination of their photochemical properties, the crude samples of 94a and 
94b (synthesised on a 1 µmol scale), were purified by preparative RP-HPLC to obtain an 
isolated sample of the trans isomer of each species.  These isolated fractions were 
stored in brown eppendorf tubes to prevent light induced photo-isomerisation from 
the trans to the cis form.   
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The UV spectra of pure 94aI and 94bI were recorded, in turn, and a difference in the 
position of the π–π* absorption band of the pendant azobenzene moiety of each 
compound was noted.  A smaller difference in the position of the n–π* band was also 
observed (table 3.2).  The π–π* transition for the parent cis azobenzene is known to 
have a λmax at 276 nm, and since these compounds’ photochemistry closely resembles 
that of the parent azobenzene, the π–π* absorption bands for 94aII and 94bII are most 
likely overlapping with the local maximum absorbance of the nucleic acid portion of 
the molecule, which strongly aborbs light at a wavelength of 260 nm.  The difference in 
the λmax of the π–π* absorption band of 94aI and 94bI is evidence that the azobenzene 
portion of these two regioisomeric conjugates has different electronic character.137 
 trans-isomer cis-isomer 
π–π* n–π* π-π* n–π* 
94a 336 nm 433 nm - 433 nm 
94b 323 nm 428 nm - 428 nm 
Table 3.2.  Position of π–π* and n–π* absorbance bands for trans and cis isomers of 
azobenzene modified oligonucleotides 94a and 94b 
In order to achieve the irradiated (Irr) photostationary states of the azobenzene-
oligonucleotide conjugates 94a and 94b, the samples were exposed, in turn, to near-
UV irradiation from a medium pressure Hg-Arc lamp at 366 nm.  Irradiation at this 
wavelength induces excitation of the π–π* transition, culminating in trans-cis 
isomerisation of the azobenzene moiety.  In each case, the degree of isomerisation 
was monitored by the decrease in absorption observed at 325 nm.  This wavelength 
was chosen because, as is shown in table 3.2 and figure 3.32, both 94aI and 94bI have 
a λmax at or near this wavelength, whereas 94aII and 94bII do not absorb light at all in 
this region.  Therefore, the decrease in absorption at this wavelength is a useful 
qualitative tool to measure the degree of trans–cis isomerisation over time.  After 
irradiation for a period of 10 min, no further decrease was observed in the intensity of 
this absorption (figure 3.33).  Dark-adapted (DA) photostationary states were induced 
by excitation of the n-π* transition following irradiation at 436 nm for 2 min.  Within 
Compound 
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this time, restoration of the original absorbances of each sample at 325 nm was 
observed.   
A sample of 94a in both the Irr and DA photostationary states was analysed by RP-
HPLC, with detection at 260 nm.  In each case, the relative peak areas of 94aI and 94aII 
were used to determine the mole fraction of 94aII (χcis) in the photostationary state.  
While a ‘truer’ value for χcis would result from HPLC detection at the isosbestic 
wavelength§ of 94aI and 94aII, analysis of the UV-Vis spectral data of these compounds 
revealed negligible difference between the molar absorptivity (ε) of 94aI and 94aII at 
the detection wavelength of 260 nm.  A parallel strategy was used to obtain the χcis 
values for 94b in the photostationary state; these results are summarised in table 3.3.  
The HPLC traces of 94a in the Irr and DA states are also shown (figure 3.34). 
 
 
 
 
 
 
                                                     
 
§
 An isobestic wavelength is a specific wavelength at which two chemical species have the same molar 
absorptivity (ε) 
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Figure 3.32.  (a) Photo-isomerisation of azobenzene-modified oligonucleotides 94a and 94b; 
(b) UV spectra of (i) 94aI (red) and 94bI (blue), and (ii) 94aII (red) and 94bII (blue) 
 χcis 
 Irr DA 
94a 0.731 0.150 
94b 0.825 0.188 
Table 3.3.  Mole fractions of cis-azobenzene appended oligonucleotides 94aII and 94bII (χcis) in 
the Irr and DA photostationary states at 26 oC. 
 
Figure 3.33.  Overlaid UV/Vis spectra of 94a upon irradiation at 366 nm for 0, 2, 4, 6, 8, 10 and 
600 s; data for 94b included in appendix (section 6.2, page 183). 
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Figure 3.34.  Overlaid HPLC traces of 94a in the Irr (blue)and DA (red) photostationary states; 
data for 94b included in appendix (section 6.2, page 183) 
 
3.2.10 Thermal stability studies of 94aII and 94bII 
The stability of the cis isomer of modified azobenzenes is an important criterion to 
consider in applications which require a bistable photoswitch.  Many examples of 
photoresponsive biomolecules display efficient photoswitching between trans and cis 
forms, but the instability of the latter limits their effectiveness.  The type and position 
of sustituent(s) on the azobenzene moiety has been shown to have a significant effect 
on both the photochemical and kinetic properties of these compounds (see section 
3.1.2.iv, pages 49-52).  Thus, the stabilities of the irradiated oligonucleotides 94a and 
94b towards thermal cis-trans isomerisation were investigated.  
Following irradiation at 366 nm for 10 minutes to achieve the Irr photostationary state, 
a series of UV spectra were recorded at temperatures ranging between 60 oC and 85 
oC.  The absorbances of 94a and 94b were measured at 325 nm over several hours; as 
thermal isomerisation from the cis to the trans form progressed the absorbance at 325 
nm increased.  A plot at each temperature of the normalised absorbance value [(At – 
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A0)/(A∞- A0)]
** against time revealed that the thermal relaxation from cis to trans 
geometry observed first order kinetics (figure 3.35).  Curve-fitting using the GraphPad 
Prism 5 software package gave the rate constant (k) for the cis-trans isomerisation at 
each temperature, and from these values an Arrhenius plot for the data was 
constructed (figure 3.36).  The Arrhenius equation can be given in the form: 
 k = AeEA/RT (1) 
or alternatively in its linear form, 
 ln(k) = ln(A) – EA/R (1/T)     (2) 
where A is the pre-exponential factor, EA is the activation energy, R is the gas constant 
and T is the temperature.  A plot of ln(k) versus 1/T for both 94a and 94b was linear, 
and application of linear regression analysis to the data gave an equation from which 
EA and A could be derived.  The Eyring equation similarly relates the rate constant (k) 
of a chemical process to temperature: 
 
 
(3) 
or written in its linear form: 
 ln(k/T) = (-ΔH‡/R)(1/T) + ln(kB/h) + ΔS
‡/R  (4) 
where ΔH‡ is the enthalpy of activation, kB is Boltzmann’s constant and ΔS
‡ is the 
entropy of activation.  Hence, a plot of ln (k/T) versus 1/T gave a straight line for both 
94a and 94b (figure 3.37), from which ΔH‡ and ΔS‡ could be obtained.  The half-life 
(t1/2) of a first order process at each temperature can be related to the rate constant 
(k): 
 t1/2 = ln2/k (5) 
                                                     
 
**
 At = absorbance at time = t; A0 = initial absorbance value; A∞ = absorbance as t→∞ 
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Since either the Arrhenius plot or the Eyring plot can be used to determine k at any 
temperature, the values of k at physiological temperature (37 oC) were obtained for 
94a and 94b and, using equation 5, t1/2 was calculated for each isomeric compound.  
The calculated values of the kinetic constants describing the thermal cis–trans 
isomerisation process for 94a and 94b are listed in table 3.4.  Significantly, these point 
towards a slower relaxation from the cis–trans form for the meta-disubstituted isomer 
94b than for the para-disubstituted isomer 94a.  
 
  
Figure 3.35.  Plots of the normalised absorbance at 325 nm against time for the azobenzene-
modified oligonucleotides 94a (a) and 94b (b) 
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Figure 3.36.  Arrhenius plots for the azobenzene-modified oligonucleotides 94a (a) & 94b (b) 
 
 
  
Figure 3.37.  Eyring plots for the azobenzene-modified oligonucleotides 94a (a) & 94b (b) 
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Compound EAct 
(kJ·mol-1) 
A (s-1) ΔH‡ (kJ·mol-1) ΔS‡ (J·mol-1K-1) t1/2 at 37 
oC 
(hr) 
94a 97.25 1.549 x 1011 94.37 -40.22 30.30 
94b 112.18 1.065 x 1013 109.22 -5.30 144 
Table 3.4.  Calculated kinetic constants describing the thermal cis-trans of isomerisation of 94a 
and 94b 
The results from section 3.2.9, in addition to those highlighted in table 3.4, clearly 
show that the isomeric oligonucleotide conjugates 94a and 94b display different 
photochemical and kinetic behaviour.  Amongst a limited number of literature studies 
comparing such properties in regioisomeric azobenzenes, Wang et al. have observed a 
sensitive relationship between the level of conjugation in substituted azobenzenes and 
the position of the π–π* absorption band.175  Specifically, electron donating groups at 
the position para to the azo group were found to shift the π–π* band towards the 
visible end of the spectrum and to effect a significant decrease in the half-life of the cis 
isomers.  The latter observation can be understood in terms of how the substituents 
affect the degree of single bond character in the azo moiety (figure 3.38).  Groups at 
the 4-position are in conjugation with the azo group and so can increase its single bond 
character through resonance regardless of whether they are electron withdrawing or 
donating in nature.  Since there is strong evidence to suggest that the transition state 
in going from cis to trans contains an N-N single bond (see section 3.1.2.iii, page 48), 
substituents contributing to a decrease in N/N bond order ought to result in a lowering 
of the activation energy for the isomerisation.  Substituents present at the 3-position 
are not in conjugation with the azo group, therefore this effect does not occur and 
there is no lowering of the activation energy for cis-trans isomerisation by rotation of 
an N-N single bond.  As a result, the half-life of the cis conformation of meta-
disubstituted azobenzenes is longer than the corresponding para-disubstituted isomer. 
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Figure 3.38.  Mesomeric delocalisation opportunities for the isomeric isoxazole bearing 
azobenzenes 94a and 94b 
Significantly, we have observed increased thermal stability of the cis form of a 1,3-
disubstituted azobenzene.  Whilst substitution at the 2-position has been reported to 
increase the half-life of cis azobenzenes in several cases,142,176,177 this is generally 
attributed to the steric clash of the bulky substituents used with the rest of the 
molecule, thus destabilising the transition state in going from cis to trans.  The 
exploitation of steric interference to reduce the rate of thermal relaxation may in 
addition have a negative impact on the efficiency of photo-isomerisation.  It is unlikely 
that there is any significant difference in the sterics of the cis–trans transition state of 
our isomeric azobenzene-modified oligonucleotides, 94a and 94b, although it remains 
possible that this may play a minor role in the kinetics of the isomerisation.  The most 
significant contribution to the increased thermal stability of 94bII relative to 94aII, 
however, is most likely the distinct electronic character of the two compounds (figure 
3.38).   
 
3.2.11 Conclusions 
NOAC chemisty has been applied successfully in the generation of a series of 
substituted azobenzene cycloadducts.  Small molecule examples demonstrate that this 
chemistry is successful for azobenzenes bearing either the alkyne, which may be linked 
via an amide or an ether group, or the dipole component of the click reaction.  
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Synthesis of azobenzene cycloadducts in which the isoxazole ring is in conjugation with 
the azobenzene moiety required initial preparation of the azo-oximes 52, which were 
used to generate the nitrile oxides 77 in situ upon reaction with Ch-T.  Condensation of 
nitrobenzaldehyde with the Grignard reagent 65 proved an inefficient route to the azo-
aldehyde precursor 67a, which was instead obtained in good yield in three steps from 
the azo-carboxylic acid 71a.  The meta-disubstituted isomer 67b was also obtained in 
three steps, albeit via a slightly different route. 
Solid phase NOAC proved to be a successful approach for the conjugation of an 
azobenzene moiety to nucleic acids.  The in situ generated azo-nitrile oxides 77 
underwent efficient cycloaddition with a range of oligonucleotides bearing a propargyl 
ether group at the 2’-position of the sugar.  Oligonucleotides modified with 
azobenzene at the 3’- and 5’-ends were prepared, in addition to those bearing a 
pendant azobenzene moiety mid-sequence.  In all cases, the reaction was remarkably 
clean and regiospecific. 
The photochemical and kinetic properties of the azobenzene-modified 
oligonucleotides 94a and 94b were examined.  A slight difference in the position of the 
π–π* absorbance band was observed between the trans isomers of the two 
compounds, highlighting a difference in the electronic properties of these two 
regioisomeric conjugates.  The photoswitching efficiency of each compound was 
excellent, with both photostationary states established within minutes.   
Thermal relaxation studies of the two compounds showed that the cis form of the 
para-disubstituted isomer 94a had a significantly shorter half-life than the cis form of 
meta-disubstituted isomer 94b.  Conjugation between the isoxazole ring, when borne 
at the 4’-position of the azobenzene, and the azo group, is considered to increase the 
single bond character of the latter and thus to lower the activation energy of cis–trans 
isomerisation.   
Azobenzene-functionalised oligonucleotides have been reported previously.  However, 
the application of solid phase NOAC, which employs simple, easily prepared 
components of the click reaction, may help to broaden the scope of these 
photoresponsive modifications.  In addition, use of 1,3-disubstituted azobenzenes 
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should be considered for applications which require a bistable photoswitch, since they 
may improve the thermal stability of the commonly unstable cis-azobenzene moiety 
without compromising the efficiency of photo-switching. 
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4.1 Introduction 
 
4.1.1 Copper-free click chemistry 
Thus far, a detailed overview of several types of 1,3-dipolar cycloaddition has been 
given, and methodologies which exploit NOAC for the modification of nucleic acids 
have been demonstrated.  One of the main advantages that NOAC can claim over the 
popular CuAAC is that no catalyst is required.  As such, potential toxicity issues arising 
from the use of Cu(I) are avoided, which is of particular importance for biological 
applications.  Indeed, other simple, efficient and selective copper-free approaches to 
biomolecule conjugation are in demand, and in this section the increasingly popular 
SPAAC will be discussed.   
 
4.1.2 Bioorthogonal reactions 
For a chemical reaction to be considered bioorthogonal, the functional groups in 
question must be mutually reactive under physiological conditions, yet remain inert to 
the biological environment;178 such reactions represent a powerful tool for 
bioconjugation.  However, it is only in the past decade, coinciding with the advent of 
the click chemistry ideology, that applications exploiting bioorthogonal reactions have 
been successfully employed.  In many cases, the ultimate goal of these applications is 
the in vivo labelling of specific biomolecules.179,180  This may be achieved via selective 
reaction between the biomolecule in question and a synthetic label, each of which 
have been suitably functionalised with complementary reactive groups.  In biological 
systems, the cellular metabolic machinery can be exploited to incorporate modified 
monomers into proteins,181 glycans,182 lipids183 and nucleic acids.184  Exposure of these 
modified biomolecules to a labelling group, e.g. biotin, fluorescein, bearing a 
complementary reaction partner, e.g. azide, alkyne, may then yield the labelled 
biomolecule. 
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The majority of such applications utilise the azide group as one of the labelling 
components.185  The azide moiety displays several characteristics which make it a 
prime candidate for bioorthogonal reactions.  It is highly inert, yet displays unique 
reactivity under the right conditions.  In addition, its small size facilitates incorporation 
into a variety of biomolecules without disrupting their overall structure.  Also, unlike 
many other functional groups employed for coupling reactions in organic chemistry, 
azides are not present in biological compounds, and as such represent an ideal 
candidate for bioorthogonal transformations.   
 
4.1.3 Strain-promoted azide-alkyne cycloadditions (SPAAC) 
Bertozzi and co-workers have arguably been the main pioneers of bioorthogonal 
chemistry, and in particular have been responsible for the resurgence in interest in the 
SPAAC.  The re-introduction of this chemical strategy arose from the need for an 
orthogonal, metal-free conjugation approach in biological systems; as such it was 
determined that the Huisgen azide-alkyne cycloaddition was an appropriate starting 
point.  
Unlike the hugely popular copper-catalysed version, the convential Huisgen process 
exhibits sluggish kinetics with simple linear alkynes, and the conditions of high 
temperature and pressure required for efficient reaction are hardly ideal for biological 
applications.52  In contrast, the reaction of cyclooctyne with neat phenyl azide was 
observed by Wittig and Krebs back in 1961 to proceed in an almost explosive 
manner.186  The high reactivity is attributed to the significant ring strain in the system, 
which is released in the transition state and cycloaddition products resulting from the 
cyclic alkyne.  It is important to note that reaction with a substituted cyclooctyne 
affords a mixture of regioisomeric cycloadducts, with little regioselectivity observed 
(scheme 4.1).  For a discussion of the regiochemistry of azide-alkyne cycloadditions in 
terms of frontier orbital theory, see section 1.4.2.ii, page 20. 
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Scheme 4.1.  Reaction of a substituted cyclooctyne with an azide to form a mixture of triazolyl 
cycloadducts 
In 2004, Bertozzi et al. reported the first application of SPAAC to chemical biology.  The 
biotin-labelled cyclooctyne 95b was prepared from the parent compound 95a and 
used to label azide-functionalised glycoproteins in cell lysates and on live cultured cells 
(scheme 4.2).187  
 
Scheme 4.2.  Synthesis of the biotin-labelled strained alkyne 95b and its application to cell 
surface labelling187 
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Whilst these results were most exciting, a study of the reaction kinetics of the 
cyclooctyne 95a with some model azides indicated that there was room for 
improvement in terms of reactivity.  Thus, in a separate study, Bertozzi and co-workers 
prepared the cyclooctyne derivatives 97a and 98a (figure 4.1).188  Selection of 
compound 97a was based on the hope that excision of the phenyl ring from 95a would 
improve aqueous solubility and decrease the steric bulk near the reactive centre.  In 
compound 98a, an electron-withdrawing fluorine substituent was introduced at the 
propargylic position to lower the energy of the LUMOdipolarophile and promote reaction 
with the azide.  In a series of model reactions, the rates of reaction of benzyl azide with 
the cyclooctynes 95a, 97a and 98a were compared.   Whilst 95a and 97a displayed 
similar kinetics, significant rate enhancement was observed with the fluorinated 
cyclooctyne 98a.  Consequently, the biotinylated derivative, 98b, was found to react 
more rapidly than the corresponding compounds 95b and 97b with azide-labelled 
glycoproteins in cell lysates and on cell surfaces. 
 
Figure 4.1.  The cyclooctynes 95, 97 and 98 prepared and investigated in SPAAC by Bertozzi et 
al.188 
The Bertozzi group reported an additional increase in the rate of cycloaddition upon 
incorporation of a gem-difluoro group at the propargylic position of the cyclooctyne   
(99, figure 4.2).189  Significantly, the extra electron-withdrawing group further 
activated the alkyne moiety without creating an electrophilic Michael acceptor capable 
of alkylating biological nucleophiles.  Similar rate enhancement for the SPAAC was 
observed with the novel cyclooctyne 100, which introduced further ring strain by 
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fusion of two aromatic rings to a cyclooctyne core.190  Incorporation of an amide 
functionality within the cyclic scaffold, as in 101, resulted in a further increase in 
reactivity.191 The structurally related azacyclooctyne 102, bearing an exocyclic amide 
bond, was also observed to undergo efficient cycloaddition with azides.192,193  Other 
examples from the literature include the photocaged and tetramethoxy 
diarylcyclooctyne derivatives 103194 and 104.195 
 
Figure 4.2.  Cyclooctyne derivatives reported in copper-free click chemistry applications 
Although aryl rings fused to the cyclooctyne scaffold may improve reactivity, the 
corresponding increase in lipophilic character may compromise the utility of these 
compounds in biological applications.  In addition to the expected poorer water 
solubility, lipophilic compounds may engage in unwanted hydrophobic interactions 
with proteins.  Indeed, even relatively hydrophilic cyclooctynes have been shown to 
experience issues of bioavailability and solubility.  In one of the few in vivo applications 
of SPAAC, Bertozzi and co-workers found that the bioavailability of a biotinylated 
derivative of the cyclooctyne 99 was compromised by binding to serum albumin.196   
The kinetic and lipophilicity data for the strained alkynes 95, 97-104 is summarised in 
table 4.1.  Rate constants (k) are for the reaction with benzyl azide in acetonitrile.  The 
calculated partition coeffecients (clogP) are a measure of molecular hydrophobicity, 
and were calculated using BioByte (embedded in ChemBioDraw 12.0) for the N-
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methylamide derivative of carboxylic acids and the N-methyl carbamate derivative of 
alcohols (high clogP =  high lipophilicity).197 
Compound clogP k (x 10-3 M-1 s-1) Ref. 
95a 3.3 2.4 187 
97a 1.7 1.3 188 
98a 4.8 4.3 188 
99 1.3 76 189 
100 4.4 57 190 
101 3.9 960 191 
102 3.5 310 192,193 
103 4.0 76 194 
104 3.7 94 195 
Table 4.1.  clogP values and rate constants (k) for the reaction of the cyclooctynes 95, 97-104 
with benzyl azide in acetonitrile197 
Synthetic accessibility is another factor which determines the general value of a 
particular cyclooctyne.  For example, the enhanced reactivity of the difluoroalkyne 99 
has to some extent been overshadowed by a lengthy, poor yielding synthesis (10 steps, 
1.2% yield),179 while the syntheses of 100 (5 steps, 10% yield) and 102 (9 steps, 41% 
yield) are also ineffecient.  The simple cyclooctynes 95a (4 steps, 52% yield) and 97a (4 
steps, 10% yield) present less of a synthetic challenge, but are as discussed less 
valuable as a result of their inferior reactivity. 
 
4.1.4 Strain-promoted modification of nucleic acids 
In the wake of recent developments such as DNA sequencing and RNAi diagnostics and 
therapeutics, there is an ever increasing demand for efficient bioconjugation strategies 
for oligonucleotides.  While conjugation using CuAAC has proven popular, issues exist 
relating to Cu(I) mediated oxidative cleavage of DNA and cytotoxicity resulting from 
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copper contamination in nucleic acid products.191,198  Careful selection of Cu(I) 
stabilising ligands has been shown recently to avoid DNA degradation and even 
facilitate CuAAC in living organisms.199  Nonetheless, chemistries which avoid the use 
of copper are still preferable for the preparation of oligonucleotide conjugates.  Our 
group has previously reported oligonucleotide conjugation by strain-promoted nitrile 
oxide cycloaddition (SPNOC) on the solid phase,200 while others have reported a similar 
approach employing azides as the dipole.201,202  However, these studies also differ in 
that they have concentrated on solution over solid phase conjugation.  The appeal of 
solid phase conjugation includes ease of purification and the possibility to automate; 
as such the next goal of our research was to design a methodology for the resin-
supported post-synthetic modification of nucleic acids using the SPAAC approach.  A 
further goal was demonstration of the SPAAC with simple, non-fluorinated monocyclic 
octynes as an alternative to the more commonly employed diarylcyclooctynes.  The 
benefits of employing a simple cyclic alkyne in strain-promoted cycloadditions should 
include ease of synthetic access and superior kinetics with bulky azides.  In addition, 
the decreased lipophilicity and steric bulk may be advantageous for drug delivery, 
biomedical and imaging applications, where aqueous solubility and a decreased 
tendency to interact with hydrophobic proteins are paramount.  Advanced applications 
in which the ‘click’ reaction is carried out in vivo between genetically encoded azides 
and cyclooctyne lablels may also proceed more smoothly.  Thus, the goal was to 
develop post synthetic oligonucleotide conjugation on the solid phase by strain 
promoted cycloaddition between azide dipoles and simple monocyclic octynes, as 
summarised in scheme 4.3. 
 
Scheme 4.3.  Resin-supported, post-synthetic oligonucleotide conjugation by SPAAC 
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4.2 Results and Discussion 
 
4.2.1 Synthesis of the resin-supported DNA-cyclooctynes 110 and 112 
The strategy for the synthesis of cyclooctyne-linked oligonucleotides required initial 
preparation of 108 as the key intermediate (scheme 4.4).  The synthesis of 108 has 
been reported previously by our research group.200  Starting from commercially 
available cycloheptene (105), the already known bicycle 106 was obtained following 
condensation with bromoform in the presence of potassium tert-butoxide.203 
Following electrocyclic ring opening of 106, the intermediate trans-allylic cation was 
captured with 1,4-butanediol to afford the bromo alcohol 107, which was used without 
further purification.  Finally, treatment of 107 with sodium hydride induced loss of HBr 
and furnished the cyclooctyne derivative 108.  For each synthetic step, reaction 
progress was monitored by TLC, with the exception of the formation of 108, since the 
starting material and product displayed identical retention factors in a range of solvent 
systems.  This reaction was thus monitored by 1H NMR spectroscopy following work-up 
of a small sample of the reaction mixture (figure 4.3).  Disappearance of the 
characteristic olefinic proton resonance was indicative of the consumption of 
compound 107.  In addition, a slight downfield shift in the signal for the proton on the 
chiral carbon atom was observed in the product 108.  Significantly, the cyclooctyne 108 
is prepared in just three steps, with an overall yield of 33%.  In terms of synthetic 
accessibility, this compares well with the simple cyclooctynes 95a (4 steps, 52% 
yield)187 and 97a (4 steps, 10% yield),188 and is significantly more efficient than the 
tedious and low-yielding syntheses of 100 and 102 (see section 4.1.3, page 106).   
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(i) CHBr3, KOtBu, pentane, rt, 24 hr 
(ii) AgClO4, 1,4-butanediol, toluene/pyridine, reflux, 4 hr 
(iii) NaH, DMF, 1 hr 
Scheme 4.4.  Synthesis of the cyclooctyne derivative 108200 
 
Figure 4.3.  1H NMR spectra of the bromoalkene intermediate 3 and the cyclooctyne 4 
The presence of a pendant hydroxy group on the cyclooctyne 108 facilitated 
straightforward conversion to the corresponding phosphoramidite 109, which was 
achieved following reaction with 2-cyanoethyl-N,N,N‘,N‘-
tetraisopropylphosphoramidite (16) in the presence of BMT as activator (scheme 4.5).  
In addition to a signal at 147.2 ppm characteristic of the desired phosphoramidite 109, 
the 31P NMR spectrum showed a number of signals in the region of ~10-30 ppm 
suggestive of some P(V) impurities (figure 4.4).  It was determined that these by-
products were not likely to be detrimental to coupling with oligonucleotides; thus 
compound 109 was used without further purification. 
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Coupling between the CPG-oligonucleotides 24 and 28 and the phosphoramidite 109 
was carried out manually on the solid phase,†† employing BMT as an activator (scheme 
4.5).  Following cleavage of the DNA-cyclooctyne conjugate from the resin, successful 
coupling was confirmed by HPLC and MALDI-TOF MS analysis. 
Figure 4.4.  31P NMR spectrum of crude phosphoramidite 109 
 
(i) BMT, 16, CH3CN, rt, 30 min 
(ii) BMT, CH3CN, rt, 30 min 
(iii) I2 (0.1 M) THF-pyridine-H2O 
Scheme 4.5.  Synthesis of resin-bound DNA-cyclooctyne conjugates 110 and 112 
                                                     
 
††
 For a description of manual phosphoramidite coupling on the solid phase, see section 2.2.3, page 34 
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4.2.2 Selection and synthesis of azide labels 
To demonstrate the utility of solid phase SPAAC with the DNA-cyclooctynes 110 and 
112, a range of azides were required.  For initial proof of concept studies we selected 
the small, simple dipoles benzyl azide (114) and cinnamyl azide (115).  The former was 
commercially available, while the latter, a known compound,204 was prepared by 
nucleophilic displacement of cinnamyl bromide with sodium azide.  
 
Figure 4.5.  Azide reaction partners for SPAAC to DNA-cyclooctynes 110 and 112 
More complex azides were required to investigate the success of coupling with 
biologically relevant labels, e.g. those used in imaging or biomedical applications.  
Oligonucleotide-carbohydrate conjugates have the potential for improved cellular 
uptake;205 with this in mind the commercially available glucose label 116 was selected 
as a relevant partner.  For the same reason, the cholesterol azide 118 was selected.  
Conjugation of oligonucleotides to lipophilic moieties has been shown to assist 
crossing of the lipid bilayer, and so provides hope of a non-toxic alternative to cationic 
liphophilic or polymeric delivery systems.202,206  The preparation of compound 118 
required access to the azidohydrazide 122 as a key building block; this was obtained in 
two steps from ethyl bromoacetate (scheme 4.6).  Nucleophilic displacement of 120 
with sodium azide proceeded quantitatively to give the intermediate 121,204 which was 
used without further purification.  Reaction of 121 with hydrazine monohydrate 
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afforded the azido compound 122, which was coupled with commercially available 
cholesterol chloroformate (124) to yield the desired product 118.   
 
(i) NaN3, H2O/Me2CO, rt, 30 min 
(ii) NH2NH2.H2O, EtOH, rt, 2 hr 
(iii) Et3N, DMF, rt, 18 hr  
Scheme 4.6.  Synthesis of the biotin and cholesterol azide labels, 117 and 118 
The 1H NMR spectral data for 118 is shown (figure 4.6).  While most of the signals are 
densely located in the region of ~0.7-2.0 ppm, some diagnostic signals are seen in the 
downfield region.  The two NH proton signals present as broad singlets at 8.19 and 
6.75 ppm, while the olefinic proton of the cholesterol moiety is represented by a 
narrow doublet at 5.38 ppm.  Other characteristic signals include the multiplet 
resonance at ~4.6 ppm which represents the proton geminal to the oxygen atom of 
the carbamate group, and the singlet at 4.08 ppm corresponding to the methylene 
protons adjacent to the azide moiety.   
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Figure 4.6.  1H NMR spectrum of the cholesterol azide 118 
Synthesis of the biotin-labelled azide 117 followed a parallel route to that described 
for the preparation of the cholesterol compound 118, with the final step involving 
coupling of 122 with the biotin NHS-ester 123 (scheme 4.6).  Biotinylation is commonly 
employed to detect biomolecules by exploiting the strong binding interaction between 
biotin and the protein streptavidin.  Conjugation of streptavidin to a reporter enzyme 
such as horseradish peroxidise (HRP) can facilitate both qualitative and quantitative 
detection of various biomolecules.207   
The labelling of oligonucleotides with fluorescent probes can have obvious benefits in 
terms of bio-imaging; the fluorescein labelled azide 119 was therefore deemed to be 
an interesting candidate for our studies.  The synthesis of 119 required initial 
preparation of the key intermediates 125 and 126 (scheme 4.7).  Compound 126 was 
known in the literature,208 and was obtained from reaction between 2 equiv. of 1,4-
dibromobutane and 1 equiv. of sodium azide.  Coupling of 126 with the fluorescein 
methyl ester 125 (itself prepared following reflux of the parent fluorescein in 
methanolic sulphuric acid for 12 hr) furnished the desired fluoroscein azide 119 in 69% 
yield. 
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The 1H NMR spectrum of 119, in which some of the characteristic signals are 
highlighted, is shown below (figure 4.7).  The two pairs of methylene protons adjacent 
to the oxygen and nitrogen atoms in the alkyl chain appear as triplets in the range of 
~3.4-4.1 ppm.  The methyl protons of the ester group present as a singlet at 3.64 ppm, 
and the relative integration of this signal to the two CH2 signals is ~3:2:2. 
 
(i) K2CO3, DMF, 70 
oC, 2 hr 
Scheme 4.7.  Synthesis of fluorescein azide 119 
 
Figure 4.7.  1H NMR spectrum of the fluorescein azide 119 
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4.2.3 SPAAC on the solid phase 
4.2.3.i Cycloadditions with the CPG-T10-cyclooctyne 110 
Exploratory cycloadditions were carried out between the simple azido compounds 114 
and 115 and the resin-bound T10-cyclooctyne 110 (scheme 4.8).  These reactions were 
performed on a 0.2 µmol scale, and initially a large excess (90 equiv.) of azide was used 
to ensure complete reaction.  To assist in solubility, aqueous DMSO was employed as 
solvent; the volume used was such that the working concentration of the azido 
compounds was ~140 mM.  Encouragingly, complete conversion of the starting 
material to the desired triazolyl products 127a,b was observed following agitation of 
the reaction mixture at rt for 30 min.  This was evidenced by HPLC and MALDI-TOF MS 
analysis of the cleaved conjugates 128a,b. 
Significantly, two product peaks of similar magnitude were observed in each case.  This 
was unsurprising, as azide-alkyne cycloadditions are known to exhibit little 
regioselectivity in the absence of a catalyst.  This loss in regioselectivity is seen as an 
acceptable trade-off for the non-toxic metal-free conditions used.  The regioisomeric 
products elute slightly later than the starting material, and the cycloaddition reaction 
displays a small preference for formation of the later eluting regioisomer (figure 4.8). 
 
Scheme 4.8.  Solid phase SPAAC to form the resin-bound cycloadducts 127a-d 
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Figure 4.8.  Overlaid chromatograms of the T10-cyclooctyne 111 (red) and the crudeT10-triazolyl 
cycloadducts 128a (blue) and 128b (green) 
When considering the optimised conditions for cycloaddition, we turned to the 
findings of a previous study by our research group, in which the solid phase strain-
promoted nitrile oxide cycloaddition (SPNOC) of the CPG-DNA-cyclooctyne 110 with a 
range of simple nitrile oxides was investigated (scheme 4.9).200  In each case, agitation 
of 110 in the presence of in situ generated nitrile oxide (30 mM, 16 equiv.) in aqueous 
EtOH for 10 min was sufficient for completion of reaction.  Guided by these results, 
cycloaddition of 110 was once more attempted with benzyl azide (114) in 50% aqueous 
DMSO, this time with a lower concentration and number of equivalents of the azide 
(50 mM, 20 equiv.). Unfortunately, these conditions were found to be insufficient for 
complete reaction.  Subsequently, the concentration of 114 was increased from 50 to 
140 mM and reaction with the resin-bound DNA-cyclooctyne 110 was re-attempted.  
Gratifyingly, quantitative conversion of 110 to the triazolyl cycloadduct 127a was in 
this case observed following deprotection/cleavage of the product and analysis by RP-
HPLC.  Employment of these conditions in the cycloaddition of 110 with cinnamyl azide 
(115) gave similar results.  These findings demonstrate that while reaction of the DNA-
cyclooctyne 110 displays slower kinetics with azides than with nitrile oxides, similar 
reaction rates can be achieved by increasing the effective concentration of the azide 
dipole. 
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Scheme 4.9.  Modification of CPG-DNA-cyclooctynes by SPNOC 
Having completed proof of concept studies with the small azides 114 and 115, the 
potential for conjugation of some more complex labels was investigated.  Thus, the 
glucose and biotin azides 116 and 117 were investigated.  Pure DMSO was necessary to 
solubilise the azido sugar 116, and a 140 mM solution was prepared.  Agitation of the 
resin-bound T10-cyclooctyne 110 in the presence of 20 equiv. of 116 for 4 hr was found 
to be sufficient for complete conversion of the starting material to the product 127c.  
Following cleavage of the products from the solid support, HPLC analysis showed peak 
splitting, which was attributed to employment of the sugar 116 as a mixture of 
anomers (figure 4.9).  MALDI-TOF MS analysis of the products 128c indicated that 
deacetylation of the glucose moiety had occurred under the basic conditions of the 
cleavage/deprotection protocol.  
Similar conditions were employed for cycloaddition with the biotin azide 117.  In this 
case, 90% aqueous DMSO was the solvent of choice.  Again, 4 hr reaction time was 
required, after which cleavage of the product 127d from the resin and analysis by HPLC 
confirmed complete consumption of the starting material 110.  Consistent with 
previous observations, two sharp regioisomeric product peaks were observed, and the 
formation of the products 128d was supported by MALDI-TOF MS.  Interestingly, the 
sugar and biotin conjugates 128c,d had a shorter retention time than the parent T10-
cyclooctyne starting material, 111 (figure 4.9). 
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Figure 4.9.  Overlaid chromatograms of the crude T10 triazolyl cycloadducts 128c (blue) and 
128d (green), and the T10-cyclooctyne starting material 111 (red) 
Since the electronics of the azide has been shown to have little influence on the 
outcome of strain-promoted cycloadditions,188 the slower reaction of the CPG-T10-
cyclooctyne 110 with 116 and 117 has been attributed to their increased steric 
demand in comparison to the azides 114 and 115.  It is also encouraging that the 
observed reaction rates compare favourably with those reported for SPAAC involving 
activated dibenzocyclooctynes conjugated to RNA.202,209  The required reaction times 
and solvent composition for formation of the SPAAC cycloadducts 128a-d is 
summarised in table 4.2. 
Azide Reaction solvent Reaction time Product 
114 50% aq. DMSO 30 min 128a 
115 50% aq. DMSO 30 min 128b 
116 DMSO 4 hr 128c 
117 DMSO 4 hr 128d 
Table 4.2.  Reaction conditions for formation of T10 conjugates 128a-d from the azides 114-117 
and the DNA-cyclooctyne 110 
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4.2.3.ii Cycloadditions with CPG-mixed 12-mer-cyclooctyne 112 
Having demonstrated the success of SPAAC with a decathymidine sequence and the 
azides 114-117, the compatibility of a mixed DNA sequence, containing all 4 bases with 
their standard protecting groups, was next explored (scheme 4.10).  The CPG-12-mer 
28 (3’-CGCACACACGCT-5’) was selected and the cyclooctyne introduced in a manner 
described in section 4.2.1. 
 
Scheme 4.10.  Solid phase SPAAC to form the resin-bound cycloadducts 130a-e 
Preliminary cycloadditions with the DNA-cyclooctyne 112 focused on the simple benzyl 
and cinnamyl labelled azides 114 and 115.  In each case a solution of the azide (20 
equiv., 140 mM) in 50% aqueous DMSO was added to the resin-bound 12-mer-
cyclooctyne 112 in an eppendorf tube and the mixture was agitated for 30 min at room 
temperature.  Following deprotection and cleavage of the reaction products 130a,b 
(28 % NH4OH, rt, 24 hr), the HPLC traces of the crude products showed complete 
consumption of the starting material (figure 4.10).  The profile of each chromatogram 
was quite similar to that observed for the T10 products, with the similar polarity 
characteristics of the starting material and the products resulting in little difference in 
retention times.  Co-injection of a sample of the DNA-cyclooctyne 113 with the 
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product sample in each case confirmed that the two major peaks did indeed represent 
the regioisomeric products.  The regioselectivity was also very similar to that observed 
for the T10 cycloadducts. 
 
Figure 4.10.  Overlaid chromatograms of the DNA-cyclooctyne starting material 113 (blue) and 
the crude DNA-triazolyl cycloadducts 131a (red) and 131b (green) 
Reaction of 112 with the biotin azide 117 was found to proceed smoothly under 
identical reaction conditions to those used for the preparation of the analogous T10-
cycloadduct 127d.  Deprotection and cleavage from the resin yielded a crude sample of 
131c.  In this case, purification of the product was deemed necessary; this was 
achieved by preparative RP-HPLC.  Removal of impurities was confirmed by re-injection 
of the pure fractions (figure 4.11).  These were then combined, concentrated and 
analysed by MALDI-TOF MS, which confirmed the structural integrity of the product 
131c. 
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Figure 4.11.  Overlaid chromatograms of crude (red) and purified (green) biotin cycloadduct 
131c, and DNA-cyclooctyne starting material 113 (blue) 
As discussed in section 4.2.2, the conjugation of lipids to oligonucleotides is known to 
improve cellular uptake.  However, despite advances in the post-synthetic modification 
of oligonucleotides, the conjugation of steroidal groups remains non-trivial.  Two 
recent reports have employed CuAAC in the preparation of steroidal oligonucleotide 
conjugates.  In one example, the key ligation step is carried out on the monomeric 
scale.206  The modified monomer is then incorporated into an oligonucleotide 
sequence using standard phosphoramidite coupling methodology.  In the second 
example, microwave-assisted click conjugation is performed with a resin-bound 
oligonucleotide-alkyne.202  Since the minimum acceptable concentration of copper for 
pharmaceutical applications is 15 ppm,210 a non-toxic, catalyst-free alternative for the 
conjugation of lipids to nucleic acids would have obvious advantages.   
Solubility can be an issue for steroidal compounds, but the cholesterol azide 118 was 
found to be satisfactorily soluble in chloroform.  Reaction beween the DNA-
cyclooctyne 112 and 118 (20 equiv., 140 mM) was thus carried out on a 0.2 µmol scale, 
employing chloroform as the solvent.  After 24 hr agitation at room temperature, the 
crude reaction products 130d were deprotected and cleaved from the resin using the 
standard protocol and analysed by RP-HPLC.  Problems arose initially in the analysis 
due to the strong retention of the lipophilic conjugate by the non-polar C18 column.  
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Consequently, the product HPLC trace showed no evidence of cycloaddition.  However, 
employment of a less-polar C8 phase resulted in weaker retention of the product, and 
two peaks representing the regioisomeric cycloadducts were observed at 23.2 and 
23.8 min (figure 4.12).  As a consequence of the slow elution of the regioisomeric 
products, considerable peak broadening was observed, although significant separation 
from the earlier eluting impurities was nonetheless achieved.  This facilitated relatively 
straighforward purification of the crude products by preparative HPLC, yielding a pure 
sample of 131d.  This was analysed by MALDI-TOF MS, which confirmed formation of 
the desired product. 
 
Figure 4.12.  Overlaid chromatograms of the crude DNA-cyclooctyne starting material 113 
(blue) and the pure cholesterol cycloadduct 131d (red) 
In recent years fluorescent tags have replaced radioactive labels as one of the most 
useful tools for probing cellular mechanisms.  We wished to investigate the 
compatibility of the azido compound 119 with the SPAAC approach, with a view to 
preparation of fluorescently labelled oligonucleotides.  Original cycloadditions 
employed either 90% aqueous DMF, DMSO or CHCl3 as the reaction solvent.  Following 
agitation of the CPG-DNA-cyclooctyne 112 in the presence of the fluorescein azide 119 
(20 equiv., 140 mM) overnight at room temperature, reaction work-up involved 
washing away the excess azide with a suitable organic solvent, e.g. CHCl3.  After 
extensive washing the resin still displayed an intense yellow colour and was highly 
fluorescent, as would have been expected if the resin-bound oligonucleotide has been 
trapped by the fluorescein azide 119.  However, upon exposure of the solid-supported 
reaction products to the basic cleavage/deprotection conditions, the yellow colour was 
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seen to gradually fade, before disappearing altogether.  At this point, we hypothesised 
that this loss of colour was due to hydrolysis of the ester moiety, which was 
convalently linked to the fluorescein chromophore, leading to a non-fluorescent 
lactone.211  Nonetheless, we continued with the characterisation of these colourless 
samples.  The HPLC traces of the crude products displayed double peaks typical of 
regioisomeric cycloaddition products (figure 4.13), and reactions were deemed to be 
85-100% complete on the basis of the relative areas of the starting material and 
product peaks.  Following purification of a representative sample by preparative HPLC, 
MALDI-TOF MS analysis supported formation of the proposed lactone form of the 
cycloadduct (compound 131f).  The structure of 131f and its proposed mechanism of 
formation are shown in scheme 4.7.  The loss of fluorescence can be attributed to the 
loss of conjugation resulting from formation of the lactone ring. 
 
Scheme 4.11.  Proposed mechanism for formation of the spiro-lactone product 
The instability of the fluorescein methyl ester under the basic conditions required for 
deprotection/cleavage lead us to pursue a solution phase approach to this 
cycloaddition.  By initial cleavage of 112 from the resin and reaction of the resulting 
DNA-cyclooctyne 113 with the fluroescein azide 119 in the solution phase, exposure of 
the fluorescein ester to base can be avoided, and thus the highly fluorescent 
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tetracyclic skeleton is preserved.  Indeed, this approach, employing 20 equiv. of azide 
(110  mM in DMF) with a reaction time of 18 hr, yielded an intensely coloured solution 
after work-up.  However, HPLC analysis of this sample demonstrated only ~35% 
conversion to the desired products.  This could be increased to 80% conversion  upon 
doubling the amount of the azide used to 40 equiv.  Following purification of the 
triazolyl products 131e by HPLC, MALDI-TOF MS analysis confirmed that the structural 
integrity of the fluorescein chromophore was indeed intact.  The HPLC traces of the 
the oligonucleotides conjugates 131e and 131f are shown in figure 4.13. 
 
(i) 28% aq. NH4OH, rt, 24 hr 
(ii) DMF, rt, 18 hr 
Scheme 4.12.  SPAAC in the solution phase 
 
Figure 4.13.  Overlaid chromatograms of the DNA-cyclooctyne starting material 113 (blue), and 
the purified triazolyl cycloadducts 131f (red) and 131e (green)  
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Azide Reaction solvent Reaction Time Product 
114 DMSO:H2O 1:1 30 min 131a 
115 DMSO:H2O 1:1 30 min 131b 
117 DMSO:H2O 9:1 4 hr 131c 
118 CHCl3 24 hr 131d 
119[a] DMSO:H2O 9:1 18 hr 131e 
119 CHCl3:H2O 9:1 18 hr 131f 
 [a] This reaction was conducted in solution phase 
Table 4.3.  Conditions for the preparation of DNA-triazolyl conjugates 131a-f 
 
4.2.4.iii Cycloadditions with CPG-2’-OMe RNA-cyclooctynes 
DNA is a relatively robust biomolecule with respect to RNA, which can be tricky to 
handle due to its sensitivity to various nucleases present on the skin or in the typical 
lab environment.  Therefore, when attempting to apply a new methodology to the 
modification of RNA, it is often useful for initial proof of concept studies to focus on 
DNA.  Owing to the vastly similar structure and chemical properties of these two 
biomolecules, results obtained with DNA more often than not translate well to RNA.  
The next goal of the project was to investigate the compatibility of the SPPAC 
approach outlined above with RNA for the provision of sequences labelled with groups 
likely to increase their stability, cellular delivery or visibility, e.g. fluorescent tagging; 
these conjugates may have significant benefits when employed in RNAi applications.   
Initial studies focused on the CPG-U4-cyclooctyne
‡‡ 134, which was prepared following 
coupling of the cyclooctyne-phosphoramidite 109 to the resin-bound U4 sequence 132 
(scheme 4.13) using a procedure parallel to that outlined in section 4.2.1.  The RNA 
                                                     
 
‡‡
 Underlined base denotes a 2’-OMe protected nucleoside 
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used was blocked at the 2’-position of each sugar with an OMe group.  Use of the 2’-
OMe ‘blocking group’ is popular when working with RNA, as it increases stability and 
nuclease resistance without interfering with the intracellular RNAi machinery.10   
 
(i) BMT, CH3CN, rt, 30 min 
(ii) I2 (0.1 M) THF-pyridine-H2O 
Scheme 4.13.  Synthesis of 2’-OMe RNA-triazolyl conjugates by SPAAC 
The benzyl, cinnamyl and biotin azides 114, 115 and 117 were chosen as test cases, 
and a large excess (~100 equiv.) was used to drive each reaction to completion.  
Agitation of the reaction mixtures for 2 hr in aqueous DMSO was followed by work-up 
and cleavage from the resin.  The work-up procedure for 2’-OMe RNA was the same as 
that used for DNA.  HPLC analysis of the products 137a-c demonstrated complete 
consumption of the starting material in each case (figure 4.14). 
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Figure 4.14.  Overlaid chromatograms of the U4-cyclooctyne 135 (blue), and the U4-triazolyl 
cycloadducts 137a (red), 137b (green) and 137c (black) 
The results observed with the U4-cyclooctyne confirmed that SPAAC was successful 
with a small RNA sequence.  Conjugation to a more complex sequence was next 
investigated.  Thus, the resin-bound 2’-OMe RNA-cyclooctyne conjugate 138, a 19-mer 
containing all four bases with their standard protecting groups, was prepared.  This 
sequence was also the approximate length of those employed for formation of 
synthetic siRNA duplexes; as such its compatibility with the SPAAC methodology could 
provide a novel route to modified siRNAs on the solid phase.   
Cycloaddition of 138 with the benzyl and cinnamyl azides 114 and 115 was carried out 
under parallel conditions to those employed for the analogous reaction with the DNA-
cyclooctyne 112.  Thus, following 30 minutes agitation of the reaction mixture at room 
temperature and cleavage from the resin, analysis of the crude products by HPLC 
showed that all of the starting material had been consumed.  Notably, the 
chromatograms of the crude reaction products 141a,b contained more early eluting 
impurities than the corresponding DNA cycloadducts (figure 4.15).  These impurities 
can be traced back to the RNA-cyclooctyne starting material, and were attributed to 
failed sequences arising from the synthesis of the 19-mer RNA.  Even if the coupling 
efficiency of each step is > 98%, these failed sequences can build up during the 
synthesis of a relatively long oligonucleotide.  In this case, however, it was reasonably 
simple to remove these impurities by preparative HPLC.  As a representative example, 
the HPLC traces of crude and purified 141a are shown in figure 4.16. 
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Figure 4.15.  Overlaid chromatograms of the crude RNA-cyclooctyne starting material 139 
(blue), and the crude RNA-triazolyl cycloadducts 141a (red) and 141b (green) 
 
 
Figure 4.16.  Overlaid chromatograms of crude (blue) and purified (red) benzyl cycloadduct 
141a 
Investigation of cycloaddition with the more complex azides 117 and 118 employed 
the same optimised conditions used for reaction with DNA.  Consequently, the 
cycloadduct 140c was formed in near quantitative yield after 4 hr reaction beween 138 
and the biotin azide 117 (20 equiv., 140 mM).  Similarly, after 24 hr agitation of 138 in 
a suspension of the cholesterol azide 118 in CHCl3, the resin-bound RNA-conjugate 
140d was formed.  Cleavage/deprotection and purification by HPLC yielded the 
cycloadducts 141c,d (figure 4.17), which were further characterised by MALDI-TOF MS. 
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Figure 4.17.  Overlaid chromatograms of purified RNA-cyclooctyne starting material 139 (blue), 
and purified triazolyl cycloadducts 141c (red) and 141d (green) 
The instability of the the fluorescein methyl ester group under the basic conditions 
necessary for deprotection/cleavage guided the approach to the preparation of a 
fluorescently labelled RNA-conjugate.  A sample of the RNA-cyclooctyne 139, purified 
by preparative HPLC, was agitated in the presence of a solution of the fluorescein azide 
119 in DMF for 18 hr at room temperature.  HPLC analysis of the products following 
work-up demonstrated complete consumption of the starting material 139 (figure 
4.18), and MALDI-TOF MS analysis confirmed formation of the triazolyl cycloadduct 
141e. 
 
Figure 4.18.  Overlaid chromatograms of purified RNA-cyclooctyne 139 (blue), and the crude 
fluorescein cycloadduct 141e (red) 
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4.2.5 Conclusions 
Solid phase SPAAC conjugation of several biologically interesting labels to both DNA 
and 2’-OMe RNA has been demonstrated.  This methodology employs mild, copper-
free conditions and is high yielding, efficient and broad in scope.  Although the rate of 
reaction of these cyclooctyne-functionalised oligonucleotides is slower with azides 
than with nitrile oxide dipoles at similar concentrations,200 this can be compensated by 
increasing the concentration of azide in the reaction mixture.  While application of 
SPAAC to oliognucleotide conjugation has been reported previously,201,212 these 
examples require lengthy (10 steps), non-trivial syntheses to produce a suitable 
cyclooctyne conjugate. In contrast, the DNA/RNA-cyclooctynes employed here can be 
obtained in five  synthetic steps,200 and still undergo efficient SPAAC with azide dipoles.  
Compatibility of this methodology has been demonstrated with azides of varying steric 
and electronic demands, including biotin, fluorescein, and cholesterol; the resulting 
conjugates may prove valuable in an array of bioanalytical and therapeutic 
applications.  Indeed, the general approach described here could potentially be used to 
modify nucleic acids with a variety of structurally and functionally diverse labels, which 
need only be functionalised with a simple azide moiety to facilitate attachment.   
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4.2.6 Future Work 
 Expand the scope of the pre-synthetic approach to chemically modified 
oligonucleotides by employing a wider range of alkyne click partners bearing 
labels of varying synthetic and biological interest. 
 Determine the photochemical properties of a range small molecule and 
oligonucleotide-azobenzene conjugates to establish the existence, or not, of a 
relationship between the extent of conjugation between the azobenzene 
moiety and the linker (isoxazole) unit to nucleic acids, e.g. compare the the λmax 
of the π- π* and n- π* transitions of the azobenzene unit in the cycloadducts 
77a,b with the oligonucleotide-conjugates 94a,b. 
 Develop a synthetic route to 67c; perhaps attempt reduction of the primary 
alcohol 74c to the aldehyde 142 prior to condensation with nitrosobenzene to 
form the azobenzene, which may avoid reactivity at the azo group.  Preparation 
of the ortho-substituted oligonucleotide-azobenzene conjugate 94c and 
comparison of its photochemical and kinetic properties with those of 94a and 
94b may yield further insight into the nature of the trans-cis equilibrium of 
these isoxazole-linked azobenzene conjugates. 
 
Scheme 4.14.  Proposed synthesis of ortho-substituted oligonucleotide-conjugate 94c 
 
Chapter 4  SPAAC labelling of nucleic acids 
132 
 
 Prepare an oligonucleotide-AB conjugate bearing the photoresponsive unit at 
an internal position, analogous to 94, and investigate the melting properties of 
the duplex composed from  such a sequence with a complementary strand of 
DNA.  This experiment will inform on the influence of the isoxazole-
modification on the thermal stability of the duplex under the Irr and DA 
adapted conditions.  
 Investigate the potential of labelled siRNAs prepared using the methodology 
described in chapter 4 to effect RNAi in a biological environment.  A key 
experiment should be designed to compare the ability of a cholesterol-labelled 
siRNA analogue of 141d and a native unlabelled duplex to effect knockdown of 
a particular gene, e.g. green fluorescent protein gene.  In such a case the 
lipophilic character of the cholesterol moiety may be expected to assist siRNA 
in crossing the cell’s lipid bilayer. 
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5.1 Instrumentation 
Standard reagents were supplied by either Apollo Scientific, TCI Europe, or Sigma-
Aldrich and were used as received without further purification.  Solvents were distilled 
before use and purified according to standard procedures. Analytical TLC was 
performed on precoated (250 μm) silica gel 60 F-254 plates from Merck. All plates 
were visualised by UV irradiation and/or staining with Hanessian’s stain (5 g 
(NH4)6Mo7O24.4H2O, 1 g Ce(SO4)2, 10 mL conc. H2SO4 in 90 mL H2O) followed by 
heating.  Flash chromatography was performed using silica gel 32–63 μm, 60 Å. 
Electrospray (ESI) mass spectra were collected on an Agilent Technologies 6410 Time 
of Flight LC/MS.  NMR spectra were obtained with a Bruker instrument at 25 °C (1H at 
300 MHz; 13C at 75 MHz, 31P at 121 MHz).  Chemical shifts are reported in ppm 
downfield from TMS as standard.  NMR spectra are recorded in CDCl3 unless otherwise 
stated.  UV-Vis spectra were recorded with a Jasco V-630BIO spectrophotometer at 25 
°C.  Infrared spectra were recorded as KBr discs or liquid films between KBr plates 
using a Perkin Elmer System 2000 FT-IR spectrometer. Melting point analyses were 
carried out using a Stewart Scientific SMP 1 melting point apparatus.   
All materials used in DNA/RNA synthesis were supplied by either Link Technologies or 
ChemGenes.  Oligonucleotide synthesis was carried out on an Expedite DNA/RNA 
synthesiser on a 1 mol scale using standard DNA and RNA phosphoramidites. 
Standard nucleobase protecting groups were used.  BMT (0.2 M) was used as 
activating agent.  Oxidation was performed using 8:1:1 THF:pyridine:H2O containing 20 
mM I2.  Deprotection/cleavage of both native and modified DNA/2’-OMe RNA was 
achieved following incubation in either: 
(i) 40% aqueous CH3NH2 (500 μL) at 65 
οC for 30 minutes (for oligonucleotides 
containing thymine bases only) 
(ii) 28% aqueous NH4OH (500 μL) at 25 
oC for 24 hr (for mixed sequences of 
oligonucleotides containing all four bases) 
CH3NH2/ NH4OH was evaporated using a concentrator.  The CPG was washed with H2O 
(3 x 150 μL aliquots), and all solutions and washings were combined to afford an 
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aqueous solution of DNA, which was analysed and if necessary, purified, by RP-HPLC 
on a Nucleosil column (unless otherwise stated) under the following conditions: 
Column: Nucleosil C18 (4.6 x 250 mm).  Buffer A: 0.1 M TEAAc, pH 6.5, 5% (v/v) MeCN, 
buffer B: 0.1 M TEAAc, pH 6.5, 65% (v/v) MeCN.  Gradient: 0-4.3 min, 5% B; 4.3-16.6 
min, 5→100% B.  Flow rate: 1.0 mL/min.  Detection at 260 nm with a diode array 
detector. 
DNA/2’-OMe RNA was desalted with illustra™ NAP™-10 Sephadex™ G-25 DNA grade 
columns purchased from GE Healthcare.  Mass spectral data was obtained by MALDI-
TOF MS recorded by Metabion, Germany, unless otherwise stated.   
 
5.2 Generation of phorphoramidite monomers by NOAC 
 
5.2.1 General procedure for the synthesis of oximes 13a-c 
A solution of the required aryl aldehyde 12a-c (1.00 g, 6.02 mmol) and hydroxylamine 
hydrochloride (1.26 g, 18.1 mmol) in EtOH (35 mL) was stirred at room temperature for 
10 min, after which a solution of sodium acetate (1.69 g, 24.1 mmol) in H2O (15 mL) 
was added. The mixture was heated under reflux for 40 min.  Following solvent 
removal under reduced pressure the crude product, obtained as a white solid, was 
taken up in EtOAc (30 mL), washed with H2O (3 x 20 mL) and dried over anhydrous 
magnesium sulfate.  Removal of the solvent under reduced pressure yielded the pure 
product as a white solid in excellent yield. 
2-(2-Hydroxyethoxy)benzaldehyde oxime (13a) 
Yield: 96%, m.p. = 98-100 oC 
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1H NMR δ 8.41 (s, 1H, CHNOH), 7.58 (d, J = 7.8 Hz, 1H, ArH), 7.35 (t,  J = 7.8 Hz, 1H, 
ArH), 7.03-6.95 (m, 2H, ArH), 4.17 (t, J = 4.0 Hz, 2H, ArOCH2), 3.98 (t, J = 4.0 Hz, 2H, 
CH2OH); 
13C NMR δ 157.0, 147.8 (ArCO & CHNOH), 131.2, 128.9, 121.6, 121.2, 113.7, (1 
x ArC, 4 x ArCH), 70.7, 61.2 (2 x CH2); IR (KBr) 3388, 3219, 1601, 1251, 764 cm
-1; HRMS 
(ESI) calcd for 204.0631 [M + Na]+, found 204.0640. 
3-(2-Hydroxyethoxy)benzaldehyde oxime (13b) 
Yield: 86%, m.p. = 94-96 oC 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
1H NMR δ 8.11 (s, 1H, CHNOH), 7.88 (br s, 1H, CHNOH), 7.33-7.28 (m, 1H, ArH), 7.19-
7.12 (m, 2H, ArH),  6.98-6.94 (m, 1H, ArH), 4.12 (t, J = 3.9 Hz, 2H, ArOCH2), 3.98 (t, J = 
3.9 Hz, 2H, CH2OH); 
13C NMR δ 156.9, 147.7 (ArCO & CHNOH), 131.2, 128.8, 121.6, 
121.2, 113.6 (1 x ArC, 4 x ArCH), 70.6, 61.2 (2 x CH2); IR (KBr) 3350, 3154, 1595, 1262, 
907, 795 cm-1; HRMS (ESI) calcd for C9H12NO3 182.0812 [M + H] +, found 182.0809. 
4-(2-Hydroxyethoxy)benzaldehyde oxime (13c) 
Yield: 88%, m.p. = 109-111 oC 
 
1H NMR δ 8.09 (s, 1H, CHNOH), 7.52 (d, J = 8.4 Hz, 2H, ArH), 7.32 (br s, 1H, CHNOH), 
6.93 (d, J = 8.7 Hz, 2H, ArH), 4.12 (t, J = 3.9 Hz, 2H, ArOCH2), 4.00-3.97 (t, J = 3.9 Hz, 
CH2OH), 2.05 (br s, 1H, CH2OH); 
13C NMR δ 160.1, 149.9 (ArCO & CHNOH), 128.6 (2 x 
ArCH), 125.2 (ArC), 114.8 (2 x ArCH), 69.3, 61.4 (2 x CH2); IR (KBr) 3262, 1605, 1259, 
836 cm-1; HRMS (ESI) calcd for 204.0631 [M + Na] +, found 204.0622. 
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5.2.2 General procedure for the synthesis of cycloadducts 15a-c 
To a round-bottomed flask containing oxime (274 mg, 1.5 mmol) and Ch-T (427 mg, 1.9 
mmol) in ethanol (5 mL) and water (5 mL) was added propargyl phenyl ether (100 mg, 
0.75 mmol).  The mixture was stirred for 18 hr at room temperature after which 
analysis by TLC (hexane:EtOAc, 6:4) indicated complete reaction.  After removal of the 
solvent under reduced pressure, the residue was taken up in EtOAc (30 mL) and the 
solution was washed with 5% NaOH (3 x 10 mL).  The organic layer was dried over 
anhydrous magnesium sulphate and the solvent was removed under reduced pressure.  
The crude products were purified by flash column chromatography (hexane:EtOAc, 
6:4) to give the cycloadduct in good yield. 
2-(2-[5-(Phenoxymethyl)isoxazol-3-yl]phenoxy)ethanol (15a) 
Colourless oil; Yield: 81%, Rf = 0.304 (hexane:EtOAc, 7:3) 
 
1H NMR δ 7.77-7.70 (m, 1H, ArH), 7.50-7.25 (m, 3H, ArH), 7.08-6.97 (m, 5H, ArH), 6.76 
(s, 1H, isox-H), 5.20 (s, 2H, CH2OPh), 4.18 (t, J = 4.5 Hz, 2H, ArOCH2), 3.93-3.90 (t, J = 4.5 
Hz, 2H, CH2OH), 3.24 (br s, 1H, CH2OH); 
13C NMR δ 167.4, 160.4, 157.8, 156.7 (4 x ArC), 
131.4, 129.8, 129.7, 121.8, 121.6 (6 x ArCH), 118.4 (ArC), 114.8, 113.9 (3 x ArCH), 104.2 
(isox-CH), 70.9, 61.3, 61.1 (3 x CH2); IR (film) 3400, 1601, 1245, 755 cm
-1; HRMS (ESI) 
calcd for C18H18NO4 312.1230 [M + H]
+, found 312.1242 
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2-(3-[5-(Phenoxymethyl)isoxazol-3-yl]phenoxy)ethanol (15b) 
White solid; Yield: 68%, m.p. = 70-72 oC 
 
1H NMR δ 7.38-7.28 (m, 5H, ArH), 7.04-6.96 (m, 4H, ArH), 6.61 (s, 1H, isox-H), 5.17 (s, 
2H, CH2OPh), 4.12 (t, J = 4.2 Hz, 2H, ArOCH2), 3.96 (t, J = 4.2 Hz, 2H, CH2OH), 2.42 (br s, 
1H, CH2OH); 
13C NMR δ 168.7, 162.4, 159.1, 157.8 (4 x ArC), 130.1 (ArCH), 130.0 (ArC), 
129.7, 121.9, 119.8, 116.8, 114.8, 112.5 (8 x ArCH), 101.5 (isox-CH), 69.4, 61.4, 61.3 (3 
x CH2); IR (KBr) 3208, 1600, 1260, 1231, 885, 755 cm
-1; HRMS (ESI) calcd for C18H18NO4 
312.1230 [M + H] +, found 312.1233. 
2-(4-[5-(Phenoxymethyl)isoxazol-3-yl]phenoxy)ethanol (15c)§§ 
White solid; Yield: 65%, m.p. = 95-97 oC 
 
1H NMR δ 7.75 (d, J = 8.4 Hz, 2H, H4), 7.32 (t, J = 7.5 Hz, 2H, H8), 7.04-6.98 (m, 5H, 
H3,7,9), 6.59 (sl br s, 1H, H5), 5.20 (sl br s, 2H, H6), 4.14 (t, J = 4.4 Hz, 2H, H2), 3.99 (t,  J = 
4.4 Hz, 2H, H1),  2.03 (br s, 1H, OH); 13C NMR δ 168.4, 162.1, 160.1, 157.8 (Cc,g,i,k), 129.7 
(Ce), 128.3 (Cm), 121.9 (Cd/l/n), 121.7 (Cf), 114.9 (Cd/l/n), 114.8 (Cd/l/n), 101.1 (Ch), 69.3 
                                                     
 
§§
 A detailed discussion of the characterisation of 15c is presented in the appendix (section 6.1) 
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(Cb), 61.5 (Ca/j), 61.4 (Ca/j); IR (KBr), 3438, 1613, 1258, 1238, 842 cm-1; HRMS (ESI) calcd 
for C18H18NO4 312.1230 [M + H] +, found 312.1245. 
 
5.2.3 General procedure for the synthesis of phosphoramidites 17a-c 
The required cycloadduct 15 (100 mg, 0.32 mmol), and BMT (31 mg, 0.16 mmol) were 
placed in a dried round bottomed flask under an argon atmosphere.  Anhydrous 
acetonitrile (5 mL) was added to the flask followed by diisopropylamine (23 μl, 0.16 
mmol) and 2-cyanoethyl-N,N,N’,N’ tetraisopropylphosphorodiamidite (112 μl, 0.35 
mmol).  The reaction mixture was stirred for 30 minutes at room temperature after 
which TLC analysis (hexane:EtOAc, 1:1) showed complete consumption of the starting 
alcohol.  The reaction mixture was diluted with ethyl acetate (25 mL) and washed with 
aqueous sodium bicarbonate (10 x 3 mL).  The organic layer was dried over anhydrous 
sodium sulfate and the solvent was removed under reduced pressure to give the crude 
phosphoramidite, which was purified by flash column chromatography (hexane:EtOAc, 
3:7) with elution under a positive pressure of nitrogen gas, yielding a colourless oil in 
each case. 
2-Cyanoethyl 2-(2-[5-(phenoxymethyl)isoxazol-3-yl]phenoxy)ethyl N,N-
diisopropylphosphoramidite (17a) 
Rf = 0.83 (hexane:EtOAc, 3:7) 
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1H NMR δ 7.94 (dd, J = 7.7, 1.7 Hz, 1H, ArH), 7.43-7.31 (m, 3H, ArH), 7.07-6.98 (m, 6H, 
ArH and isox-H), 5.19 (s, 2H, CH2OPh), 4.25-4.22 (m, 2H), 4.16-3.54 (m, 6H), 2.55-2.51 
(m, 2H), 1.19-1.14 (m, 12H); 31P NMR δ 148.8. 
2-Cyanoethyl 2-(3-[5-(phenoxymethyl)isoxazol-3-yl]phenoxy) ethyl N,N-
diisopropylphosphoramidite (17b) 
Rf = 0.83 (hexane:EtOAc, 3:7) 
 
1H NMR δ 7.39-7.32 (m, 5H, ArH), 7.05-6.98 (m, 4H, ArH), 6.64 (s, 1H, isox-H), 5.21 (s, 
2H, CH2OPh), 4.20 (t, J = 5.1 Hz, 2H), 4.10-3.49 (m, 6H), 2.63 (t, J = 6.4 Hz, 2H), 1.20 (dd, 
J = 6.8, 2.1 Hz, 12H); 31P NMR δ 149.1. 
 
2-Cyanoethyl 2-(4-[5-(phenoxymethyl)isoxazol-3-yl]phenoxy)ethyl N,N-
diisopropylphosphoramidite (17c) 
Rf = 0.83 (hexane:EtOAc, 3:7) 
 
1H NMR δ 7.73 (d, J = 8.7 Hz, 2H, ArH), 7.32 (t, J = 7.6 Hz, 2H, ArH), 7.04-6.95 (m, 5H, 
ArH), 6.59 (s, 1H, isox-H) 5.20 (s, 2H, CH2OPh), 4.29 (t, J = 5.1 Hz, 2H, CH2), 4.10-3.77 
(m, 4H), 3.70-3.57 (m, 2H), 2.63 (t, J = 6.5 Hz, 2H), 1.20 (dd, J = 6.8, 2.9 Hz, 12H); 31P 
NMR δ 149.0. 
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5.2.4 General procedure for manual conjugation of phosphoramidite monomers to 
CPG-DNA–OH; preparation of 22, 26 and 30 
To manually couple the phosphoramidites 17a-c to the resin supported 
nucleoside/oligonucleotide, 20, 24 or 28, separate solutions of the phosphoramidite 
(500 µL, 100 mM in anh. CH3CN) and of BMT (500 µL, 0.3 mM in anh. CH3CN), both in 1 
mL syringes were attached to either end of a DNA synthesis column containing CPG-
DNA (1 μmol).  The mixture was reacted for 15 minutes at room temperature with 
mixing between the two syringes. This reaction was repeated with a second portion of 
each of a new solution of the phosphoramidite and BMT. The CPG was washed with 
CH3CN (5 x 2 mL) prior to treatment with oxidizer (700 μL, 0.1 M Iodine solution in THF: 
pyridine: water; 8:1:1).  Further washing with CH3CN (2 x 5 mL) and drying yielded the 
resin-bound DNA-conjugates 22, 26 or 30. Deprotection/cleavage was followed by 
analysis by RP-HPLC. 
 
Compound Mass calculated Mass found 
23a 638.1510 [M + Na+] 638.1534 [M + Na+][a] 
27a 3353 3353 
31a 3948 3949 
31b 3948 3949 
31c 3948 3949 
[a] LC/MS-ESI-TOF mass data 
Table 5.1.  Mass data for the oligonucleotide conjugates 23a, 27a and 31a-c 
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5.3 Site specific introduction of azobenzene to DNA by NOAC 
 
5.3.1 General procedure for the synthesis of the aryl oximes 57b-c 
To a solution of the aldehyde (50 mmol) in EtOH (10 mL) was added hydroxylamine 
hydrochloride (7.24 g, 75 mmol) and pyridine (6.07 mL, 75 mmol).  The resulting 
solution was heated for 30 min under microwave irradiation (T = 125 oC, Pmax = 300 W) 
and after completion of reaction, the solution was cooled to 0 oC and water (5 mL) was 
added.  This precipitated the pure product, which was filtered off as a white solid in 
excellent yield. 
2-Fluorobenzaldehyde oxime (57b) 
 
Yield: 95%, m.p. = 61-62 oC (lit. value = 61.8-62.3 oC)73 
1H NMR spectral data corresponded to that reported in the literature; (200 MHz, 
CDCl3) δ 9.20 (br s, 1H, OH), 8.38 (s, 1H, CH=N), 7.77 (t of d, 1H, J = 7.4, 1.8 Hz), 7.37 (t 
of dd, 1H, J = 7.8, 5.3, 1.8 Hz), 7.16 (br t, 1H, J = 7.5 Hz), 7.09 (ddd, 1H, J = 10.4, 8.2, 1.2 
Hz).73 
1-Naphthaldehyde oxime (57c) 
 
Yield: 92%, m.p. = 96-97 oC (lit. value 96 oC) 
1H NMR data corresponded that reported in the literature; (400 MHz, CDCl3) δ 8.82 (s, 
1H), 8.48 (d, J = 8.3 Hz, 1H), 7.93-7.87 (m, 2H), 7.78 (d, J = 7.0 Hz, 1H), 7.62-7.46 (m, 
3H).71 
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5.3.2 Synthesis of the ether linked isoxazole cycloadducts 55a-d 
5.3.2.i General procedure for synthesis of the cycloadducts 55a-c 
To a solution of the oxime (1.27 mmol) in EtOH (2.5 mL) was added a solution of Ch-T 
(289 mg, 1.27 mmol) in H2O (2.5mL).  The resulting solution was stirred for 10 min at 
room temperature, after which it was added to a solution of the alkyne 54213 (100 mg, 
0.423 mmol) in EtOH (5 mL).  This solution was then heated for 1 hr at 40oC, after 
which the reaction mixture was cooled to -20 oC, yielding the product as an orange 
precipitate in good yield. 
3-Phenyl-5-((4-(phenylazo)phenoxy)methyl)isoxazole (55a) 
Yield: 91 %, m.p. = 125-127 oC 
 
1H NMR δ 7.97-7.81 (m, 6H, ArH), 7.53-7.45 (m, 6H, ArH), 7.11 (d, 2H, J = 8.8 Hz, ArH), 
6.69 (s, 1H, isox-H), 5.28 (s, 2H, CH2); 
13C NMR δ 167.9, 162.6, 160.0, 152.6, 147.7 (5 x 
ArC), 130.7, 130.3, 129.1, 129.0 (6 x ArCH), 128.6 (QC), 126.9, 124.9, 122.7, 115.0 (8 x 
ArCH), 101.7 (isox-CH), 61.5 (CH2); HRMS (ESI) calcd for C22H18N3O2 356.1402 [M + H]
+, 
found 356.1402. 
3-(2-Fluorophenyl)-5-((4-(phenylazo)phenoxy)methyl)isoxazole (55b) 
Yield: 86 %, m.p. = 108-109 oC 
 
1H NMR δ 8.02-7.87 (m, 5H, ArH), 7.53-7.40 (m, 4H, ArH), 7.27-7.10 (m, 4H, ArH), 6.84 
(d, 1H, J = 3.5 Hz, isox-H), 5.29 (s, 2H, CH2); 
13C NMR δ 167.6 (d, J = 1.8 Hz, ArC), 160.3 
(d, J = 250.3 Hz, ArC-F), 160.0, 158.0, 152.6, 147.7 (4 x ArC), 131.9 (d, J = 8.5 Hz, ArCH), 
130.7, 129.1, 129.1, 124.8 (6 x ArCH), 124.7 (d, J = 3.5 Hz, ArCH), 122.7 (2 x ArCH), 
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116.7 (d, J = 11.8 Hz, ArC), 116.4 (d, J = 21.7 Hz, ArCH), 115.0 (2 x ArCH), 104.3 (d, J = 
9.0 Hz, isox-CH), 61.4 (CH2) ; HRMS (ESI) calcd for C22H17FN3O2 374.1299 [M + H]
+, 
found 374.1295. 
3-(Naphthalen-1-yl)-5-((4-(phenylazo)phenoxy)methyl)isoxazole (55c) 
Yield: 86 %, m.p. = 112-114 oC 
 
 1H NMR δ 8.39-8.35 (m, 1H ArH), 7.98-7.88 (m, 6H, ArH), 7.71 (d, J = 6.6 Hz, 1H, ArH), 
7.57-7.45 (m, 6H, ArH), 7.15 (d, J = 8.2 Hz, 2H, ArH), 6.72 (s, 1H, isox-H), 5.37 (s, 2H, 
CH2); 
13C NMR δ 167.2, 167.8, 160.0, 152.6, 147.7, 133.8, 130.9 (7 x ArC), 130.7, 130.5, 
129.1, 128.6, 127.9, 127.2 (7 x ArCH), 126.4 (ArC), 125.4, 126.5, 125.2, 124.9, 122.7, 
115.0 (9 x ArCH), 105.1 (isox-CH), 61.6 (CH2); HRMS (ESI) calcd for C26H20N3O2 406.1550 
[M + H]+, found 406.1558.  
5.3.2.ii Synthesis of the cycloadduct 55d 
To a solution of 2-nitrobenzaldehyde oxime 57d (211 mg, 1.27 mmol) in EtOH (2.5 mL) 
was added a solution of Ch-T (434 mg, 1.91 mmol) in H2O (2.5mL).  The resulting 
solution was stirred for 20 min at rt, after which it was added to a solution of the 
alkyne213 (100 mg, 0.423 mmol) in EtOH (5 mL).  This solution was then heated for 1 hr 
at 40oC.  Once the reaction was complete, EtOAc (20 mL) was added, the organic layer 
was washed with 1 M NaOH (3 x 10 mL) and dried over anhydrous magnesium 
sulphate.  Removal of the solvent under reduced pressure yielded the crude product, 
which was purified by flash column chromatography (Hex:EtOAc, 4:1) to yield the 
product as an orange solid. 
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3-(2-nitrophenyl)-5-((4-(phenylazo)phenoxy)methyl)isoxazole (55d) 
Yield: 35 %, m.p. = 96-98 oC 
  
1H NMR δ 8.02 (d, J = 7.7 Hz, 1H, ArH), 7.95 (d, J = 9.0 Hz, 2H, ArH), 7.90-7.88 (m, 2H, 
ArH), 7.72-7.64 (m, 3H, ArH), 7.53-7.45 (m, 3H, ArH), 7.11 (d, J = 9.0 Hz, 2H, ArH), 6.51 
(s, 1H, isox-H), 5.31 (s, 2H, CH2); 
13C NMR δ 167.8, 160.1, 159.9, 152.7, 148.6, 147.8 (6 x 
ArC), 133.1, 131.7, 130.8, 130.6, 129.1, 124.8, 124.6 (9 x ArCH), 124.0 (ArC), 122.7, 
115.1 (4 x ArCH), 104.0 (isox-CH), 61.4 (CH2); HRMS (ESI) calcd for C22H17N4O4 401.1244 
[M + H]+, found 401.1243. 
 
5.3.3 General procedure for the synthesis of amide linked cycloadducts (62-64) 
To a solution of the oxime 57a (138 mg, 1.14 mmol) in EtOH (2.5 mL) was added a 
solution of Ch-T (259 mg, 1.14 mmol) in H2O (2.5 mL).  The resulting solution was 
stirred for 10 min at room temperature, after which it was added to a solution of the 
alkyne169 (100 mg, 0.380 mmol) in EtOH (5 mL).  This solution was then heated for 1 hr 
at 40oC, after which the reaction mixture was cooled to -20 oC, yielding the product as 
an orange precipitate in good yield. 
2-(Phenylazo)-N-((3-phenylisoxazol-5-yl)methyl)benzamide (62) 
Yield: 78%, m.p. = 136-138 oC 
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1H NMR δ 9.29 (br t, J = 5.5 Hz, 1H, NH), 8.44-8.40 (m, 1H, ArH), 7.86-7.73 (m, 5H, ArH), 
7.62-7.42 (m, 8H, ArH), 6.55 (s, 1H, isox-H), 4.89 (d, J = 5.5 Hz, 2H, CH2); 
13C NMR δ 
169.4, 165.9, 162.6, 152.3, 149.5 (5 x ArC), 132.4, 132.2, 131.7, 131.7 (4 x ArCH), 130.5 
(ArC), 130.1, 129.6, 128.9 (5 x ArCH), 128.8 (ArC), 126.8, 123.2, 115.9 (5 x ArCH), 100.7 
(isox-CH), 36.0 (CH2); HRMS (ESI) calcd for C23H19N4O2 383.1503 [M + H]
+, found 
383.1513. 
3-(Phenylazo)-N-((3-phenylisoxazol-5-yl)methyl)benzamide (63) 
Yield: 81%, m.p. = 160-161 oC 
 
1H NMR δ 8.31 (t, J = 1.8 Hz, 1H, ArH), 8.07 (d, J = 8.0 Hz, 1H, ArH), 7.98 (d, J = 7.8 Hz, 
1H, ArH), 7.94-7.90 (m, 2H, ArH), 7.79-7.75 (m, 2H, ArH), 7.62-7.42 (m, 7H, ArH), 7.04 
(br t, J = 5.8 Hz, 1H, NH), 6.60 (s, 1H, isox-H), 4.85 (d, J = 5.8 Hz, 2H, CH2); 
13C NMR δ 
169.1, 166.9, 162.8, 152.5, 152.4, 134.6 (6 x ArC), 131.6, 130.1, 129.7, 129.2, 128.9 (8 x 
ArCH), 128.7 (ArC), 126.8, 126.7, 123.0, 120.6 (6 x ArCH), 100.8 (isox-CH), 35.8 (CH2); 
HRMS (ESI) calcd for C23H19N4O2 383.1503 [M + H]
+, found 383.1501.  
4-(Phenylazo)-N-((3-phenylisoxazol-5-yl)methyl)benzamide (64) 
Yield: 70%, m.p. = 198-199 oC 
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1H NMR δ 7.98-7.94 (m, 6H, ArH), 7.81-7.78 (m, 2H, ArH), 7.54-7.44 (m, 6H, ArH), 6.78 
(br t, J = 5.9 Hz, 1H, NH), 6.62 (s, 1H, isox-H), 4.86 (d, J = 5.9 Hz, 2H, CH2) ; 
13C NMR δ 
168.9, 166.7, 162.8, 154.6, 152.5, 135.2 (6 x ArC), 131.7, 130.2, 129.2, 129.0 (6 x ArCH), 
128.7 (ArC), 128.1, 126.9, 123.1, 123.1 (8 x ArCH), 108.8 (isox-CH), 35.8 (CH2); HRMS 
(ESI) calcd for C23H19N4O2 383.1503 [M + H]
+, found 383.1500.  
 
5.3.4 Synthesis of 4-(phenylazo)benzaldehyde (67a) by the Grignard method 
To a 1 M solution of ethylmagnesium bromide (24 mL) in THF (34 mL) was added a 
solution of aniline (1.15 g, 12.3 mmol) in THF (10 mL) under an atmosphere of argon at 
0 oC.  The mixture was stirred gently at 55 oC for 45 min to complete the evolution of 
ethane.  The resulting solution of the phenyliminodimagnesium intermediate 65 was 
added to a solution of 4-nitrobenzaldehyde (227 mg, 1.50 mmol) dissolved in THF (10 
mL) at 0 oC under argon, where upon the colour of the mixture turned a deep reddish-
brown colour.  The coloured mixture was stirred at 55 oC for 3 hr, after which it was 
quenched with aqueous NH4Cl (20 mL), extracted with diethyl ether (3 x 30 mL), and 
washed with 1 M HCl (3 x 30 mL) to remove any unreacted aniline.  After washing with 
water (1 x 30 mL), the organic layer was dried over anhydrous MgSO4 and 
concentrated under reduced pressure, yielding the crude product as a dark reddish-
brown oil, which was purified by flash column chromatography (hexane:EtOAc, 9:1) 
giving the desired product 67a as a red solid. 
Yield: 38%, m.p. = 118-119 oC 
 
1H NMR δ 10.08 (s, 1H, CHO), 8.01 (br s, 4H, ArH), 7.96-7.93 (m, 2H, ArH), 7.53-7.51 (m, 
3H, ArH); 13C NMR δ 191.6 (CHO), 155.9, 152.6, 137.5 (3 x ArC), 132.0 (ArCH), 130.7 (2 x 
ArCH), 129.2 (2 x ArCH), 123.3 (2 x ArCH), 123.3 (2 x ArCH); HRMS (ESI) calcd for 
C13H11N2O 210.0793 [M + H]
+, found 210.0880.  
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5.3.5 Synthesis of 4-(phenylazo)benzaldehyde (67a) starting from 4-
(phenylazo)benzoic acid  
5.3.5.i Synthesis of 4-(phenylazo)phenylmethanol (72a) 
To a solution of 4-(phenylazo)benzoic acid (1.00 g, 4.42 mmol) in anhydrous THF (25 
mL) was added LAH (210 mg, 5.53 mmol) at 0 oC, and the resulting mixture was stirred 
at rt for 30 min.  The remaining LAH was then quenched with 3 % KOH.  The resulting 
solution was diluted with EtOAc (30 mL) and washed with brine (1 x 10 mL).  The 
combined organic layers were dried over anhydrous MgSO4 and concentrated under 
reduced pressure to yield the product as an orange solid (619 mg, 66 %). 
 
Yield: 66%, m.p. = 140-142 oC (lit. value = 142 oC)214 
1H NMR data corresponded that reported in the literature; (500 MHz, CDCl3) δ 7.90 (d, 
J = 8.0 Hz, 4H), 7.52.7.45 (m, 5H), 4.76 (s, 2H).173 
 
5.3.5.ii Synthesis of 4-(Phenylazo)benzaldehyde (67a) 
To a solution of 4-(phenylazo)phenylmethanol (72a) (300 mg, 1.41 mmol), in 
anhydrous DCM (10 mL) was added DMP (730 mg, 1.72 mmol).  The resulting solution 
was stirred at rt for 1 hr.  The solvent was then removed under reduced pressure and 
the resulting orange solid was dissolved in EtOAc (30 mL).  This solution was washed 
with saturated  NaHCO3 (10 mL), brine (10 mL) and water (10 mL).  The organic layer 
was then dried over anhydrous sodium sulphate and concentrated under reduced 
pressure, yielding the pure product as an orange solid (289 mg, 97 %). 
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1H NMR data corresponded to that observed for the product obtained using the 
Grignard method (see section 5.3.4, page 147). 
 
5.3.6 Synthesis of of 3-(phenylazo)benzaldehyde (67b) 
5.3.6.i Synthesis of 3-(phenylazo)phenylmethanol (72b) 
The amine 74b (500 mg, 4.06 mmol) was added to a solution of nitrosobenzene (652 
mg, 6.09 mmol) in CH3COOH (5 mL) at 0 
oC.  The resulting mixture was stirred at this 
temperature for 1 hr, after which it was warmed to rt and stirred for another 3 hr.  
EtOAc was added and the organic layer was washed with aqueous NaHCO3 (3 x 20 mL) 
to remove the CH3COOH.  The organic layer was then dried over anhydrous MgSO4 and 
concentrated under reduced pressure, yielding an orange solid as the crude product.  
This was then purified by flash column chromatography (hexane:EtOAc, 6:4), giving the 
product as an orange oil in good yield. 
Yield: 82%, m.p. = 35-36 oC 
 
1H NMR δ 7.93-7.90 (m, 3H, ArH), 7.85 (dt, J = 6.8, 1.9 Hz, 1H, ArH), 7.55-7.45 (m, 5H, 
ArH), 4.79 (s, 1H, CH2); 
13C NMR δ 152.9, 152.6, 142.1 (3 x ArC), 131.1, 129.4, 129.3, 
129.1, 122.9, 122.6, 120.6 (9 x ArCH), 64.9 (CH2); HRMS (ESI) calcd for C13H13N2O 
213.1022 [M + H]+, found 213.1030.  
 
5.3.6.ii Synthesis of 3-(phenylazo)benzaldehyde (67b) 
To a solution of 3-(phenylazo)phenylmethanol (72b) (300 mg, 1.41 mmol), in 
anhydrous DCM (10 mL) was added DMP (1.20 g, 2.82 mmol).  The resulting solution 
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was stirred at rt for 3 hr.  The solvent was then removed under reduced pressure and 
the resulting orange solid was dissolved in EtOAc (30 mL).  This solution was washed 
with saturated  NaHCO3 (10 mL), brine (10 mL) and water (10 mL).  The organic layer 
was then dried over anhydrous sodium sulphate and concentrated under reduced 
pressure, yielding the pure product as an orange solid. 
Yield: 71%, m.p. = 53-56 oC 
 
1H NMR δ 10.04 (s, 1H, CHO), 8.32 (t, J = 1.8 Hz, 1H ArH), 8.10 (dt, J = 7.9, 1.3 Hz, 1H, 
ArH), 7.93-7.89 (m, 3H, ArH), 7.58 (t, J = 7.9 Hz, ArH); 13C NMR δ 191.6 (CHO), 152.8, 
152.3, 137.3 (3 x ArC), 131.7, 131.1, 129.8, 129.2, 128.7, 123.8, 123.2 (9 x ArCH); HRMS 
(ESI) calcd for C13H11N2O 211.0866 [M + H]
+, found 211.0868.  
 
5.3.7 General procedure for the synthesis of 3- & 4-(phenylazo)benzaldehyde oximes 
(52a,b) 
To a solution of the aldehyde (350 mg, 1.66 mmol) in EtOH (10 mL) was added 
hydroxylamine hydrochloride (173 mg, 2.49 mmol) and pyridine (2.49 mmol, 0.201 
mL).  The resulting solution was heated for 1 hr under microwave irradiation (T = 125 
oC, Pmax = 300 W).  Water (5 mL) was then added and the resulting orange precipitate 
was filtered off to yield pure product in excellent yield. 
3-(Phenylazo)benzaldehyde oxime (52b) 
Yield: 88%. m.p. = 101-103 oC 
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1H NMR δ 8.37 (br s, 1H, NOH), 8.26 (s, 1H, CHNOH), 8.13 (t, J = 1.7 Hz, 1H, ArH), 7.96-
7.91 (m, 3H, ArH), 7.71 (d, J = 7.7 Hz, 1H), 7.56-7.48 (m, 4H, ArH); 13C NMR δ 152.9, 
152.5 (ArC), 149.8 (CHNOH), 133.1 (ArC), 131.4, 129.6, 129.2, 129.0, 124.4, 123.0, 
121.6 (9 x ArCH); HRMS (ESI) calcd for C13H12N3O 226.0975 [M + H]
+, found 226.0979.  
 
4-(Phenylazo)benzaldehyde oxime (52a) 
Yield : 94 %, m.p. = 151-152 oC 
 
1H NMR δ 8.20 (s, 1H, CHNOH), 7.96-7.92 (m, 4H, ArH), 7.74 (d, J = 8.5 Hz, 2H, ArH), 
7.60 (br s, 1H, NOH), 7.56-7.49 (m, 3H, ArH); 13C NMR δ 153.3, 152.6 (2 x ArC), 149.7 
(CHNOH), 134.4 (ArC), 131.4, 129.2, 127.8, 123.3, 123.0 (9 x ArCH); HRMS (ESI) calcd 
for C13H12N3O 226.0975 [M + H]
+, found 226.0986.44  
 
5.3.8 General procedure for the synthesis of the isoxazole cycloadducts 77a-b 
The oxime 52 (150 mg, 0.667 mmol) was dissolved in EtOH (3 mL) and Ch-T (152 mg, 
0.667 mmol) was added, followed by H2O (1 mL).  The resulting solution was stirred for 
10 min at rt.  The alkyne 14 (29 mg, 0.222 mmol) was then added followed by EtOH 
(1.5 mL) and H2O (0.5 mL).  The reaction was heated at 40 
oC for 1 hr, after which H2O 
(30 mL) was added and the aqueous layer was extracted with DCM (3 x 10 mL).  
Following drying of the combined organic extracts over anhydrous magnesium 
sulphate, the solvent was removed under reduced pressure.  The resulting crude 
product was purified by flash column chromatography (hex:EtOAc, 4:1) to the pure 
product as an orange solid.  
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5-(phenoxymethyl)-3-(3-(phenylazo)phenyl)isoxazole (77b) 
Yield: 46%, m.p. = 105-107 oC 
 
1H NMR δ 8.32 (t, J = 2.1 Hz, 1H, ArH) 8.01-7.93 (m, 4H, ArH), 7.61 (t, J = 7.8 Hz, 1H, 
ArH), 7.57-7.49 (m, 3H), 7.36-7.30 (m, 2H, ArH), 7.05-6.99 (m, 3H, ArH), 6.75 (s, 1H, 
isox-H), 5.24 (s, 2H, CH2); 
13C NMR δ 168.9, 162.1, 157.8, 153.0, 152.5 (5 x ArC), 131.4 
(ArCH), 129.8 (ArC), 129.8, 129.7, 129.2, 129.0, 124.7, 123.0, 122.0, 121.1, 114.8 (13 x 
ArCH), 101.5 (isox-CH), 61.5 (CH2); HRMS (ESI) calcd for C22H18N3O2 356.1394 [M + H]
+, 
found 356.1391. 
5-(phenoxymethyl)-3-(4-(phenylazo)phenyl)isoxazole (77a) 
Yield: 89%, m.p. = 121-122 oC 
 
1H NMR δ 8.04-7.93 (m, 6H, ArH), 7.60-7.50 (m, 3H, ArH), 7.34 (t, J = 8.1 Hz, 2H, ArH), 
7.06-7.00 (m, 3H, ArH), 6.72 (s, 1H, isox-H), 5.24 (s, 2H, CH2); 
13C NMR δ 169.0, 161.9, 
157.8, 153.5, 152.6 (5 x ArC), 131.4 (ArCH), 131.0 (ArC), 129.7, 129.2, 127.7, 123.4, 
123.0, 122.0, 114.8 (13 x ArCH), 101.4 (isox-CH), 61.5 (CH2); HRMS (ESI) calcd for 
C22H18N3O2 356.1394 [M + H]
+, found 356.1393. 
 
5.3.9 Synthesis of 2-(phenylazo)phenyl)methanol (72c) 
Procedure was the same as that used to prepare 72b, except reaction time was 18 hr. 
Yield = 79%, m.p. = 76-79 oC 
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1H NMR δ 7.90 (d, J = 8.2 Hz, 2H, ArH), 7.82 (d, J = 6.6 Hz, 1H, ArH), 7.57-7.42 (m, 6H, 
ArH), 5.04 (d, J = 4.8 Hz, 2H, CH2), 3.17 (br t, J = 4.8 Hz, 1H, OH); 
13C NMR δ 152.5, 
150.2, 138.7 (3 x ArC), 131.4, 131.4, 129.3, 129.1, 128.4, 123.0, 128.1 (9 x ArCH), 63.0 
(CH2OH); HRMS (ESI) calcd for C13H11N2 195.0917 [(M + H)
+ - H2O], found 195.0919. 
5.3.10 Synthesis of 2-phenyl-2H-benzo[d][1,2,3]oxadiazine (76) 
5.3.10.i With base 
The primary alcohol 72c (68 mg, 0.319 mmol) was dissolved in DMF (5 mL) and sodium 
hydride (11 mg, 0.478 mmol) was added under an atmosphere of argon.  After one 
hour stirring at rt, the reaction was quenched at 0 oC with MeOH (10 mL), and  EtOAc 
(30 mL) was added. The organic layer was washed several times with H2O (3 x 10 mL), 
dried over anhydrous MgSO4, and concentrated under vacuum, yielding the crude 
product as a brown solid.  This was purified by flash column chromatography 
(hexane:EtOAc, 6:4), giving the pure product as an off-white solid in 73% yield.   
 
5.3.10.ii Without base 
The primary alcohol 72c (118 mg, 1.80 mmol) was dissolved in DMF (5 mL) and the 
resulting solution heated under reflux for 1 hr.  After this time, the solvent was 
removed under reduced pressure, yielding a pure sample of product 76 in quantitative 
yield. 
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1H NMR δ 8.39 (d, J = 0.9 Hz, 1H, H5), 7.91 (d, J = 7.6, Hz, 2H, H3), 7.84 (dd, J = 8.9, 0.9 
Hz, 1H, H6), 7.72 (d, J = 8.5 Hz, 1H, H9), 7.52 (t, J = 7.6 Hz, 2H, H2), 7.42-7.33 (m, 2H, H1, 
H7), 7.14 (t, J = 8.5 Hz, 1H, H8); 13C NMR δ 149.8, 140.6 (2 x ArC), 129.6, 127.9 , 126.9 (4 
x ArCH), 122.8 (ArC), 122.5, 121.0, 120.4, 120.4, 118.0 (6 x ArCH); HRMS (ESI) calcd for 
C13H11N2O 211.0871 [(M + H)
+], found 211.0875. 
 
 
5.3.11 Synthesis of the 2’-O-propargylated oligonucleotides 89 and 51 
 
 
 
 
Separate solutions of the phosphoramidite 88 (500 µL, 100 mM in anhydrous CH3CN), 
and BMT (500 µL, 0.3 mM in anhydrous CH3CN), both in 1 mL syringes were attached 
to either end of a DNA synthesis column containing the CPG-T4 87 (1 µmol).  The 
mixture was reacted for 15 min at rt with mixing between the two syringes.  This 
reaction was repeated with a second portion each of a new solution of the 
phosphoramidite and BMT.  The column was then re-installed on the oligonucleotide 
synthesiser where standard washing, capping, oxidation and deblocking programmes 
were carried out.  Where the oligonucleotide 89 was required, the column was 
removed from the synthesiser at this point.  Where the oligonucleotide 51 was 
required, the column was left installed on the synthesiser and the remaining DNA 
phosphoramidites were coupled using the standard procedure.  Deprotection/cleavage 
of the resin-bound oligonucleotides was followed by RP-HPLC analysis. 
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5.3.12 Synthesis of the azobenzene-oligonucleotide conjugates 82, 84, 86, 92 and 94 
 
To a solution of the azo-oxime, 52 (30 µL, 250 mM in EtOH) was added a solution of 
Ch-T (10 µL, 750 mM in 1:1 EtoH:H2O).  This was then agitated at rt for 10 minutes to 
facilitate formation of the nitrile oxide, after which 20 µL (3.6 µmol) of this nitrile oxide 
solution was added to the CPG-2’-O-propargylated nucleic acid material (0.12 µmol).  
The mixture was agitated at rt for 24 hr, after which the excess starting material was 
washed away with DMSO (10 x 200 µL) and CH3CN (2 x 200 µL).  Deprotection/cleavage 
of the resin-bound oligonucleotides was followed by analysis and if necessary, 
purification by RP-HPLC. 
Compound Mass calculated Mass found 
82a 528.1490 [M + Na+] 528.1463 [M + Na+][a] 
84a 1113 1115 
86a 1436 1437 
90 1498 1501 
92 1721 1723 
93 2716 2714 
94a 2938 2937 
94b 2938 2936 
[a] LC/MS-ESI-TOF mass data 
Table 5.2.  Mass data for azobenzene- and alkyne-modified oligonucleotide conjugates  
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5.3.13 Photochemical characterisation of the azobenzene-oligonucleotide conjugates 
94a and 94b 
5.3.13.i Photo-switching of azobenzene-oligonucleotide conjugates 94a and 94b 
A medium pressure Hg-Arc lamp (100 W, Engelhard Hanovia of Canada Ltd.) was used 
to effect photo-isomerisation of the azobenzene moieties.  A band-pass filter was used 
for irradiation at 366 nm (4.13 W) and a cut-off filter was used for irradiation >400 nm 
(435 nm, 3.36 W) in combination with a water filter (1 cm) to prevent warming of the 
samples. 
 
5.3.13.ii UV analysis of E → Z photoswitching following irradiation at 366 nm 
UV spectra of solutions of the azobenzene-oligonucleotide conjugates 94a and 94b (15 
μM in Milli-Q H2O) were measured following irradiation at 366nm for 2, 4, 6, 8, 10 and 
600 seconds.  The appearance/disappearance of the λmax at ~325 nm was used to 
monitor the degree of isomerisation. 
5.3.13.iii Determination of the mole fraction of the cis-azobenzene appended 9-mers 
98aII and 98bII (χcis) in the photostationary state using RP-HPLC 
Solutions of the azobenzenze-oligonucleotides conjugates 94a and 94b (15 μM in Milli-
Q H2O) were analysed by RP-HPLC on a Hichrom C18 column following irradiation at 
366 nm for 10 min and at >400 nm for 2 min.  The  χcis values for 94a and 94b in both 
photostationary states were quantified from the relative peak areas of 94aI and 94aII, 
and 94bI and 94bII. 
 
5.3.14 Thermal stability studies of the cis-azobenzene appended 9-mers 98aII and 
98bII 
Following irradiation to the cis form at 366 nm for 10 min, UV spectra of the 
azobenzene-oligonucleotides conjugates 94a and 94b (10 μM in buffer: 10 mM pH 7.0 
NaxHxPO4, 100 mM NaCl, 0.5 mM EDTA) were measured at regular intervals up to a 
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period of 10 hr.  This procedure was carried out at the following temperatures; 60, 65, 
70, 75, 80, 85 °C.  The normalised absorbance values [(At-A0)/A∞-A0)] at 325 nm were 
plotted against time, and by curve-fitting using the GraphPad Prism 5 software 
package, the rate constants (k) at each temperature were obtained.  Arrhenius and 
Eyring plots were generated from these data, and from these plots a range of kinetic 
constants were obtained for the cis-trans isomerisation process of both 94a and 94b 
(see table 3.4, page 96) 
 
 
5.4 Conjugation to DNA/RNA by SPAAC 
 
5.4.1 Synthesis of the biotin and cholesterol azides 117 and 118 
5.4.1.i Synthesis of 2-azidoacetohydrazide (122) 
To a solution of ethyl 2-azidoacetate204 (2.0 g, 15.5 mmol) in EtOH (10 mL) was added 
hydrazine hydrate (1.3 mL, 25.3 mmol).  The mixture was allowed to stir at rt for 2 hr 
after which TLC analysis (DCM:MeOH, 9:1) indicated complete consumption of starting 
material. Following removal of the solvent under reduced pressure, the crude product 
was purified by flash column chromatography (DCM:MeOH, 9:1) to yield a colourless 
oil (1.6 g, 90 %). 
 
1H NMR δ 8.14 (br s, 1H, NHNH2), 4.06 (br s, 2H, NHNH2), 4.01 (s, 2H, CH2); 
13C NMR δ 
167.5 (C=O), 51.6 (CH2N3); HRMS (ESI) calcd for C2H5N5ONa 138.0386 [M + Na]
+, found 
138.0390.  
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5.4.1.ii Synthesis of N'-2-azidoacetyl biotin hydrazide (117) 
To a solution of the biotin-NHS ester 123215 (870 mg, 2.55 mmol) and 2-
azidoacetohydrazide 122 (352 mg, 3.06 mmol) in anhydrous DMF (20 mL) was added 
TEA (1.5 mL, 20.4 mmol).  The resulting mixture was stirred overnight at rt under an 
atmosphere of argon.  Following removal of particulate matter by filtration, the filtrate 
was evaporated to yield the crude product as a white solid, which was washed with 
DCM (5 x 10 mL) to yield pure product (745 mg, 86%). 
 
1H NMR (DMSO-d6) δ 10.05 (br s, 1H, NH), 9.86 (s, 1H, NH), 6.43 (s, 1H, NH), 6.36 (s, 1H, 
NH), 4.33-4.29 (m, 1H, Ha/b), 4.16-4.12 (m, 1H, Ha/b), 3.89 (s, 2H, CH2N3), 3.14-3.07 (m, 
1H, Hc/d/e), 2.86-2.80 (m, 1H, Hc/d/e), 2.60-2.56 (m, 1H, Hc/d/e), 2.14 (t, 2H, J = 7.2 Hz, 
CH2C=O), 1.64- 1.30 (m, 6H, 3 x CH2); 
13C NMR (DMSO-d6) δ 170.9 (C=O), 166.3 (C=O), 
162.7 (C=O), 61.0, 59.2, 55.4, 49.3, 39.7, 32.9, 28.0, 27.9, 25.0 (9 x alkyl C); HRMS (ESI) 
calcd for C12H20N7O3S 342.1343 [M + H]
+, found 342.1352. 
5.4.1.iii Synthesis of cholesteryl 2-(2-azidoacetyl)hydrazine carboxylate (118) 
To a solution of 2-azidoacetohydrazide (122) (0.62 g, 5.39 mmol), and TEA (620 µL) in 
DCM (50 mL) was added a solution of cholesterol chloroformate (124) (2.00 g, 4.45 
mmol) in DCM (100 mL).  The resulting mixture was stirred at rt overnight.  The solvent 
was removed under reduced pressure and the crude product was purified by flash 
column chromatography (hexane:EtOAc, 7:3) to yield a white solid (800 mg, 34%).  
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1H NMR δ 8.19 (s, 1H, NH), 6.75 (s, 1H, NH), 5.38 (d, 1H, J = 5.1 Hz, Hb), 4.62-4.51 (m, 
1H, Ha), 4.08 (s, 2H, CH2N3), 2.40-2.33 (m, 2H, alkyl H), 2.03-0.85 (m, 38H, alkyl H), 0.68 
(s, 3H, CH3); 
13C NMR δ 166.2 (C=O), 155.5 (C=O), 139.3 (C=CHb), 123.0 (C=CHb), 56.7, 
56.1, 51.5, 50.0, 42.3, 39.7, 39.5, 38.2, 36.9, 36.5, 36.2, 35.8, 31.9, 31.8, 28.2, 28.0, 
27.9, 24.3, 23.8, 22.8, 22.6, 21.0, 19.3, 18.7, 11.9 (25 x alkyl C); Anal. calcd for 
C30H49N5O3: C 68.27; H 9.36; N 13.27, Found: C 68.02; H 9.39; N 13.33. 
 
5.4.2 Synthesis of the fluorescein azide 119 
To a solution of 1-azido-4-bromobutane 216  (270 mg, 1.26 mmol) in anhydrous DMF (5 
mL) was added fluorescein methyl ester 125 217 (314 mg, 0.90 mmol) and potassium 
carbonate (170 mg, 1.23 mmol).  The mixture was heated to 70 oC under an argon 
atmosphere for 2 hr after which TLC analysis (DCM:MeOH, 9:1) indicated complete 
reaction. The mixture was diluted with EtOAc (20 mL) and washed with water (3 x 10 
mL).  The organic layer was dried over anhydrous MgSO4 and the solvent was removed 
under vacuum to yield an orange-brown solid.  This was washed with hexane (6 x 10 
mL) to remove the excess azide, thus yielding the product as an orange-brown solid 
which was used without further purification (276 mg, 69%). 
Methyl 2-(6-(4-azidobutoxy)-3-oxo-3H-xanthen-9-yl)benzoate (119) 
 
1H NMR δ 8.25 (d, 1H, J = 7.5 Hz), 7.77-7.65 (m, 2H, ArH), 7.31 (d, 1H, J = 7.2 Hz, ArH), 
6.95-6.83 (m, 3H, ArH), 6.73 (d, 1H, J = 8.7 Hz, ArH), 6.54 (d, 1H, J = 9.6 Hz, ArH), 6.45 
(s, 1H, ArH), 4.10 (t, 2H, J = 6.0 Hz, OCH2), 3.64 (s, 3H, COOCH3), 3.39 (t, 2H, J = 6.6 Hz, 
CH2N3) 1.98-1.73 (m, 4H, -CH2CH2-); 
13C NMR δ 185.5, 165.6, 163.3, 158.9, 154.2, 150.3, 
134.5, 132.7, 131.1, 130.5, 130.2, 130.2, 129.7, 129.7, 128.9, 117.4, 114.8, 113.6, 
105.6, 100.8 (4 x ArC, 3 x ArCO, 1 x ArC=O, 1 x COOCH3, 11 x ArCH), 68.1, 52.3, 51.03, 
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26.2, 25.6 (4 x CH2, 1 x COOCH3 ); HRMS (ESI) calcd for C25H22N3O5 444.1554 [M + H]
+, 
found 444.1574. 
 
5.4.3 General procedure for the synthesis of the T10-triazolyl conjugates 128a-d 
 
To solid supported T10-cyclooctyne 24 (0.2 μmol) in an eppendorf tube was added a 
solution of the azide in DMSO (20 µL of a 200 mM stock solution, 4.0 µmol, 20 
equivalents).  The final volume was adjusted to 30 µL with DMSO and water according 
to the solubility of the azide (table 5.3), and the mixture was agitated at rt.  After 
completion of reaction, the supernatant liquid was removed by syringe and the CPG 
was washed firstly with a suitable organic solvent (5 x 300 μL, see table 5.3) and then 
H2O (1 x 300 μL).  Deprotection/cleavage of the resin-bound oligonucleotides was 
followed by RP-HPLC analysis. 
R group Reaction solvent Work-up solvent Reaction Time Product 
Benzyl DMSO:H2O, 1:1 CH3CN 30 min 128a 
Cinnamyl DMSO:H2O, 1:1 CH3CN 30 min 128b 
Glucose DMSO CH3CN 240 min 128c 
Biotin DMSO:H2O, 9:1 DMSO 240 min 128d 
Table 5.3.  Reaction conditions and work-up procedures for the synthesis of the DNA-
conjugates 128a-d 
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R group Mass calculated Mass found Product 
Benzyl 3371 3371 128a 
Cinnamyl 3397 3395 128b 
Glucose 3443 3443 128c 
Biotin 3579 3579 128d 
Table 5.4.  Mass data for the cleaved DNA-conjugates 128a-d 
 
5.4.4 Synthesis of the mixed 12-mer DNA-triazolyl conjugates 131a-f 
 
5.4.4.i General procedure for the synthesis of the mixed 12-mer DNA-triazolyl 
conjugates 131a-c 
To the solid supported DNA-cyclooctyne 112 (0.14 μmol) in an eppendorf tube was 
added a solution of the azide (10 µL of a 280 mM stock solution in DMSO, 2.8 µmol, 20 
equivalents). The volume was adjusted to 20 µL with DMSO and water according to the 
solubility of the azide (table 5.5) and the reaction mixture was agitated at rt.  After 
completion of the reaction, the CPG was washed firstly with a suitable organic solvent 
(5 x 300 μL, see table 5.5) and then H2O (1 x 300 μL).  Deprotection/cleavage of the 
resin-bound oligonucleotides was followed analysis and if necessary, purification, by 
RP-HPLC. 
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5.4.4.ii Synthesis of the cholesterol-labelled DNA conjugate 131d 
To the solid supported DNA-cyclooctyne 112 (0.14 μmol) in an eppendorf tube was 
added a solution of the cholesterol azide 118 (20 µL of a 140 mM stock solution in 
CHCl3, 2.8 µmol, 20 equivalents).  The reaction mixture was agitated at rt overnight.  
The CPG was then washed firstly with CHCl3 (5 x 300 μL) and then H2O (1 x 300 μL).  
Deprotection/cleavage of the resin-bound oligonucleotide was followed by RP-HPLC 
analysis and purification on a Phenomenex C8 column.  
5.4.4.iii Synthesis of the non-fluorescent DNA conjugate 131f 
To the solid supported DNA-cyclooctyne 112 (0.14 μmol) in an eppendorf tube was 
added a solution of the fluorescein azide 119 (10 µL of a 280 mM stock solution in 
CHCl3, 2.8 µmol, 20 equivalents).  The volume was adjusted to 20 µL with CHCl3 (table 
5.5) and the reaction mixture was agitated at rt overnight.  The CPG was then washed 
firstly with CHCl3 (5 x 300 μL) and then H2O (1 x 300 μL).  Deprotection/cleavage of the 
resin-bound oligonucleotide was followed by analysis and purification by RP-HPLC 
5.4.4.iv Synthesis of the fluorescent DNA conjugate 131e 
Following deprotection/cleavage of the CPG-DNA-cyclooctyne 112, a solution of the 
resulting DNA-cyclooctyne 113 (125 µL, 200 µM, 0.025 µmol) was evaporated to 
dryness.  To this was added a solution of the fluorescein azide 119 (4.5 µL of a 112 mM 
stock solution in DMSO, 1.0 µmol, 40 equivalents) and H2O (0.5 µL).  Following 
agitation overnight at rt, H2O (300 µL) and EtOAc (300 µL) were added and the 
aqueous layer was washed with EtOAc (10 x 300 µL) to remove the excess azide.  Any 
remaining EtOAc was removed under vacuum and the resulting aqueous solution was 
analysed and purified by RP-HPLC.  
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R group Reaction solvent Work-up solvent Reaction Time Product 
Benzyl DMSO:H2O 1:1 CH3CN 30 min 131a 
Cinnamyl DMSO:H2O 1:1 CH3CN 30 min 131b 
Biotin DMSO:H2O 9:1 DMSO 4 hr 131c 
Cholesterol CHCl3 CHCl3 24 hr 131d 
Fluorescein (ester) DMSO:H2O 9:1 EtOAc 18 hr 131e
[a] 
Fluorescein (lactone) CHCl3:H2O 9:1 CHCl3 18 hr 131f 
[a] This reaction was conducted in the solution phase 
Table 5.5.  Reaction conditions and work-up procedures for synthesis of the DNA conjugates 
131a-f 
R group Mass calculated Mass found Product 
Benzyl 3967 3969 131a 
Cinnamyl 3993 3996 131b 
Biotin 
Cholesterol 
4175 
4361 
4176 
436 
131c 
131d 
Fluorescein (ester) 4277 4277 131e 
Fluorescein (lactone) 4262 4262 131f 
Table 5.6.  Mass data for the DNA-conjugates 131a-f 
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5.4.5 General procedure for the synthesis of the U4-triazolyl conjugates 136a-c 
 
To the solid supported U4-cyclooctyne 134 (0.1 μmol) in an eppendorf tube was added 
a solution of the azide (40 µL of a 250 mM stock solution in DMSO, 10 µmol, 100 
equivalents) and H2O (10 µL).  The reaction mixture was agitated at rt for 2 hr.  The 
CPG was then washed firstly with DMSO (5 x 300 μL, see table 4.3) and then H2O (1 x 
300 μL).  Deprotection/cleavage of the resin-bound oligonucleotides was followed by 
RP-HPLC analysis. 
 
5.4.6 Synthesis of the 2’-OMe RNA-triazolyl conjugates 141a-e 
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5.4.6.i General procedure for the synthesis of the 2’-OMe RNA-triazolyl conjugates 
141a-c 
To the solid supported 2’-OMe RNA-cyclooctyne 138 (0.14 μmol) in an eppendorf tube 
was added a solution of the azide (10 µL of a 280 mM stock solution in DMSO, 2.8 
µmol, 20 equivalents).  The volume was adjusted to 20 µL with DMSO and water 
according to the solubility of the azide (table 5.7) and the reaction mixture was 
agitated at rt.  After completion of the reaction, the CPG was washed firstly with a 
suitable organic solvent (5 x 300 μL, see table 5.7) and then H2O (1 x 300 μL).  
Deprotection/cleavage of the resin-bound oligonucleotides was followed by RP-HPLC 
analysis and purification. 
 
5.4.6.ii Synthesis of the cholesterol-labelled 2’-OMe RNA conjugate 141d 
To the solid supported 2’OMe RNA-cyclooctyne 138 (0.14 μmol) in an eppendorf tube 
was added a solution of the cholesterol azide 118 (20 µL of a 140 mM stock solution in 
CHCl3, 2.8 µmol, 20 equivalents).  The reaction mixture was agitated at rt overnight.  
The CPG was then washed firstly with CHCl3 (5 x 300 μL) and then H2O (1 x 300 μL).  
Cleavage/deprotection, analysis and purification by RP-HPLC on a Phenomenex C8 
column followed according to the procedures described above.  
 
5.4.4.iii Synthesis of the fluorescein-labelled 2’-OMe RNA conjugate 141e 
Following deprotection and cleavage of the CPG-RNA-cyclooctyne 138 from the resin, 
the resulting crude sample of the RNA-cyclooctyne 139 was purified by RP-HPLC.  The 
purified sample (125 µL, 200 µM, 0.025 µmol) was then evaporated to dryness.  To this 
was added a solution of the fluorescein azide 119 (4.5 µL of a 112 mM stock solution in 
DMSO, 1.0 µmol, 40 equivalents) and H2O (0.5 µL).  Following agitation overnight at rt, 
H2O (300 µL) and EtOAc (300 µL) were added and the aqueous layer was washed with 
EtOAc (10 x 300 µL) to remove the excess azide.  Any remaining EtOAc was removed 
under vacuum and the resulting aqueous solution was analysed by RP-HPLC. 
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R group Reaction solvent Work-up solvent Reaction Time Product 
Benzyl DMSO:H2O 1:1 CH3CN 30 min 141a 
Cinnamyl DMSO:H2O 1:1 CH3CN 30 min 141b 
Biotin DMSO:H2O 9:1 DMSO 4 hr 141c 
Cholesterol CHCl3 CHCl3 18 hr 141d 
Fluorescein (ester) DMSO:H2O 9:1 EtOAc 18 hr 141e
[a] 
[a] This reaction was conducted in solution phase 
Table 5.7.  Reaction conditions and work-up procedures for preparation of the 2’-OMe RNA 
conjugates 141a-e 
 
R group Mass calculated Mass found Product 
Benzyl 6624 6623 141a 
Cinnamyl 6650 6650 141b 
Biotin 
Cholesterol 
6831 
7018 
6833 
7020 
141c 
141d 
Fluorescein (ester) 6931 6934 141e 
Table 5.8.  MS data for the 2’-OMe RNA conjugates 141a-e 
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6.1 Detailed analysis of spectral data of a representative isoxazole 
cycloadduct 
In order to characterise the novel compounds prepared in this thesis, a range of NMR 
spectra were gathered; these included 1H (300 MHz), 13C (75 MHz), DEPT (45, 90, 135), 
homonuclear and heteronuclear COSY, and 31P (121 MHz).  For all compounds initially 
the 1H NMR spectra were examined, and resonance positions, multiplicity and relative 
integrations were recorded.  Peaks were assigned based on resonance position and 
multiplicity.  Homonuclear COSY data highlighted coupling between the protons and 
the 13C peaks were assigned with the help of DEPT (45, 90, 135) spectra and as 
necessary heteronuclear COSY spectra. 
 
NMR spectral data of 2-(4-(5-(phenoxymethyl)isoxazol-3-yl)phenoxy)ethanol (15c) 
 
Included below is the NMR data which was used to assign peaks and characterise the 
structure of the isoxazole cycloadduct 15c.  All spectra are recorded in CDCl3. 
  Appendix 
176 
 
 
Figure 6.1.  1H NMR spectrum of 15a 
 
 
Figure 6.2.  1H1H COSY NMR spectrum of 15a 
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Figure 6.3.  13C NMR spectrum of 15a 
 
Figure 6.4.  DEPT135 NMR spectrum of 15a 
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Figure 6.5.  1H13C  COSY NMR spectrum of 15a 
The use of relative integrations and coupling constants in the 1H NMR spectrum (figure 
6.1) and a range of additional NMR spectra were used to assign the peaks.  In the 1H 
NMR spectrum, the aromatic peaks are located between 6.98 and 7.76 ppm.  The 
isoxazole proton (H5) presents as a singlet at 6.60 ppm.  This chemical shift is typical of 
that observed for all 3,5-disubstituted isoxazoles prepared in this thesis.  The next 
signal, integrating for two protons, represents the methylene protons H6.  Assignment 
of the protons H5 and H6 is confirmed by analysis of the 1H1H COSY spectrum (figure 
6.2), which shows coupling between these protons.  This 4J coupling is perhaps 
surprising, although closer inspection of the 1H NMR spectrum confirms slight 
broadening of the two signals in question. 
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The two signals at 4.14 and 3.99 ppm, each integrating for two protons, clearly 
represent the two sets of methylene protons H1 and H2.  The final peak, a broad singlet 
at 2.04 ppm, is that of the OH proton. Assignment of the protons H1 and H2 is aided by 
analysis of the 1H1H COSY spectrum, which shows coupling between the signal at 3.99 
ppm and the OH signal at 2.04 ppm.  Therefore, the signal at 3.99 ppm must be that of 
the H1 protons.  The only coupling observed for the protons at 4.14 ppm is between 
those at 3.99 ppm; the peak at 4.14 ppm must therefore represent the H2 protons. 
The aromatic region of the 1H NMR spectrum contains three discrete signals: a doublet 
at 7.75 ppm integrating for 2 protons, a triplet at 7.32 ppm integrating for 2 protons 
and a multiplet at 7.04-6.98 ppm integrating for 5 protons.  Assignment of the 
aromatic protons requires consideration of the possible resonance structures of this 
molecule (figure 6.6).  Each aromatic ring bears an electron donating alkoxy 
substitutuent.  The lone pair of the oxygen can delocalise into the aromatic ring, which 
results in resonance structures for each ring with a negative charge at the positions 
ortho and para to the electron donating group.  As the true structure is a weighted 
average of all the contributing resonance forms, the protons at the ortho and para  
positions will be shielded relative to those which are meta to the alkoxy group, and as 
such will appear further upfield.  This will affect the H3, H7 and H9 protons, which are 
all represented by the relatively upfield multiplet at 7.04-6.68 ppm.  The more 
downfield signals at 7.75 ppm and 7.32 ppm therefore represent the H4 and H8 
protons. 
 
Figure 6.6.  Selected resonance contributors for the cycloadduct 15c 
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The doublet at 7.75 ppm integrates for 2 protons and has a coupling constant of 8.7 
Hz, which suggests 3J coupling to one other aryl proton.  This doublet must therefore 
represent the H4 protons, which are coupled to the adjacent H3 protons.  By 
elimination, this means the triplet at 7.32 ppm must correspond to the H8 protons.  As 
these are coupled to both the H7 and H9 protons, this singal would be expected to 
present as a doublet of doublets.  However, due to overlappling of the two middle 
peaks of the signal, a triplet is observed.  Table 6.1 below lists the assignments of all 
signals in the 1H NMR spectrum of 15c. 
Entry Peak (ppm) Multiplicity 
Coupling 
Constant (Hz) 
Proton(s) 
1 7.75 d 8.4 H4 
2 7.32 t 7.5  H8 
3 7.04-6.98 m - H3,7,9 
4 6.59 sl br s - H5 
5 5.20 sl br s - H6 
6 4.14 t 4.4  H2 
7 3.99 t 4.4 H1 
8 2.03 br s - OH 
Table 6.1.  Assignment of signals in the 1H NMR spectrum of 15c 
The 13C NMR spectrum (figure 6.3) can be assigned with the help of DEPT135 (figure 
6.4) and CH correlation (figure 6.5) spectra.  A glance at the DEPT135 spectrum 
immediately reveals the idenitity of the CH2 signals at 69.3, 61.5 and 61.4.  Analysis of 
the CH correlation spectrum shows coupling between the carbon peak at 69.3 ppm 
and the H2 protons (entry 6, table 6.1), confirming that this peak represents Cb.  Due to 
the almost negligible difference in the chemical shift of the carbon atoms Ca and Cj 
(61.5 and 61.4 ppm), it is impossible to unambiguously assign these signals based on 
analysis of the CH correlation spectrum. 
The aromatic and isoxazole carbon atoms resonate in the range of 168.4-101.1 ppm.  
Those carbons bearing a proton can be assigned following analysis of the CH 
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correlation spectrum.  Coupling is observed between the peak at 101.1 ppm and the H5 
signal (entry 4, table 6.1); therefore this peak must represent Ch.  Coupling is also 
observed between the carbon peaks at 129.7 and 128.3 and the protons H4 (entry 1, 
table 6.1) and H8 (entry 2, table 6.1), respectively.  These peaks can therefore 
unambiguously be assigned as representing the carbons Ce (129.7 ppm) and Cm (128.3 
ppm).  The carbon signals at 121.9, 114.9 and 114.8 ppm are all coupled to protons 
within the multiplet at 7.04-6.98 ppm.  These signals therefore represent carbon atoms 
Cd, Cl, and Cn, although individual assignment is impossible, as the signals representing 
protons H3, H7 and H9 cannot themselves be distinguished. 
Finally, analysis of the DEPT135 spectrum reveals signals representing quaternary 
carbon atoms at 168.4, 162.1, 160.1, 157.8 and 121.7.  Of these signals, the peak at 
121.7 ppm can be definitively assigned as the carbon Cf.  This is logical, as it is the only 
quaternary carbon not directly bound to an electronegative atom, and is therefore less 
deshielded than the others.  The remaining quaternary signals can be assigned as Cc, 
Cg, Ci and Ck. 
 
1H NMR δ 7.75 (d, J = 8.4 Hz, 2H, H4), 7.32 (t, J = 7.5 Hz, 2H, H8), 7.04-6.98 (m, 5H, 
H3,7,9), 6.59 (sl br s, 1H, H5), 5.20 (sl br s, 2H, H6), 4.14 (t, J = 4.4 Hz, 2H, H2), 3.99 (t,  J = 
4.4 Hz, 2H, H1),  2.03 (br s, 1H, OH); 13C NMR δ 168.4, 162.1, 160.1, 157.8 (Cc,g,i,k), 129.7 
(Ce), 128.3 (Cm), 121.9 (Cd/l/n), 121.7 (Cf), 114.9 (Cd/l/n), 114.8 (Cd/l/n), 101.1 (Ch), 69.3 
(Cb), 61.5 (Ca/j), 61.4 (Ca/j). 
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6.2 Photochemical characterisation data for 94b  
Figure 6.7.  Overlaid UV/Vis spectra of 94b upon irradiation at 366 nm for 0, 2, 4, 6, 8 and 10 s 
 
 
Figure 6.8.  Overlaid HPLC traces of 94b in the Irr (blue) and DA (red) photostationary states 
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